Characterising mycobacterial persisters. by Hernandez, Johana E.
  
 
 
Characterising mycobacterial  
persisters  
 
 
 
By 
 
Johana E. Hernandez Toloza 
 
Submitted for the degree of Doctor of Philosophy 
 
 
 
Department of Microbial and Cellular sciences 
September 2018 
2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by Johana E. Hernandez Toloza 2018 
All rights reserved 
 
 
 
 
 
 
 
 
 
 
3 
 
 
 
Abstract 
 
 
Treatment of tuberculosis requires multiple drugs and takes 6-9 months. The lengthy treatment 
has been mainly attributed to the pre-existing population of bacteria that are tolerant to the 
antibiotics, but not genetically resistant, known as persisters. Persisters are a small fraction of 
the bacterial population that survive in the presence of the antibiotic. They can be detected by 
the presence of a bimodal time–kill curve that deviates from the simple decay expected from 
a uniform bacterial population. The generation of bacterial persisters from normal cells has 
been extensively studied in E. coli. Mechanisms of switching to persistence include activation 
of Toxin-Antitoxin (TA) genes and switching to slow growth. However, much less is known 
about mycobacteria persisters and the factors involved in generating persisters.  
The overall aim of this study was to characterise mycobacterial persisters in order to better 
understand the factors influencing their generation and how they survive exposure to 
antibiotics, with the long-term aim of stimulating new approaches to tuberculosis control. 
Growth parameters that are associated with persistence were identified by tracking individual 
cells of M. smegmatis and measuring parameters such as birth and division size and division 
time for individual cells. In this study, it was discovered that mycobacterial subpopulations 
utilise different growth control models to maintain their size homeostasis that depends on their 
birth size. Whilst smaller cells follow a timer model of cell division in which cells divide after a 
particular time from birth, longer cells were more compatible with an adder model in which 
cells add a fixed length before division. I was also found that growth parameters, such as birth 
and division length, were inherited from between mother to daughters.  
It was attempted to measure the relationship between persistence and growth rate by 
engineering strains of M. smegmatis whose growth rate could be controlled by adjusting the 
expression level of the essential gene leuD. The results allowed us to propose a laboratory 
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approach to select and quantify drug-tolerant M. smegmatis persisters in batch cultures using 
rifampicin (RIF) and streptomycin (STM).  
Finally, it was intended to identify genes that affected the persisters frequency in M. 
tuberculosis by transposon mutagenesis. A transposon mutant library of M. tuberculosis was 
exposed to antibiotics under conditions that selected for drug-tolerant persisters. Examination 
of genes affecting persister frequency to rifampicin were found to be completely different from 
those affecting persister frequency to streptomycin, indicating that different mechanisms are 
involved in persistence to these antibiotics. Genes identified after RIF selection were mainly 
associated with cell wall and cell processes and metabolism and respiration functions, 
whereas several toxin genes were identified after STM treatment. These results indicate that 
the mechanism behind persisters is drug-specific and highly coordinated. In addition, there 
was a marked redundant functionality within the identified genes.  
Overall, findings of this study have opened a new insight into mycobacterial persisters, and 
further investigation of the results presented in this project could contribute to advancement 
in the development of therapies to control this mycobacterial sub-population and reduce 
treatment length.  
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1. Introduction and aims 
 
 
1.1 Tuberculosis, general aspects and phenotypic heterogeneity  
 
Tuberculosis (TB) is an infectious bacterial disease caused by Mycobacterium tuberculosis 
(M. tuberculosis), which is transmitted from person to person via aerosol droplets from the 
throat and lungs of people with active respiratory disease. Inhaled infectious droplets lodge in 
the lung alveoli and bacilli are taken up there by macrophages. In most healthy people, 
infection with M. tuberculosis often causes no symptoms, since the person’s immune system, 
through innate and acquired immunity, acts to kill the bacteria. Acquired cell-mediated 
immunity develops two to eight weeks after infection, and granulomas (infiltrating 
macrophages and lymphocytes) wall off the infection and limit further replication and spread 
of the organism (Bloom BR, 2017) 
Infections of M. tuberculosis are often asymptomatic, chronic in a clinically symptomatic state 
and highly recalcitrant to antibiotics. Although molecular mechanisms underlying persistence 
of the pathogen against the host immune system and chemotherapy remain unclear. 
Persistence of M. tuberculosis against antibiotics in a non-replicative state has been inferred 
from the microscopic detection of acid-fast bacilli in culture-negative smears of drug-treated 
patients (Islam M. S., 2012). 
Three terms, latency, persistence, and dormancy, are commonly used in describing M. 
tuberculosis and tuberculosis pathogenesis. Latency means the presence of any tuberculous 
lesion which fails to produce symptoms of its presence, and it can be achieved through either 
the early restriction of M. tuberculosis growth in the lungs prior to the onset of tuberculosis 
disease, or the spontaneous resolution of primary tuberculosis (J., 2004).  Most people 
exposed to M. tuberculosis mount a vigorous cell-mediated immune response that arrests the 
progress of the infection, largely limiting it to the initial site of invasion in the lung parenchyma 
and the local draining lymph nodes (the so-called ‘‘Ghon complex’’). The complete elimination 
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of the pathogen, however, is slow and difficult to achieve. Without antibiotic treatment, chronic 
or latent infection is thought to be the typical outcome of TB infection. Latent tuberculosis can 
reactivate after years or even decades of subclinical persistence, leading to progressive 
disease and active transmission of the pathogen (J., 2004). 
 
Dormancy has been used to describe both tuberculosis disease as well as the metabolic state 
of the tubercle bacillus. Tuberculosis lesions are described as active or dormant, based on 
whether the associated pathology is progressing or healing, respectively. Active lesions 
generally contain easily detectable populations of acid-fast, culturable M. tuberculosis the 
precise bacteriological status of dormant lesions remains unclear despite nearly a century of 
study and debate (J., 2004).  
Persistence means continuing steadfastly, especially in the face of adversity.  As a pathogen, 
M. tuberculosis manifests its unusual capacity to persist in many ways. On the cellular level, 
mycobacteria reside within macrophages, cells that typically function to eliminate pathogens 
and other foreign material from the body. At a more systemic level, M. tuberculosis can avoid 
elimination from the human host despite the development of vigorous cell-mediated immunity. 
Another important manifestation of M. tuberculosis persistence is the slow rate at which this 
bacterium is cleared by anti-tuberculous drugs (J., 2004).  
 
Despite 90 years of vaccination and 60 years of chemotherapy, tuberculosis (TB) remains the 
world’s leading cause of death from an infectious agent, exceeding human immunodeficiency 
virus/acquired immune deficiency syndrome (HIV/AIDS) for the first time (Bloom BR, 2017).  
In 2016, the TB incidence was 10.4 million people with an estimation of 1.3 million TB deaths 
among HIV negative cases and 374 000 deaths among HIV-positive people. Several factors 
drive the persistence and fatality of the disease. First, case detection has been deficient: in 
2014, only about 64 percent of people who developed TB were notified as newly diagnosed 
cases, leaving approximately 3 million to 4 million cases that either were not diagnosed or 
were diagnosed but not reported to national TB programs (WHO, 2017) 
18 
 
 
Second, the emergence of highly drug-resistant tuberculosis, including MDR TB (resistance 
to at least isoniazid and rifampicin) and XDR TB (MDR plus resistance to at least one 
fluoroquinolone and one injectable antitubercular antibiotic), has proved a serious hurdle for 
effective control of tuberculosis in many settings. The most recent estimates of the burden of 
MDR TB suggest that approximately 480,000 new cases of MDR TB occur each year, of which 
only 20 percent are enrolled in treatment (Geneva, 2017). 
Third, the ability of the tubercle bacilli to persist in the human host and to cause latent life-long 
infections which can reactivate after years or even decades, leading to progressive disease 
and active transmission of the pathogen (Gomez J., 2014). (J., 2004).  It is estimated that one-third of 
the world’s population is infected with M. tuberculosis with an estimated lifetime risk of TB 
reactivation of 5–10%, with the majority developing the disease within the first five years after 
initial infection (WHO, 2015). 
 
Achieving a long-term cure for TB infection requires a lengthy and complex drug regime 
(Gomez J., 2014,(J., 2004, Davies G. R., 2006).  A new patient with pulmonary TB, presumed or known 
to have drug-susceptible TB should receive a regimen of 2 months of treatment with a 
combination of four antituberculosis drugs, rifampicin (RIF), isoniazid (INH), pyrazinamide 
(PZA), and ethambutol (EMB), followed by at least 4 months of continuing therapy with RIF 
and INH. In all cases the treatment should be directly observed therapy (DOT) to reduce the 
patient non-compliance which can cause therapeutic failures and increase the genetic 
resistance rates (WHO, 2015). 
 
Explanations for this lengthy treatment include  the ability of M. tuberculosis to transform into 
several phenotypes ranging from non-culturable organisms and lazy persisters to rapidly 
dividing bacteria and a cord-forming, biofilm creating phenotype (Gomez J., 2014).(J., 2004). .  Whereas, 
the active replicators are efficiently and quickly killed during the first days to few weeks of 
therapy, the non-replicating persisters requires at least six months of treatment to their 
eradication (Zumla A., 2013).  
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Likewise, heterogeneity of mycobacterial population has been observed in clinical settings. 
Hence, the existence of at least two bacillary subpopulations has been found by examining 
serial sputum samples from patients with pulmonary tuberculosis who received STM and INH 
and either thioacetazone (SHT) or RIF and pyrazinamide (SHRZ).  The bacterial populations 
are eliminated at different rates, “fast” and “slow”, and eradication is different to each treatment 
regimen. While 7.5 and 13.2 days are required to eliminate the fast population under SHT or 
SHRZ regimens respectively, longer times are required to eliminate the slow population, 74.3 
days for SHT regimen and 56.2 days for SHRZ. Overall, results suggested that the elimination 
of the “slow” component is a key point to achieve treatment success (Davies G. R., 2006). 
 
Phenotypic heterogeneity of mycobacteria was also confirmed by Jindani A., et al. (Jindani A., 
2003) whom demonstrated that there are two distinct phases in the bactericidal activity of anti-
tuberculosis drugs by counting colony-forming units of M. tuberculosis in sputum at 2-day 
intervals in 100 patients treated with 22 regimens of INH, RIF, PZA, EMB, or STH, given alone 
or in combinations. The exponential fall in colony-forming units was measured by linear 
regression coefficients of the log counts during the initial 2-day phase of rapid, drug-
determined killing and during the subsequent 12 days of much slower sterilizing activity. In the 
first phase, lasting about 2 days the bacterial population is faster and exponentially killed and 
the speed is determined by drug action. In the second phase, the persistent bacilli are killed 
in a process of slow sterilization in which speed is determined by bacterial factors, (Figure1.1). 
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Figure 1.1 Colony-forming unit counts of M. tuberculosis in sputum during treatment  
Group 1 (H only), Group 2 (R only), Group 3 (HR), or Group 4 (other drugs). H (isoniazid), R (rifampicin). 
The SDs within patients, suitable for assessing linearity, are 0.492 for Group 1, 0.467 for Group 2, 0.558 
for Group 3, and 0.423 for Group 4. Taken from Jindani A. et al., (Jindani A., 2003). 
 
In addition, phenotypic variability has been observed in vitro by the development of a ‘non-
culturable’ state in which cells remain viable but non-culturable (VBNC) and shown to be 
antibiotic tolerant. The mechanism whereby cells lose their ability to grow (either on solid or in 
liquid media) under conditions that are demonstrably adequate for the growth of normal cells 
has been explained by two different models. First, loss of cultivability is due to bacterial 
senescence and cell deterioration and therefore that transition to the non-culturable state is 
stochastic in nature. The other suggests that the formation of NC cells reflects an adaptive 
strategy of cell survival and therefore that it should be considered as genetically ‘programmed’ 
and deterministic.  If “persisters” and “viable but non culturable” cells are same phenotype 
remains unknown  
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Phenotypic heterogeneity between individual bacteria in clonal populations is always present, 
to varying degrees, and can be quantified for almost any phenotype that can be scored at the 
single-cell level. Cell-to-cell variation is masked by traditional batch culture experimental 
approaches in which calculating the mean value of a trait in a population would be the same 
for each of the very different cell subpopulations. This illustration gives an solid argument for 
the necessity of single-cell studies to reveal the underlying population structure responsible 
for average cellular behaviour (Dhar N., 2007). (D., 2007). 
 
Microfluidics techniques have allowed single-cell examination of mycobacterial population to 
improve the understanding of its phenotypic heterogeneity.  So far, results suggested that 
mycobacterial cells divide asymmetrically, while one daughter inherits the growth pole (old 
pole) her sister must assemble a new growth pole. Therefore, a heterogeneous mycobacterial 
population with different elongation rates and sizes are produced and more importantly those 
cells have variable susceptibility to different classes of antibiotics (Singh B., 2013, Aldridge B., 
2012). 
 
Due to the suggested spectrum responses in mycobacteria at single-cell level to drug 
treatment examining the phenotypic subpopulations is essential to design drug therapies. 
Therefore, it is supremely important to understand how mycobacteria grow, and how it could 
be related to antibiotic susceptibility.  
So far, three models to cell size-control have been proposed, the “sizer,” “timer,” and “adder. 
In a perfect sizer model, the cell is permanently controlling its size and activates the cell cycle 
once it reaches a critical size. On the other hand, the timer model proposes that the cell tries 
to grow for a determined amount of time before dividing. Finally, the adder model is a model 
in which cells incorporate a constant volume each generation, irrespective of their size at birth 
(Aldridge B., 2012, Taheri-Araghi S., 2015).   
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Investigators have examined bacterial growth parameter under the these three models, and 
for E. coli and B. subtilis it was indicated that cells add a constant volume each generation 
irrespective of their new-born sizes which is consistent with the adder model assumptions  
(Taheri-Araghi S., 2015).  The mechanism used by mycobacteria remains controversial. 
Aldridge et al., (Aldridge B., 2012) examined the mycobacteria growth by tracking single M. 
smegmatis cells cultured in a microfluidic chamber. Results revealed no correlation between 
birth and elongation size of individual cells (regression line slope of 0.0) suggesting that M. 
smegmatis use timer model to maintain size homeostasis.  
In the other hand, a recent study in which single M. smegmatis cells were examined indicated 
that mycobacterial cell adds a constant volume before dividing regardless its birth size 
(regression line slope of 1) which is compatible with adder model (Priestman M., 2017).  
 
Investigators have found in M. smegmatis an attractive model organism to study mycobacterial 
heterogeneity for several reasons. The major advantage is its fast growth rate, the generation 
time of M. smegmatis is only 2–3 h, as compared to that of M. tuberculosis, which is 24 h. 
Thus M. smegmatis will yield colonies on nutrient agar plates in 2–4 days compared to 3–4 
weeks for M. tuberculosis. Unlike M. tuberculosis, M. smegmatis is non-pathogenic and thus 
can be safely used in standard laboratory conditions. M. smegmatis, mc2155 is the most 
commonly used laboratory strain can be easily transformed with foreign DNA, undergoes 
homologous recombination and is useful for expressing genes of M. tuberculosis making it a 
patent tool for mycobacteria research. Furthermore, mutations in the genes of M. smegmatis 
can be readily complemented with genes from M. tuberculosis, thus proving mc2155 to be a 
valuable surrogate host (Gupta S., 2008). (D., 2008) 
 
1.2 Defining bacterial persisters 
 
One of the most serious issues for global public health is the increasing failure of antibiotic 
treatment (WHO, 2014) which in most cases is attributed to bacterial genetic resistance, 
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however there are less obvious explanations for antibiotics to fail. One reason is that bacteria 
can escape the lethal action of antibiotics by entering a physiological state in which the 
antibiotics do not kill them (Maisonneuve E, 2014). (K., 2014). 
 
In 1942, Gladys Hobby discovered that the killing of haemolytic Streptococci at a given 
concentration of penicillin caused the destruction of approximately 99% of the organisms 
originally present while 1% remained viable (Hobby G., 1942).  Two years later, Joseph Bigger 
noticed that penicillin could not sterilize a Staphylococcal culture completely, and termed this 
surviving bacterial population ‘persisters’ (Bigger,1944).      (J., 1944). 
 
Recently, Zhang Y.  proposed a new definition of persister, “persisters refer to genetically drug 
susceptible quiescent (non-growing or slow growing) organisms that survive exposure to a 
given cidal antibiotic or drug and have the capacity to revive (regrow or resuscitate and grow) 
under highly specific conditions (upon extended incubation in liquid medium or changing 
medium composition or addition of resuscitation factors)” (Zhang Y., 2014).  (Y., 2014). 
 
In general, when an isogenic culture of bacteria is treated with a bactericidal antibiotic, the 
majority of the population is killed rapidly, with log-linear kinetics. Following this initial period, 
the rate of cell death slows markedly.  However, a small fraction of cells of between 0.001% 
to 0.1% persists for a much longer period under the presence of antibiotic, despite the 
population being clonal (Keren I., 2004b, Helaine S., 2014, Shi and Zhang, 2010). The slower rate of 
killing of this persistent subpopulation is non- heritable: when persistent bacterial cells are 
isolated, regrown and re-exposed to same antibiotic, same heterogeneous response to the 
drug will be observed as in the original population (Bigger J.,1944).(J., 1944)Overall, the 
heterogeneous response of persistent and non-persistent cells to the antibiotic is revealed by 
a biphasic time-kill (Maisonneuve E., 2014), (K., 2014), details showed in (Figure 1.2). 
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Figure 1.2  Killing kinetics during treatment with a bactericidal antibiotic  
Lethal dose of a bactericidal antibiotic is added at time zero to a growing population of bacteria. The 
experiment reveals a characteristic biphasic killing curve. (2) The slope of the initial phase reveals the 
susceptibility of the bulk of the population. The initial log-linear relationship reveals an exponential killing 
kinetics (green line). (3) The slope of the second inactivation phase (red line) reveals the existence of 
a persister subpopulation.  Killing kinetics for a high persister mutant (hip) strain is also shown (dark 
dashed line). After removal of the antibiotic (pointed by the arrow flanking the right panels), persister 
cells resume growth and give rise to progeny cells that are genetically identical to the cells of the original 
population and, therefore, as drug-sensitive as the original cells. The grey dashed line indicates how a 
drug-resistant mutant strain would support growth under these conditions. Adapted from Maisonneuve 
E. et al., 2014 (Maisonneuve E., 2014).). (K., 2014). 
 
In contrast to bacterial  resistance which has the inherited ability to grow at high concentrations 
of an antibiotic, irrespective of the duration of treatment, and is quantified by the minimum 
inhibitory concentration (MIC), persister cells survive transient exposure to high 
concentrations of an antibiotic without a change in the MIC  (Brauner A., 2016).  Moreover, 
reversible adoption of a slowly growing or non-growing state was described in E. coli 
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persisters, and the identification of the switch responsible for persistence required singular 
experimental systems able to demonstrate cell population heterogeneity (Helaine S., 2014, (E., 2014, 
Balaban N. Q., 2004).  For instance, Balaban et al. (Balaban N. Q., 2004) studied the 
persistence of high persister (hip) mutants of E. coli at the level of single cells using a 
microfluidics platform. This technology allowed the researchers to record the growth of 
individual bacteria under normal conditions, to expose them to antibiotic, to identify unusual 
survivors, and to examine their history, all at a single cell level. Excitingly, results showed that 
E. coli persisters have a reduced growth rate compared with normal cells even before the 
antibiotic exposure. Additionally, those cells could spontaneously switch to fast growth and 
generate a sensitive population to the antibiotic (Balaban N. Q., 2004). 
 
Interestingly, two bacterial persisters types were identified, type I and type II. Type I constitute 
a pre-existing population of non-growing cells generated at stationary phase: characterised by 
a minor spontaneous switching rate from normal to persister during exponential growth. After 
inoculation into fresh media from stationary phase these cells switch back to growing cells. In 
contrast, Type II persisters grow and divide continuously but at slower time scale than non 
persisters. This persistence growth state is inherited for several generations and does not 
originate from passage through stationary phase (Balaban N. Q., 2004). 
 
In contrast, single-cell studies revealed that  M. smegmatis persisters are pre-existing slow or 
non-growing cells (Wakamato Y., 2013).(Yuichi Wakamoto and  François Signorino-Gelo , 2 013)Wakamoto et al., showed that M. smegmatis cells 
continue to divide under isoniazid (INH) presence. In addition, results suggested no 
differences between pre-INH elongation rates among persisters and non-persistent cells, 
therefore there is no correlation between single-cell growth rates and the cell fates in  M. 
smegmatis stressed with INH (Wakamato Y., 2013).(Yuichi Wakamoto  a nd  Fran çois Signorino-Gelo,  2 013) . Moreover, it was proposed that the 
persistence phase in M. smegmatis treated with INH is a dynamic state in which the rates of 
cell division and death are balanced (Wakamato Y., 2013).   (Yuichi Wakamoto and Fr ançois Signorino-Gel o, 2013). 
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1.3 Toxin-antitoxin based persistence 
 
Persistence has remained a long recognized but poorly understood phenomenon, however 
important contributions have been made.  For instance, Moyed et al. (Moyed HS, 1983) 
overcame the limitation of the small number of persister cells by obtaining a Hip (high 
persistence) mutant strain  which produced a  larger fraction of up to 10-2 persisters compared 
to the wild-type. In order to achieve that, they performed a chemical mutagenesis-based 
screen on an E. coli K-12 strain using ethylmethanesulfate (EMS). In addition, the genetic 
analyses by conjugation and transduction methods revealed a responsible gene which they 
called hip (Moyed HS, 1983). Subsequently, studies by DNA sequence analysis and plasmid 
complementation showed that the hip locus contained two genes, hipA and hipB. hipA extends 
from nucleotides 603 to 1922 and encodes a 49,489 Da protein whilst hipB extends from 
nucleotides 337 to 600, encoding a 10,005Da protein, with the stop codon of hipB overlapping 
the first possible start codon of hipA by 1 bp (Black D., 1991).  In addition, mutant allele 
complementation studies revealed that a defect in or complete absence of hipB causes hipA 
toxicity, so hipA expression is linked to hipB and uncoordinated expression of the hip operon 
causes a relative excess of hipA that might be deleterious (Black D., 1991). 
Following these studies the Hip system was recognized as one of the toxin-antitoxin (TA) 
families which are broadly spread among bacteria but their role is largely unknown (Hayes F., 
2013). (F., 2013). Whereas, the toxin gene encodes a stable protein, the antitoxin is either a labile 
protein or an untranslated, antisense RNA species. The toxin is neutralized by inhibition of 
toxin translation when the antitoxin is an RNA (type I), or by avid binding of the partner antitoxin 
when the latter is a protein (type II). The toxins are extremely potent, and their overproduction 
leads to rapid and massive cell killing. The protein antitoxins neutralise their cognate toxins by 
forming tight complexes with them. The antitoxins are frequently found in greater 
concentrations than toxins and are degraded by the cellular proteases Lon and Clp whereas 
the toxins are usually stable (Gerdes K.,2000) (K., 2000), (Figure 1.3) 
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Figure 1.3. General genetic and functional setup of the TA loci. 
The antitoxins neutralize the toxins by forming tight complexes with them. The TA complexes bind to 
operators in the promoter regions and repress transcription (shown by broken arrow pointing to the 
promoter region). Cellular proteases (Lon or Clp) degrade the antitoxins, thereby leading to activation 
of the toxins in plasmid-free cells and perhaps during other, yet unknown, conditions. Modified from 
Gerdes K., 2000 (Gerdes K., 2000). (K., 2000). 
 
Bacterial chromosomes have multiple TA modules, and it has been observed that starvation 
induce several TA loci expression, however the reason for this apparent redundancy of genes 
is poorly understood (Christensen S., 2003).   
In the M. tuberculosis H37Rv genome, a total of 79 TA systems have been identified, (Figure 
1.4).  From which 67 belong to type II TA families: VapBC (50 systems), MazEF (10 systems), 
YefM/YoeB (1 system), RelBE (2 systems), HigBA (2 systems), and ParDE (2 systems); one 
triple type II TAC (Toxin-Antitoxin-Chaperone) system controlled by a SecB-like chaperone; 
three potentially type IV systems; and eight uncharacterised putative TA systems (Sala A., 
2014a). 
Several VapBC of M. tuberculosis have been found to be induced in response to relevant 
stress conditions encountered during the infection process including hypoxia (VapBC15, 
VapBC7, and VapBC25) and in IFN-γ-stimulated murine bone marrow-derived macrophages 
(VapBC11,VapBC3, and VapBC47) (Albrethsen J., 2013). Additionally, VapBC3, VapBC31, 
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and VapBC49 were shown to be among the TA systems most up-regulated in mycobacterial 
persisters (Keren I., 2011). 
 
Figure 1.4.  TA system in M. tuberculosis H37Rv chromosome. 
TA systems are noted according to the Tuberculist database except for VapBC45 (Rv2018-Rv2019), 
VapBC49 (Rv3181c-Rv3180c), VapBC50 (Rv3750c-Rv3749c), HigBA2 (Rv2022c-Rv2021c), HigBA3 
(Rv3182-Rv3183), YefM/YoeB (Rv3357-Rv3358), and MazEF10 (Rv0298-Rv0299). Most of the TA 
systems depicted here likely belong to type II, expect for those marked with an asterisk, which are 
putative type IV systems. For each system, the functionality in E. coli (Ec), M. smegmatis (Msm), and 
M. tuberculosis (Mtb), is depicted: red color stands for “inhibition of growth”, grey for “no inhibition of 
growth”, and white for “not tested”. The 10 most induced TA systems in persister cells are highlighted 
with a dark blue background. Taken from Sala A. et al., 2013 (Sala A., 2014b). 
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RelE proteins were involved in determining the fraction of M. tuberculosis drug-tolerant 
persisters in vitro and these persisters were specific to the drug as well to RelE isoform.  
Therefore, relE1 expression was 3-fold induced by RIF, relE2 11, 4, and 2.5-fold by RIF, 
gentamicin (GM) and levofloxaxin (levo), respectively, and relE3 was induced 3, 5 and 2-fold, 
by RIF, GM and levo, respectively (Singh R., 2010). Surprisingly, all three toxins were 
upregulated during in vivo growth within mouse lungs, but all three toxins individually were 
dispensable for replication and chronic persistence in mouse tissues. Furthermore, knockout 
mutants of mazF (mazF6, mazF1 and mazF5) were not compromised to growth or persistence 
in lungs of infected mice (Singh R., 2010). 
 
1.4 Deciphering the mechanisms responsible for mycobacterial 
persisters 
 
Despite the important impact of persisters in recalcitrant infections such as TB, there is a 
scarcity of knowledge about these cells in M. tuberculosis (Keren I., 2011), and one of the 
main reasons for that is the lack of suitable tools to identify, isolate and characterise these tiny 
bacterial sub-populations (Mouton J., 2016). Future studies that improve the understanding of 
the physiological state of mycobacterial persisters and their role in active TB is extremely 
important to TB treatment and prevention. 
 
Studies of the dynamics of mycobacterial persister formation suggests that growth rate alone 
cannot explain the dynamics of persister formation and that other factors must be involved 
(Keren I., 2011). Cultures of M. tuberculosis exposed to STM, ciprofloxacin or D-cycloserine 
showed a low level of persisters at early exponential phases, followed by a sharp increase in 
mid-exponential phase and then levelling off in stationary phase. This suggests that persister 
population growth rate is not directly proportional to general population growth rate. So, at the 
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beginning, the growth rates are similar, then, in early stationary phase the persister cells 
continue increasing while the general population stops growing (Keren I., 2011). 
 
Furthermore, bactericidal drugs such as quinolones, aminoglycosides and β-lactams utilise a 
common mechanism of killing whereby they stimulate the production of lethal doses of 
hydroxyl radicals (Grant S. S., 2012).  Recently, a model which examines factors important for 
the formation and survival of the persister population in both M. tuberculosis and M. smegmatis 
suggested that this sub-population differs from the larger population in its ability to withstand 
hydroxyl radicals generated by antibiotic challenge. Moreover, in an environment where 
dissolved oxygen saturation is high, the smaller persister subpopulation rapidly dies and can 
no longer be identified (Grant S. S., 2012).  
 
Excitingly, the transcriptome of the M. tuberculosis persister cell was obtained (Keren I., 2011). 
Cells in exponential phase were challenged with 100 µg/mL D-cycloserine (DSC). The RNA 
extracted at different times were amplified and examined by the Affymetrix array. In addition, 
bias in gene expression because of antibiotic addition was examined by a hierarchical 
clustering analysis. Results indicated that 282 and 68 genes were upregulated >2- and >4-
fold, respectively in persister cells (14 days) relative to cell before antibiotic exposure (0 time). 
In contrast, a massive number of genes were down-regulated; 1,408 and 628 genes >2- and 
>4-fold respectively. Genes encoding conserved hypothetical proteins, conserved membrane 
proteins, universal stress protein (UspA), the alternative stationary-phase sigma factor sigma 
F and its cognate anti-sigma factor RsbW and the error-prone DNA polymerase dnaE2 were 
found. Also of interest was the massive down-regulation of growth and energy metabolism 
genes that were compatible with dormancy, therefore it could support the close link between 
persister phenotype and dormancy (Keren I., 2011). 
 
More recently, Rego et al., (Rego E.H., 2017) identified mmpS3lamA (form loss of asymmetry 
mutant A) using a fluorescent reporter and a FACS-based transposon screen to determine the 
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mechanism underlying the variability in calcein staining (calcein accumulation predicts 
susceptibility to RIF on a single-cell level). Results showed that deletion of lamA decreases 
the amount of heterogeneity in the population by decreasing asymmetric polar growth.  lamA 
is a member of the mycobacterial division complex (divisome) which inhibits cell wall synthesis 
at the new pole during the switch between division and elongation. In addition, cells that lacked 
lamA were killed more uniformly and more rapidly with rifampicin and vancomycin which 
targets the cell wall. Thus, it was demonstrated that if cells have decreased size and growth 
rate heterogeneity, they should be killed at a more uniform rate. 
 
Overall, while there have been tremendous advances to understanding the mechanisms 
behind mycobacterial drug tolerant persisters, many key questions remain unanswered, i.e., 
are there genes “essential” to be a mycobacterial persister? What is the specificity of genes 
involved in persistence? Which biological functions are linked to persisters’ genes? 
 
Currently, an attractive approach to identify the essentiality of genomic features in bacteria is 
transposon sequencing (Tn-seq) (De Jesus M. A., 2017a). In this technique, functions of genes 
are probed through construction of complex random transposon insertion libraries and 
quantification of each mutant’s abundance, in relation to the condition tested is determined 
using next-generation sequencing (Opijnen T., 2009).  In addition, the mutant's fitness in 
several growth conditions can be tested by growing the insertion mutants library under 
selective conditions, so that mutants that are attenuated under a specific condition of interest 
are outcompeted and mutants with increased growth and survival become overrepresented in 
the population (Chao M. C., 2016). 
Tn-seq has allowed researchers to identify specific metabolic pathways required for M. 
tuberculosis to grow on cholesterol, a critical nutrient during infection (Griffin J. E., 2011), and 
for identifying genetic interactions (De Jesus M. A., 2017b). 
 
32 
 
 
1.5 Characterisation of persisters in in vivo models of infection 
 
Most of the research on persisters are based on in vitro experiments, and little is known about 
persister behaviour in vivo. However, studies of Salmonella typhimurium persisters during 
infection determined that the internalization of bacterial cells by macrophages induced the 
formation of non-replicating drug-tolerant persisters (Helaine S., 2014). Macrophages were 
noted to contain heterogeneous subpopulations of non-replicating Salmonella, including cells 
which were metabolically inactive (possibly dormant), metabolically active but which failed to 
regrow following their release from macrophages, cells competent for regrowth in culture 
medium, and cells competent for regrowth in naïve macrophages. In addition, single-deletion 
mutants for each of the 14 recognised class II TA modules in the Salmonella genome were 
analysed. The results suggested that after phagocytic uptake those TA modules are activated 
by acidification and/or nutrient starvation causing rapid formation of non-replicating persisters. 
Also, the Salmonella shpAB locus, which encodes a functional TA module, contributed to 
persister formation during infection of mice (Helaine S., 2014). 
 
In vivo studies of M. tuberculosis persistence have been done in INH-treated mice (J.D., 2010).  
Groups of C57BL/6 mice (n= 4) were infected intravenously with pools of M. tuberculosis 
mutants generated by signature-tagged transposon mutagenesis.  From 4 weeks onwards, 
half of the mice were treated with INH, their lungs were then harvested from both untreated 
and INH-treated mice at early therapy stage (6 weeks) or later stage (12 weeks), and the 
recovered signature tags were quantified. A total of 576 transposon mutants were screened. 
As a result, three distinct classes of mutants were identified: reduced, enhanced, or normal 
persistence. Most of the mutants showed normal representation in these pools.  Persistence-
reduced mutants were defined as underrepresented in INH-treated mice as compared with 
untreated mice and conversely with persistence-enhanced mutants. Interestingly, a 
persistence reduced mutant contained a transposon insertion in the cydCORF which is the 
last ORF in an annotated four-gene cluster (cydABDC). Moreover, the infection experiment 
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with the cydC::Tn mutant demonstrated that M. tuberculosis persistence in INH-treated mice 
was dependent on the putative ABC transporter encoded by cydDC. Also the mutation is INH-
specific, because both wild type bacteria and cydC::Tn were similar cleared in mice treated 
with RIF or PZA (J.D., 2010). 
 
As previously described for  E. coli hip mutant selection (Moyed HS, 1983), M. tuberculosis 
mc2 6020 was similarly chemically mutagenenized with ethyl methanesulfonate to obtain a 
high persistent mutant (Torrey H. L., 2016). The resultant mutants were grown until 
exponential phase and then treated with a combination of streptomycin and rifampicin and 
after the fourth round the representative mutants were characterised. It was determined that 
some strains produced 100 to 1000-fold more persisters which were multidrug tolerant and 
independent of antibiotic class concentration, growth phase and carbon source, i.e. hip strains. 
In addition, TA modules and carbon and amino acid metabolism genes were associated with 
mycobacterial hip mutants by transcriptome analysis, and genes that may be unique to M. 
tuberculosis persisters, such as lipid biosynthesis were found (Torrey H. L., 2016). Importantly 
in this study M. tuberculosis high persister strains were also obtained from tuberculosis 
patients (relapses or treatment failures). These strains showed 10-fold increase in the level of 
persister formation after treatment with kanamycin (125 μg/ml). Overall, high persister mutants 
selection occurs in clinical settings and is likely to be involved in the delayed killing of M. 
tuberculosis isolates from patients with relapse (Torrey H. L., 2016). 
 
In addition, the whole genome sequencing of  high persister isolates allowed the identification 
of some candidate persister genes, i.e., acyl-CoA dehydrogenase fadE30, a phosphate ABC 
transporter (Rv0072), isoleucyl- tRNA synthetase (Rv1536), and the TA tripartite module 
HigBA1 comprised of toxin-antitoxin-chaperone (TAC) was highly upregulated (Torrey H. L., 
2016).  
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1.6 Main aim 
 
Even though several topics have been explored in M. tuberculosis, little is known about 
persister cells able to survive transient exposure to high concentrations of antibiotics. Most 
stress responses involve reduction or even arrest of growth. Accordingly, growth variability 
has been shown to underlie many persistence phenomena, as reduced growth or growth 
arrest significantly diminishes the potency of most antibiotics (Balaban N. Q., 2011). (Q., 2011). While 
single-cell studies allowed to stablish that growth variability underlie persistence in E. coli 
(Balaban N. Q., 2004), there is no evidence that growth arrest triggers persistence in 
mycobacteria probably because it is still unclear how the general population of mycobacteria 
control its grow.   
Due to the low sensitivity of methods to detect the small fraction of persisters (Keren I., 2004a), 
and the suggestion that  slow growth is one of the mechanism responsible of bacterial 
persisters, an attractive alternative could be using strains that grow at different rate, if growth 
variability is a mechanism contributing to mycobacterial persisters it should be observed a 
higher level of this phenotype in slow growing strains. Also, increasing the fraction of persisters 
can facilitate their characterisation.    
Additionally, to growth reduction, other mechanism such as toxin-antitoxin modules have been 
recognized in E. coli and Salmonella persisters (Keren I., 2004b, Helaine S., 2014). If toxin-
antoxin is the mechanism underlying mycobacterial persistence or are there other mechanism 
requires future examination. Together these illustrations, and due to the central impact of 
persisters for TB treatment.  
This study was mainly aimed to improve the knowledge about mycobacterial persisters by 
investigating growth features which can contribute to persistence, characterising the dynamic 
of persister formation by antibiotic treatment, and identifying genes affecting the frequency of 
mycobacterial persisters. Overall, our results could contribute to clarify the effects of 
mycobacterial growth on persistence, as well to decipher possible mechanism (s) utilized by 
M. tuberculosis persisters to design new therapies to TB treatment. 
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1.7 Specific aims 
 
The project purposes are summarised below: 
 Chapter 3: To investigate the dynamics of growth and division in the M. smegmatis 
general population using single-cell analysis and time-lapse videos in the controlled 
environment of a microfluidics chamber to clarify which growth model used to maintain cell 
size homeostasis operates in mycobacteria. 
 Chapter 3: To establish if growth parameters are heritable within the mycobacterial 
population by correlation analysis between mother and daughter cells to gain a better 
understanding of the factors involved in persistence 
 Chapter 4: To establish an experimental model exposing batch cultures of M. 
smegmatis to RIF and STM in order to measure the level of persisters 
 Chapter 4: To investigate the relationship between persistence and growth rate by 
engineering strains of M. smegmatis with controlled growth rate by adjusting the expression 
level of the essential gene leuD 
 Chapter 5: To identify genes that modify the frequency of persisters in M. 
tuberculosis populations by screening a Himar1 transposon library in M. tuberculosis H37Rv 
with RIF or STM independently. 
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2. General materials and methods 
 
All standard protocols are described in this chapter. However, any modifications to specific 
protocols will be described within the respective chapters. 
 
2.1 Bacterial strains  
 
All strains were kept at -80°C as frozen stocks with 15% glycerol. 
M. smegmatis mc2 155 strain was cultured in the lysogeny broth (LB) with the addition of 
0.05% Tween 80 (Sigma-Aldrich), to prevent colony clumping during growth, and with aeration 
(shaking at 175 rpm) or alternatively on LB medium (Oxoid) with 1.2% agar  
M. smegmatis auxotrophic ΔleuD strain was cultured in the same media supplemented with 
100 µg/mL of L-Leucine (Sigma). 
E. coli strains were cultured in either LB broth with aeration (shaking at 225 rpm) or on LB 
plates at 37°C. 
M. tuberculosis H37Rv strain was cultured in Middlebrook 7H9 broth (Difco) supplemented 
with 10% Oleic acid albumin dextrose-catalase (OADC) enrichment (BD BBL™), 0.05% 
Tween 80 (Sigma Aldrich) and glycerol (Sigma Aldrich) (2 mL/L) at 37°C with aeration (shaking 
at 150 rpm) or with Middlebrook 7H11 (Difco) medium supplemented with 5% OADC and 
glycerol (2 mL/L) at 37°C.  
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2.2 M. smegmatis growth curves  
 
2.2.1 Inoculum culture preparation 
 
For the starter culture, M. smegmatis mc2155 was grown on LB solid media at 37°C for 48-72 
hours. Then, a single colony was inoculated in 10 ml of LB plus 0.05% Tween 80 for 48 h at 
37°C in an orbital shaker at 200 rpm until an OD600 of 1.0 was obtained. 
2.2.2 Flask inoculation  
 
A conical flask with 100 ml of LB plus 0.05% tween 80 was inoculated with the starter culture 
to a starting OD600 of 0.05. Incubation conditions were the same as used for starter culture 
preparation. In addition, the purity of the culture was tested by streaking for single colonies on 
a LB plate. 
2.2.3 Colony-forming units (CFU) determination 
 
Samples for CFU counts and OD readings from the culture were taken every 2 h, and the 
culture was maintained up to 3 days.  
The Miles and Misra method was used to determine the CFU (Miles A.A., 1938). Briefly, 1:10 
dilutions were prepared in microcentrifuge tubes with sterile PBS (phosphate-buffered saline) 
using dilutions ranging from 10-1 to 10 -7. 
LB plates were dried and divided in labelled sectors.  A total of three 20 µl were dropped on 
each quadrant of the plates. Plates were incubated at 37oC up to 5 days for the growth of the 
bacterium for enumeration.  The CFU was calculated using the formula below: 
 
CFU ml-1 = Dilution factor X plating factor X number of colonies 
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2.3 Determination of MIC using resazurin 
 
This method was used to determine the minimal inhibitory concentration (MIC) to M. 
smegmatis or M. tuberculosis exposed to RIF or STM. 
2.3.1 Inoculum preparation  
M. smegmatis or M. tuberculosis was grown on 7H9+ADC (OADC for M. tuberculosis) + 
0.05%. Tween and incubated at 37ºC for 2-3 days in the case of M. smegmatis and 1-2 weeks 
for M. tuberculosis. The OD600 of the culture was measured, and the culture was diluted to 
0.001 in the case of M. smegmatis and 0.01 for M. tuberculosis, in 5 mL of 7H9+ADC or OADC 
and 0.2% glycerol. 
 
2.3.2 Antibiotic solution preparation 
 
RIF suspension at 100 µg/ml was prepared, filter-sterilized and kept at -20°C, and STM 
suspension at 50 µg/ml was prepared, filter-sterilized and kept at -20°C. 
Antibiotic stocks were prepared and tested in the range showed in Table 2.1.  
 
 M. smegmatis M. tuberculosis 
Antibiotic Stock (mg/ml) [tested] µg/ml Stock (mg/ml) 
[tested] 
µg/ml 
STM 1 (or 8) in water 0.0625-2 1 (or 8) in water 0.0625-2 
RIF 2 in methanol 0.25-8 2 in methanol 0.0156-0.5 
 
Table 2.1 Stock solutions and range of antibiotic concentrations used to measure MIC 
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2.3.3 Setting up the MIC plate  
200 µl of sterile water were added to the outer perimeter wells of a 96-well plate to avoid 
dehydration of the experimental wells. Then, 100 µl of 7H9-OADC-glycerol was added to the 
experimental wells. 100 µl of the 4 times antibiotic solution was aseptically pipetted to wells 
B2-B10. Subsequent two-fold dilutions were done in the rest of wells, and 100 µl was 
discarded from wells G2-G10, therefore all the wells keep a final volume of 100 µl. Following 
this, 100 µl of inoculum were added to all the wells except well B11 in which 100 µl of medium 
were as the negative control.  C11-G11 were growth controls. Finally, plate was sealed and 
placed in a secondary container for further incubation at 37°C for 1 day in the case of M. 
smegmatis, and 7 days for M. tuberculosis. 
 
2.3.4 Determining the MIC of the plate 
30 µl of 0.01% resazurin were added to well C11 and incubated for 24 h. If the resazurin 
changed from blue to pink, resazurin was added to all the wells and incubated 24 h. If not, 30 
µl of 0.01% resazurin were added to well D11 and incubated for 24 h more. Pink colour was 
considered positive for growth, a lilac and purple colour was read as negative. The MIC was 
the lowest antibiotic concentration that inhibited the mycobacteria growth. 
 
2.4 Agarose gel extractions 
 
DNA fragments requiring a gel extraction were excised from the gel under UV light and 
cleaned up following the manufacturer’s guidelines using a QIAquick Gel Extraction Kit 
(Qiagen). Briefly, the excised band was weighed, and then 3 times the weight of buffer QC 
was added before incubating at 50°C for 10 min. The sample was then added to the spin 
column and spun for 1 minute at 13,000 rpm, the flow through was then discarded and 750 µl 
of buffer PE with ethanol was added before spinning again. The flow through was again 
discarded and the column spun again before placing the column in an Eppendorf tube and 
adding 30-50 µl of warm molecular grade water. The columns were kept for 3 minutes before 
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eluting the sample with a final spin. The samples were quantified using the Nanodrop 2000 
spectrophotometer (Thermo Scientific). 
 
2.5   DNA quantification 
DNA was quantified using the Nanodrop 2000 spectrophotometer (Thermo Scientific) with 1 
µl of sample. The concentration based on the absorbance at 260 nm, and purity based on the 
ratio of absorbance at 260 and 280 nm was assessed. An optimum ratio of ~1.8 suggested 
good quality DNA. 
 
2.6   Restriction enzyme digestions 
Digestions with restriction enzymes (NEB or Promega) were carried out according to the 
restriction enzyme requirements as in the manufacturer’s instructions, using appropriate 
buffers and serum albumen (BSA) (Promega) if required. Alkaline phosphatase (CIAP) 
(Promega) was used to prevent the re-circularisation of the vectors where applicable. In the 
case of double digestions, the NEB or Promega digestion calculators were used on-line to 
determine the optimal buffers for the double digest. Normally the digestions were incubated 
for 2 h at 37°C, unless otherwise stated in the instructions 
 
2.7   Primers 
All primers used in this study were provided by Eurofins genomics using High-Purity, Salt-Free 
(HPSF) purification.  Primers design criteria included a length of 18–30 nucleotides, melting 
temperature (Tm) of the primers between 65°C - 75°C, and within 5°C of each other, and GC 
content between 40 - 60%. For qPCR primers the IDT tool, PrimerQuest, was used. In all 
cases, the primer specificity was tested using the NCBI, Basic Local Alignment Search Tool 
(BLAST), https://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi?LINK_LOC=BlastHome.   
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Primer name Sequence 5’ to 3’ Explanation 
 
PL1    GGAACCAGCTATGAC   amplify PL5 promoter 
PL2    CATATGCGATCTCCC   amplify PL5 promoter 
SIGA_F   GAAGACACCGACCTGGAACT  amplify sigma factor  
SIGA_R   GACTCTTCCTTCGTCCCACAC amplify sigma factor 
GYRB_F   ATGACATCCGTGAGGGTTTG  amplify gyrase subunit B2 
GYRB_R   ATCTTCTGGACGAACGACTTG amplify gyrase subunit B2 
GYRB1_F   CAAGTCGTTCGTCCAGAAGAT amplify gyrase subunit 
B2GYRB1_R   GACGAGACCGCTTTGTTGA     amplify gyrase subunit B2 
DNAJ_F   CAAGAAGGCCTATCGGAAACT amplify Dna J   
DNAJ_R   CGTCATACTCCTTGCGCTTA  amplify Dna J 
DNAJ1_F   ACCATCAACGTGCGGATT  amplify Dna J  
DNAJ1_R   GTGCACGGTGACGTAGAG  amplify Dna J 
SMEG_LEU_F   GGAAGGTGATCGAGCAGAAT  amplify leuD gene. M. smeg 
SMEG_LEU_R   TTCAGGATTGATGACTACACCC amplify leuD gene. M. smeg 
PDO23A_1   GGCTGGATACGACGATTCCG  pDO23A plasmid verification 
PDO23A_2   GTTTTCCCAGTCACGACGTTG pDO23A plasmid verification 
PEN41A_1   CGCGTTAACGCTACCATGGAG pEN41A-T02 plasmid  
         verification   
PEN43_1   GCTAGTTAACTACGTCGACATCG pDE43-MCK plasmid  
         verification   
PEN43_2   CAGTCACGACGTTGTAAAACGACG pDE43-MCK plasmid  
         verification 
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PEN43_3   CCGACGAGAACAGGGGCCTG pDE43-MCK plasmid  
         verification   
PUV15_1   GCATGGATGTTTTCCCAGTCACG puv15 promoter verification 
PUV15_2   CCTGACATCAGCTGGATGGC  puv15 promoter verification 
PTB21_1   CACGACGTTGTAAAACGACG  ptb21 promoter verification 
PTB21_2   CCTTTTTGCGTTTAATACTG  ptb21 promoter verification 
SMEG_LEU_ATTB2  GGGGACAGCTTTCTTGTACAAAGTGG   BP reaction to  
    ATGGAGGCTTTCACCACTCACACCGGCATC Gateway cloning 
SEMG_LEU_ATTB3  GGGGACAACTTTGTATAATAAAGTTGTCA BP reaction 
    GGCCGGGAGAGTGGCGGTTTCCAGGCC Gateway cloning 
ptb21_F   GGAATATTGGATCGTCGCACCGGG   amplify ptb21  
ptb21_R   GGGGATCCGTGGCANGAGGGTC   amplify ptb21 
puv15_F   GGAGAAATATTGGATCGTCGGC   amplify puv15 
ptb21_R   GGCGGATCGTGCTCATTTCGGG   amplify puv15 
 
Table 2.2  Primers used in this study 
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3. Results chapter: deciphering how 
mycobacteria control their size 
 
 
3.1 Introduction and aims 
 
Measurement of the heterogeneous response to antibiotics observed in populations with 
persisters was only made possible with the development, in the past two decades, of single-
cell techniques. By tracking individual E. coli cells, microscopy images before exposure to the 
antibiotic could be stablished that the small number of bacterial cells that survived treatment 
with antibiotic were either slow growing (Balaban N. Q., 2004). 
Cell size is an important determinant of cellular physiology, and cell size control is the coupling 
between growth and division (Turner J. , 2012). Maintaining cell size implies that all cells must 
coordinate a continuous process such as cell growth with a discontinuous process of 
chromosome replication/segregation and cell division (Santi I., 2013). (Santi et al.,  2013)Moreover, to study 
bacterial heterogeneity is essential to establish the co-regulation of growth and division as well 
as to decipher how bacteria can connect their cell cycle without mistakes in the absence of 
eukaryotic-cell cycle check points to control their size and maintain homeostasis (Sandler O., 
2015) (Amir A., 2014).(A., 2014)Determining the cell size control mechanism requires accurate 
measurements of cell length over the cell cycle (Campos M., 2014) , and in the specific case 
of bacteria it is essential to measure single cell rather than population level using powerful 
technologies such as microfluidics (Amir A., 2014).(A., 2008) 
Three models have been proposed to answer the long-standing question, how bacterial cells 
maintain their size control?  Firstly, the sizer model which suggests that the cell is controlling 
its size and activates the cell cycle once it reaches a critical size (Donnan L., 1983).(PC., 1983).   Secondly, 
the timer model that proposes that the cell tries to grow for a determined length of time before 
dividing (Donnan L., 1983). (PC., 1983)Classically, the cell size-control was attributed to sizer or timer 
models as a mechanism to control their size (Taheri-Araghi S., 2015). Moreover, it was thought 
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that E. coli controlled their cell cycle using the sizer model (Balaban N. Q., 2004).  Recently 
the adder model in which cells aim to grow by a constant volume at each generation, 
irrespective of their size at birth (Taheri-Araghi S., 2015, Aldridge B., 2012).  
Since data of added size (size between birth and division) from bacteria to single-cell 
eukaryotes has been described by a linear line, the model of cell-size maintenance is typically 
stablished by plotting length at birth vs added length from individual cells.  As it is shown in 
(Figure 3.1), a slope = +1 corresponds to perfect timer, - 1 to perfect sizer, and 0 to perfect 
adder (S., 2015).  
 
 
  
 
 
 
 
 
Figure 3.1 Relationship between added length vs birth length can reveal the growth model 
A diagram presenting the relationship between added length vs. birth length.  Slope +1 corresponds to 
perfect timer model (grey line), -1 to perfect sizer model (blue line), and 0 to perfect adder model (red 
line).  Modified from Jun et al., (S., 2015). 
 
Single cell analysis of M. smegmatis have allowed to measure and to compare growth 
parameters such as birth length, division time, final length and elongation rate (Aldridge B., 
2012, Turner J. , 2012, Priestman M., 2017, S., 2015).  So far, single-cell examination of 
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mycobacterial growth has generated conflicting views on how mycobacteria control their size.  
In one study, it was showed that mycobacterial cells grow asymmetrically at each division 
resulting in two distinctive sister cells with variable elongation rates and sizes.  This 
asymmetric growth creates physiologically distinct subpopulations of cells that vary in their 
susceptibility to antibiotics. In addition, the measurement of the association between birth and 
elongation length revealed that small cells did not grow more than long cells before dividing,  
therefore it was proposed that mycobacterial growth is regulated by the timer model  rather 
that the sizer model (Aldridge B., 2012). 
Conversely, other investigators suggested that division is size-dependent and therefore 
mycobacteria maintain cell size using an alternative mechanism they called “sloppy” size- 
control, and growth heterogeneity did not affect sensitivity to killing by antibiotics (Santi I., 
2013). (Santi et  al ., 2013). 
Recently, it was indicated that mycobacteria follow the adder model of cell size control when 
a carbon source supplied by standard laboratory mediums such as glycerol was used as a 
carbon source. A lineal regression of measurements of cell length at birth and at division 
indicated that cells grow an average 3.5 µm per cell cycle, independent of birth size.  
Moreover, it was also suggested that carbon source  can affect cell size control, so cell size 
and interdivision time  were  altered between pyruvate and acetate compared with glycerol 
(Priestman M., 2017). 
In this chapter we mainly aimed to investigate the dynamics of growth and division in the M. 
smegmatis general population using single-cell analysis and time-lapse videos in the 
controlled environment of a microfluidics chamber.  Firstly,  growth parameters were compared 
following the method previously described (Jun S., 2015)(S., 2015)to clarify which growth model to 
maintain cell size homeostasis operates in mycobacteria. Then, we aimed to establish if 
growth parameters are inheritable within the mycobacterial population. The overall aim was to 
gain a better understanding of the factors involved in persistence.  
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3.2 Materials and methods  
 
3.2.1 Strains and culture media 
 
M. smegmatis mc2155 kindly provided by William Jacobs Jr., Yeshiva University, New York 
was used for all experiments. It was grown in LB broth with 0.05% Tween 80 at 37°C / 200 
rpm until it reached OD600 ~1.2-1.5.   
M. smegmatis wag31-GFP kindly provided by Prof John McKinney J., École Polytechnique 
Fédérale de Lausanne EPFL, Switzerland.  
Experiments in which M. smegmatis wag31-GFP was used were done in same culture medium 
and under identical growth conditions to mc2155.  
  
3.2.2 Single-cell growth using a microfluidics device 
 
The CellASIC ONIX Microfluidics Platform with the B04A Microfluidic Bacteria Plate (Millipore 
Corporation) was used to grow M. smegmatis for observation at the single level.  Bacterial 
culture was diluted 1:25 in LB broth added with 1 µg/ml Propidium iodine, (Sigma) to 
discriminate non-viable cells along the experiment.  After cells were filtered ten times through 
a 21G needle to reduce mycobacteria clumps they were loaded into the devices loading 
chamber. Three independent experiments were carried out.  
Media flow was controlled with a pump (CellASICs) at a flow rate of ~10 µl/h. Imaging was 
performed under a Nikon confocal microscope (Nikon A1M on Eclipse Ti-E) equipped with an 
environmental chamber set top 37oC, motorized stage and perfect focus system.   
Automated multi area imaging was carried out using a 40X air objective lens (Nikon Apo λ) 
with a numerical aperture of 0.95. The ‘perfect focus’ system locked the cells in the objective 
lens focal plane for the whole period of experiments with a resolution of ± 25 nm. The media 
used for growth experiments was LB added with 0.05% Tween 80 and 1 µg/ml Propidium 
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iodine. The experiment time was approximately 80 hours and the time loop had intervals of 15 
min.  
3.2.3 Time-lapse videos of mycobacterial growth:  manual analysis  
  
Nikon advanced microscope software was used to obtain single cell crops from larger time-
lapse videos. In addition, the NIS-Elements Viewer 4.20 was used to analyse division time of 
the cells in the microfluidic platform experiments. Data from division time were obtained by 
manual tracking, each cell was followed until division that was defined as the moment in which   
septum appeared. The division time was calculated as the product between experimental time 
and time-loop interval = 7 min (defined on the time-lapse experiment settings).  An 
approximate number of 50 crops representing an approximate number of 1000 cells was 
analysed each time, in three independent experiments  
3.2.4 Time-lapse videos of mycobacterial growth:  semi-automatic analysis  
 
From the manually analysed crops a random sample of 100 cells was taken for semi-automatic 
examination using MatLab.  Therefore, Dr Lilian Tang and Yin Hu from Computer Sciences, 
Faculty of Engineering & Physical Sciences, University of Surrey developed and implemented 
an algorithm which allow to track and analyse the cell growth patterns. The overall steps were 
as follows: (a) remove patterns caused by the microfluidics platform by subtracting an image 
of empty microfluidic device from the growth chamber of microfluidic device containing cells, 
(b) remove artefacts by using a Gaussian filter, (c) detect/segment cells in consecutive frames 
automatically by using level set algorithm 25 and check segmentation results manually, (d) 
extract properties of detected cells for next tracking step, such as major axis (length) and 
centroid position of cells, (e) given the information of detected cells in each image, track cell 
from one frame to the next to form the trajectories automatically by combining the Kalman filter  
and Hungarian method, and then check tracking results manually and (f) extract information 
based on segmentation and tracking results for data analysis, such as division time, length of 
cells and genealogy tree. 
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3.2.5  Statistical analysis 
  
The steady state was defined as the period for which the division time remained constant for 
a cell population represented by approximately 1000 cells. 
Graphs and statistical data analysis was performed with Excel Office 15 and GraphPad Prism 
7 software. Normality was examined by D’Agostino and Pearson test, 95% confidence. 
Relationship between birth length (L0) vs division time (T), final length (Lf) or added length (D) 
was evaluated thought a lineal regression and correlation analysis (S., 2015). 
Growth inheritance between mother and daughters was made by correlation using Pearson 
and or Spearman coefficients. To determinate if the correlation was significant the p-value was 
calculated using 0.05 as a significance level. A p value less than or equal to significance level 
allow to conclude that the correlation is different from 0 and a correlation of 0 indicates that is 
no linear relationship (Minitab expressTM support). 
 
3.3 Results  
 
 
3.3.1 Division time is variable within the mycobacterial population 
 
To assess division time variation, M. smegmatis cells growing in the microfluidics device were 
tracked from birth up to division.  Each cell was tracked through approximately 5 generations, 
and the steady state was established in the experimental period between 300 min and 1000 
min, (Figure 3.2). 
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Figure 3.2  Steady state for division time analysis of M. smegmatis using microfluidics and 
time-lapse videos  
Dispersion plot of division time. A total of 2486 cells were measured by tracking M. smegmatis growing 
in a microfluidics device in LB media. Each dot represents a different cell, colour was assigned by 
random in X axis in Y axis. The grey brackets = steady state growth. The analysis was repeated three 
times independently with similar results suggesting high reproducibility.  
 
Under our experimental conditions and using a manual method to measure the division time 
we determined an average division time of 151 min ± 37 min (mean ± standard deviation), this 
result was consistent across three independent experiments indicating high reproducibility in 
our analysis (Figure 3.3, Table 3.1).  Data normality was examined to define the appropriate 
statistics methods to further correlation, and results indicated that division time data were no 
normally distributed, then Spearman coefficient was selected. 
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C.  
 
Figure 3.3 A-C  Division time analysis of M. smegmatis by manual cell tracking  
Dispersion plots of three independent experiments in which M. smegmatis single-cells growing in a 
microfluidics device were followed since birth to division to calculate their division time.  In the graphs 
each point represents a different cell, and colour intensity was assigned by random. In X- axis the 
experimental time, and Y-axis the division time calculated as previously.  Experiment was repeated 
three times with similar results A to C. 
 
To measure inheritability of division time within the mycobacterial population we followed 
described methods (Aldridge B., 2012, Priestman M., 2017).  Cell were categorized into three 
main groups mother (M), daughter (D), and sister (S), (Figure 3.4), and correlation between 
their division time calculated.  Results showed a low negative correlation of - 0.2 between M 
and D; indicating that, if the mother grows slow then the daughter grows faster and vice versa. 
In contrast, we found a positive moderate correlation between S-S indicating that they divide 
at similar times, (Table 3.1).  So far, these results confirmed earlier findings in both E. coli and 
mycobacteria; there is a factor inherited by both sister cells at the birth time which determines 
the time for cell division, however this factor is reset during each cell-cycle (Sandler O., 2015, 
Priestman M., 2017). (Sandler O.,  2015) ( Priestman M., 2017). 
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Figure 3.4 M. smegmatis single-cell growing in a microfluidics device is tracked from birth 
time to division  
M. smegmatis single-cell obtained from time-lapse videos.  Cell grows up to septum formation, then it 
divides into two daughter cells, and each of them follows the mother’s life cycle. Image was using 40X 
objective magnification   
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Analysis 
 
Experiment 1 
 
 
Experiment 2 
 
 
Experiment 3 
 
 
Cell number 
 
1611 
 
1527 
 
1128 
average division time 
(min)  
1-all cell 
2-mother cell 
3-daughter cell 
 
 
145.10 
147.2 
143 
 
 
154.22 
156.4 
152.1 
 
 
152.78 
154.5 
149.1 
 
standard deviation 
1-all cell 
2-mother cell 
3-daughter cell 
 
 
36.48 
40.47 
31.92 
 
 
38.03 
43 
32.19 
 
 
37.43 
41.67 
30.21 
 
Correlation M –D 
Pearson 
Spearman 
 
 
-0.216, p <0.0001 
-0.234, p <0.0001 
 
 
-0.116, p =0.0002 
-0.137, p <0.0001 
 
 
-0.310, p <0.0001 
   -0.288, p <0.0001 
 
Correlation S-S 
Pearson 
Spearman 
 
 
0.607, p <0.0001 
0.624 p <0.0001 
 
 
 0.48,  p <0.0001 
 0.517,p <0.0001 
 
 
0.583, p <0.0001 
0.565, p <0.0001 
 
Table 3.1  Correlation analysis of the division time within the mycobacterial population  
The M. smegmatis division time (min) was calculated by tracking individual cells growing in a 
microfluidics device and the correlation of the division time for mother (M) and daughter (D), sister and 
sister (S) was examined by Pearson or Spearman coefficients.   Correlation analysis was considered 
significant for p<0.05. The experiment was repeated three different times with similar results 
(Experiment 1-3). 
 
A limitation in processing bright field images was to pinpoint the moment of cell division and 
measurements appeared to suffer from a high degree of technical noise.  To overcome this 
problem, we took advantage of dual reporter strains that express cell division proteins fused 
to fluorescent molecules.  Wag 31 is an essential late-division protein that localizes to the 
division septum and fused with GFP (green fluorescent protein) facilitates the visualization of 
mycobacteria cell division septum (Santi I., 2013, Kang C.M., 2088).(Santi  et  al ., 2013, Kang C. M.,  2008)  
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Microfluidic experiments set up with M. smegmatis expressing Wag31 GFP (Figure 3.5) in 
which the septum was clearly observed. At this stage we checked to see whether the 
expression of Wag31-GFP could affect the division time, so a small number of cells were 
tracked to measure division time. Cells were analysed in bright field (under same conditions 
as previously) and the fluorescent labelled septum was used to identify the cell division, (Table 
3.2).  Results suggested no significant difference in average division time between both types 
of measurement (F test for variances, p= 0.23, t-test equal variances p=0.62). 
 
 
Figure 3.5  M. smegmatis cell expressing Wag31 GFP  
A time-lapse image of M. smegmatis cell division, 40X magnification. A cell grows up to septum 
formation which is evidenced by GFP expression (green colour).   
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Analysis 
 
Bright field /uncoloured 
septum 
 
 
Fluorescent septum 
 
 
Cell number 
 
 
84 
 
84 
 
average division time (min) 
 
 
156.08 
 
151.83 
 
standard deviation 
 
 
44.01 
 
47.65 
 
Correlation M –D 
 
 
-0.27 
 
-0.12 
 
Correlation S-S 
 
 
0.68 
 
0.64 
 
Table 3.2 Division time was reliable in both the mutant M. smegmatis wag31-GFP and wild 
type M. smegmatis MC2 155  
A small sample of M. smegmatis wag31-GFP was analysed under previous conditions (bright field) and 
using fluorescent labelled septum.  Pearson coefficients were calculated between Mother (M) and 
daughter (D) division time as well as between sister cells (S) for each condition.  
 
Our results suggested no significant differences on the division time to M. smegmatis wag 31-
GFP and wild type, therefore the use of this modified strain was validated to further growth 
analysis. However, our analysis was limited to bright field images using the wild-type due to 
the technical complexity to process fluorescent field images. 
 
 3.3.2 Building a model of mycobacteria growth  
So far, our analysis was limited to division time using manual methods that were very labour 
intensive. To generate more data, we developed a semi-automatic method using MatLab 
software which allowed to investigate mycobacterial growth on our time-lapse images. The 
process included images preparation, segmentation and cell tracking, and allowed to measure 
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several growth parameters like length at birth (L0), length at the division time (Lf), added length 
(difference between division length, Lf – and birth length, L0 named as D), and division time 
(T).   
Measuring the correlation between these growth parameters have been used to decipher how 
cells control their growth (Sandler O., 2015,(S., 2015, Priestman M., 2017), thus we examined our data 
under these methods to investigate the mycobacterial growth. 
 
We initially determined whether our results obtained through the semi-automatic method using 
the MatLab code were comparable with the previous manual tracking analysis. Therefore, a 
random pooled sample obtained from time-lapse images manually analysed was examined 
by MatLab. Then, division time was measured along the mycobacterial population and the 
correlation between M-D and S-S was calculated as previously. The average division time was 
156 min, and division time was negatively correlated between mother and daughter cells while 
sister’s division time was positively correlated, (Table 3.3), results were very similar to those 
obtained by the manual method confirming that the different measurements were comparable.  
 
Cell number 
 
96 
 
average division time (min) 
 
156 
 
standard deviation 
 
51,6 
 
Correlation M –D 
 
-0.40 
 
Correlation S-S 
 
0.41 
 
Table 3.3 Pearson correlation for division time analysis in the mycobacteria population by 
MatLab  
A random sample of time-lapse M. smegmatis growth images processed by MatLab. Division time was 
calculated and compared between Mother (M) and daughter (D) as well as between sister cells (S) 
using Pearson coefficient.  
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An important advantage of semi-automatic analysis using MatLab was the capability of 
measuring other growth parameters such as birth, division length and elongation length. Like 
our division time analysis, we examined the birth length (cell size at the birth time), division 
length (cell size immediately before division time) and added length (division length- birth 
length). The statistic description for measured growth parameters is shown in Figure 3.6.  For 
birth length (L0) the mean was 6.58µm with standard deviation 1.82 µm, and data ranged 
between 2.79 µm and 11.85 µm. In addition, data were normally distributed (D’Agostino & 
Pearson, p=0.14), (Figure 3.6A).   Then, cell length immediately before division (Lf) was 
examined, the mean was 12.39 µm with standard deviation 3.21 µm, data ranked between 
6.79 µm to 20.54 µm and non-normal distributed (D’Agostino & Pearson, p=0.07), (Figure 
3.6.4 B). Finally, for elongation length (D), the mean was 5.80 µm with standard deviation 2.25 
µm, data ranked between 2.20 µm to 13.48 µm and they did not follow a normal distribution 
(D’Agostino & Pearson, p=0.0009), (Figure 3.6C).    
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Figure 3.6 A-C.  Frequency distribution for L0, Lf and D data  
Bar plots showing the frequency distribution for the growth parameters.  A.  L0, B. Lf, C. D.  X axis 
growth parameters measurement t, Y axis number of cells. 
 
As it can be extracted from the graphs, there was a high variability of growth parameters 
across mycobacteria population suggesting the existence of different phenotypes. 
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To investigate which model was consistent with our measurements we started by comparing 
length at birth and elongation length as others have previously done (Aldridge B., 2012, Osella 
M., 2014, Turner J. , 2012).  
In the sizer model  cells should divide after reaching a certain length, and a plot comparing 
birth length and division length should show a negative association (Turner J. , 2012). Our 
comparison L0 vs Lf revealed a strong positive correlation (0.7) between both variables 
suggesting that no smaller cells growing more before division neither longer cells are growing 
less.  Results obtained in this study indicate that mycobacteria do no follow sizer model to 
growth control, (Figure 3.7). Despite the fact that experimental conditions can affect the 
growth control in mycobacteria (Priestman M., 2017), our observation are line with previous 
reports  that indicated that  both smaller and longer cells maintain their length differences until 
cell division (Santi I., 2013). (Santi  et  al ., 2013).  
 
Figure 3.7 mycobacteria do not use sizer model as a growth control mechanism 
Measurement of the relationship between birth length and division length calculated from single-cell of 
M. smegmatis growing up in a microfluidics device. Red line, lineal regression CI, confidence intervals, 
n, sample number.  
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The fact that our data showed a slope of 1.29 revealed a non-perfect relationship between 
both variables and it might suggest that other model might be involved. We then hypothesized 
that if birth length does not affect mycobacteria growth, then short or longer cells at birth should 
divide at the same length.  Therefore, to test our hypothesis cell were stratified according to 
their L0 as others have done in similar studies (Santi et al., 2013). Smaller cells had a L0 ≤ 
6.5 µm and longer cell L0>6.58 µm.  As earlier, the new analysis showed a positive correlation 
between L0 and Lf for both smaller and longer cells, 0.58 and 0.51 respectively, (Figure 3.8).  
Taken together these results indicate that birth length does not determine division; thus M. 
smegmatis cell size homeostasis is not maintained by a sizer mechanism.  
 
A.   
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Figure 3.8   Investigating the role of birth length (L0) on mycobacteria growth  
Relationship between birth length and division length was examined for mycobacterial cells. A. Smaller 
had a L0≤ 6.58 µm, and B. longer cells L0> 6.58 µm.  Black dotted line represents the linear regression. 
R2 means determination coefficient, r correlation coefficient, and n, sample size.  
 
To continue our investigation about how mycobacteria, maintain its size-homeostasis, we next 
examined our data under the timer model.  Previous single cell study from M. smegmatis 
population revealed no correlation between birth and elongation lengths, results that 
suggested that mycobacteria maintain size by the timer model (Aldridge B., 2012).  To 
investigate our data under the timer model criteria, we examined the relationship between 
division time and birth length. As is shown on Figure 3.9, the linear regression results show 
that smaller cell grow for a longer time compared with cells that are longer at birth (slope -0.06 
and slope not significantly different to zero (p=0.1989) indicating that mycobacteria use timer 
as control growth mechanism. However, we also found an extremely low determination 
coefficient (0.017) which suggested that our data were not totally fitted to the regression line, 
and it could be caused by the variability of our data set.  
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Figure 3.9   Exploring mycobacteria growth under timer model  
Relationship between birth length and division time (T) was examined to whole mycobacterial 
population. Red line represents the lineal regression, R2 means determination coefficient, and n sample.  
 
We next decided to examine whether cells of different birth size are controlled by different 
homeostasis mechanism, (Figure 3.10). Our new analysis revealed important differences in 
the growth mechanism when cells were stratified by L0. To smaller cells we did not observe a 
correlation between the L0 and T (slope 0.08) which suggested that this sub-population divides 
at same time which is consistent with timer model (Figure 3.10A). In contrast, the division 
time is variable to longer birth length cells (slope -0. 1095), which indicated that other 
mechanism not timer is followed for size regulation in this subpopulation, (Figure 3.10). 
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A. 
 
 
Figure 3.10 Birth length affects the growth control mechanism in mycobacteria cells 
Relationship between birth length (L0) and division time (T). A linear regression equation was calculated 
for A. smaller cells, and B. longer cells.  Red line represents the linear regression. R2 means 
determination coefficient, and n sample size. 
 
Overall, the no correlation found between L0 and T (slope 0.0) confirm that timer model is 
used at least by smaller mycobacteria sup-populations  to maintain their size-homeostasis, 
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and this  results confirm previous findings (Aldridge B., 2012).  However, it should be borne in 
mind that the experiments are quite noisy and the measurements should be repeated with an 
increased sample size in the stratified subpopulations (Chen X., 2016). 
 
Because the timer model does not fully explain mycobacteria growth, we decided to 
investigate mycobacterial size control under adder model, thus we compared L0 with added 
length (Delta, difference between Lf and L0) using a lineal regression. Results showed in 
Figure 3.11, equation y= 0.2897x + 3.898, suggested a low positive association between L0 
and D. In a perfect adder model it is expected to be 0 correlation between these parameters 
(Osella M., 2014), therefore our data indicate that mycobacteria do not follow a perfect adder 
model instead they follow a timer-like adder model as was previously suggested for C. 
crescentus  and in which cells correct size deviations faster than if they were size-like adders 
(Iyer-Biswas S., 2014). 
 
Figure 3.11 Relationship between added length and birth length 
Relationship between birth length and added length. Red line represents the linear regression, R2 
means determination coefficient, and n sample size. 
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Based on our previous findings with the timer model that indicated that cell size could affect 
the growth control mechanism, we reasoned that smaller and longer subpopulations could 
also have a different behaviour under adder model analysis.  Therefore, we examined each 
cell size group for fit to the adder model by a linear regression. 
Excitingly, as it is presented in Figure 3.12, in this study was found a moderate positive 
relationship between L0 and D, slope 0.51 for smaller cells which suggested a deviation of 
adder model compared with our results for all population and which reinforce that smaller sub-
population fixes to other growth mechanism. On the other hand, it was also observed a weak 
positive relationship between L0 and D (slope 0.11) which suggested that longer mycobacteria 
sub-population adds a constant volume before division and  which is consistent to a perfect 
adder (expected slope is 0)  (Osella M., 2014, Turner J. , 2012). In addition, this observation 
supports our observation in which longer birth cells did not fix to timer model. However, the 
results should be cautiously interpreted because of technical noise attributed to the limited 
sample, and given further time we would increase our data set  (Chen X., 2016). 
A.        
 
 
 
 
66 
 
 
 B. 
 
Figure 3.12 Relationship between added length and birth length for smaller and longer 
subpopulations 
Relationship between birth length and elongation length.  Black dotted line represents the lineal 
regression to smaller A, and longer cells B.  R2 represents determination coefficient, and n sample size. 
 
 
3.3.3 How are growth parameters inherited? 
 
Previously, we showed that division time was not inherited between mothers and daughters 
within the mycobacterial population. To further explore the inheritance of factors that might 
contribute to persistence, we next investigated the inheritance of measured growth 
parameters, L0, Lf and D by measuring their relationship between mother - daughter and sister 
- sister cells, (Table 3.4). 
Our birth and division lengths comparison revealed a moderate positive significant correlation 
between mother and daughter cells but correlation between sisters was low.  In contrast, to 
added length we found no correlation between mother and daughters neither between sister 
cells.  
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Table 3.4 Correlation analysis for measured growth parameters 
Inheritance of growth parameters, L0, Lf and D was done by measuring their relationship between 
mother – daughter, and between sister - sister cells. L0 (birth length, Lf (division length), D (difference 
between division length, Lf – and birth length, L0), M (mother cell), D (daughter cell), S (sister cell).   L0 
correlation was calculated by Pearson coefficient while to Lf and D by Spearman coefficient.   
 
Overall these results suggest that L0 and Lf are inherited from a mother to daughters while 
elongation length is reset each cell generation (Sandler O., 2015).  Despite the fact our sample 
size was small (mother-daughter correlations, n=64 cell pairs, and sisters n=32), our results 
are consistent with a recent study in which birth length and growth rates were positively 
correlated between mother and daughters but not in sisters. Same study also showed that  
added length and interdivision time was uncorrelated between mother and daughters whereas 
they were highly correlated between sisters (Priestman M., 2017).  
Although, sample size is important to obtain accurate results analysing very small  sample of 
50 pair of sisters, allowed  investigators demonstrated that deletion of the highly conserved 
mycobacteria gene lamA decreases the heterogeneity in the population by decreasing the 
asymmetric growth (Rego E.H., 2017).  Data presented in this study indicates for first time that 
different growth models can occur simultaneously in the mycobacterial population and this 
variability assures the maintenance of heterogeneity in the population. Some of the results 
obtained in this study confirmed previous findings which validated the methods and analysis.  
 
L0  Lf D 
M-D    0.4    (p=0.005) M-D    0.5    (p>0.0001) M-D    (-0.07)    (p=0.5) 
S-S    0.2    (p=0.27) S-S    0.02    (p=0.9) S-S     (0.1)       (p=0.5) 
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3. 4 Conclusions 
 
a) Our experimental set up using microfluidics technology and time lapse coupled to 
confocal microscopy allowed us to obtain single cells images from M. smegmatis cells 
growing in steady state.  
b) The MatLab algorithm is a useful tool to accurately process time-lapse images and to 
obtain information about mycobacterial growth along the cell cycle. 
c) Our data suggested that mycobacterial subpopulations utilise different growth control 
models to maintain their size homeostasis that depends on their birth size. Whilst 
smaller cells follow a timer model, longer cells were more compatible with an adder 
model. 
d) It was revealed that the growth parameters division time and added length are not 
inherited across mycobacterial population. In contrast, birth and division length are 
positively correlated between mother and daughters, hence understanding how they 
are determined could have important effects to mycobacterial size control and 
persistence. 
e) It was found that mycobacteria control its growth in different ways, and this variability 
creates a functionally heterogeneous population in which cell could be differentially 
susceptible to antibiotic. 
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4. Results chapter: measuring 
mycobacterial persisters  
 
 
 
4.1 Introduction and aims 
 
In general, when an isogenic culture of bacteria is treated with a bactericidal antibiotic, the 
majority of the population is killed rapidly, with log-linear kinetics. Following this initial period, 
the rate of cell death slows markedly. However, a small fraction of cells, approximately 0.001% 
to 0.1%, spontaneously go into a dormant state that survive the bactericidal antibiotic 
treatment (Keren I., 2004b, Helaine S., 2014). As a result, a biphasic killing pattern upon 
treatment with bactericidal antibiotics is observed (Keren I., 2014).  (K., 2014).  
The first aim of this chapter was to establish an experimental model to measure the 
mycobacterial persisters in batch cultures using the antibiotics used for tuberculosis treatment, 
RIF) and STM. In order to do that, we decided to follow the method described by Keren I. et 
al., (Keren I., 2011) who tracked the level of M. tuberculosis persisters on a growing culture 
exposed to antibiotic. Culture samples were removed and washed at chosen time points along 
7 incubation days, and the persister cells were quantified by plating for colony counts. 
On the other hand, the slower growing or non-growing state is considered a strategy for 
persistence. However, while single cell analysis of E. coli exposed to ampicillin showed a 
reduced growth rate in persister cells (Balaban N. Q., 2004), a recent study of M. smegmatis 
exposed to isoniazid suggested no correlation between persistence and single-cell growth 
rates (Wakamoto Y., 2013). (Yuichi Wakamoto and Fr ançois Signorino-Gelo, 2013).   
These results suggest that the relationship between persistence and growth rate requires 
further investigation.  
70 
 
 
Many studies have investigated the influence of growth rate on persistence in bacteria, for 
instance, by changing the growth rate in a chemostat (Balaban N. Q., 2004) or by examining 
stationary phase vs exponential phase bacteria. These studies have generally demonstrated 
that slower growth rate leads to higher levels of persisters. However, many factors are different 
in these experiments, so it isn’t clear whether differences in persister levels are due to growth 
rate or the other factors. Our second aim in this chapter was to grow M. smegmatis at two or 
more different growth rates in the same media so that the influence of growth rate could be 
examined without confounding factors. We therefore aimed to engineer isogenic strains of M. 
smegmatis that would nevertheless grow at different growth rates in the same media. To do 
this, we firstly planned to control M. smegmatis growth rate by adjusting the expression level 
of an essential gene for growth such as leuD and then measure the frequency of the persisters 
in slow and fast-growing conditions in the same media using antibiotic killing curves. 
Several genes can be used to regulate growth of bacteria. Genes whose inactivation causes 
auxotrophy, e.g., those involved in amino synthesis pathways, are good candidates because 
inactivation is lethal, that is, it is associated with zero growth. However, addition of a, now 
essential nutrient, such as the amino acid that can no longer be made, can rescue growth and 
growth rate can then be controlled by the level of the growth-limiting nutrient in the media. 
However, our aim was to engineer strains of M. smegmatis to grow at different rates in the 
same media. We therefore selected two approaches.  In one hand, an auxotrophic mutant 
which was rescued by complementation with a functional copy of the inactivated gene was 
used. We reasoned that we could generate strains that would grow at different growth rates 
in the same media, by placing the complementing gene under the control of a set of promoters 
that drive different levels of gene expression.  
On the other side, we tested the variable strength promoters pUV15 and pTB21 previously 
identified and characterized  by Ehrt S. et al., (Ehrt S., 2005), who examined  a promoter 
library  in an E. coli-mycobacteria shuttle vector with a promoter-less gfp gene. Among the 
isolated plasmids, the highest GFP activities was observed with the plasmid pUV15, whereas 
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pTB21 showed intermediate GFP activity in both M. smegmatis and M. bovis BCG strains. We 
thought that by using these variable strength promoters to replace the native promoter of the 
leuD gene in the wild type M. smegmatis strain, we could create two mutant strains expressing 
different levels of leucine which will therefore have a different growth rate when cultured in a 
minimal culture media. 
In this study, we replaced the leuD native promoter by pUV15 or pTB21 promoters using the 
high throughput cloning system Gateway. This molecular tool uses in vitro site-specific 
recombination to exchange DNA fragments flanked by recombination sites between two 
parental molecules. This system provides both high activity as well as specificity (attB1 reacts 
with attP1 but not attP2.), thereby maintaining orientation of the transferred DNA segment and 
yielding a high proportion of desired clones (Hartley J., 2000). 
Having obtained a new set of leuD-controlled strains by the promoter replacement approach, 
we made a validation of our results by quantifying the gene expression level using a 
quantitative real time PCR (RT-PCR).  This is one of the methods broadly used to measure 
quantities of target nucleic acid, since it offers important advantages such as its ability to 
quantify nucleic acids over an extraordinarily wide dynamic range (at least 5 log units)(J., 
2005). Moreover, our detection method was based on intercalation of double-stranded DNA-
binding dyes complemented by melting-curve analysis is required to differentiate between 
specific and nonspecific PCR products using (K., 2002). 
Overall, our hypothesis was that growth rate would then be controlled by the level of gene 
expression, rather than the media, so isogenic strains engineered to have different levels of 
gene expression, would grow at different growth rates. Furthermore, antibiotic killing 
experiments using these strains might clarify the relationship between mycobacterial growth 
rate and the persisters’ level. 
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4.2 Materials and methods   
 
4.2.1 Time killing experiments 
 
M. smegmatis mc2155 was grown on LB plate for 48-72 h at 37oC, then a single colony was 
inoculated in 3 mL of LB 0.05% Tween 80 and incubated at 37oC, with shaking at 200 rpm. 
When the culture was in stationary phase an aliquot was removed and transferred to new 
media and incubated under the same conditions. Once the culture reached mid-exponential 
phase of 0.5 OD600 the antibiotic was added. 
Antibiotic stocks were prepared at 100 µg/mL, filtered and aliquoted into small volumes. They   
were kept at -20°C until use and discarded after use. Streptomycin (STM), with a concentration 
of 15 µg/mL and 60 µg/mL rifampicin (RIF) were used.  
For persister quantification,  the survivor CFU were established by the Miles and Misra method 
(Miles A.A., 1938) as previously described in the material and methods chapter. Graphic 
representations which required data normalization was done using the formula below:  
 
Survivor CFUs = CFU obtained at each sample-time in three technical 
replicates /CFU obtained at zero time 
Each experiment was done at least three times. 
4.2.2 M. smegmatis DNA extraction 
 
A 10 mL M. smegmatis culture was incubated for 24 hrs with shaking at 37°C. The culture was 
harvested (4,000 rpm for 10 min) and re-suspended in 450 µL GTE solution (glucose 50 mM, 
Tris-HCL 25 mM pH.8.0, EDTA 10 mM) and 50 µl of 10 mg/mL lysozyme solution (Sigma), 
then re-incubated overnight shaking at 37°C. Then 100 µl of 10% SDS (sodium dodecyl 
sulphate) and 10 mg/mL proteinase K (Sigma) were added and incubated at 55°C for 40 min. 
After which 200 µl of 5 M NaCl was gently added followed by 160 µl of cetyltrimethylammonium 
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bromide, CTAB (Sigma) and further incubated at 65°C for 10 min. Then 1 mL of chloroform-
isoamylic alcohol 24:1 (Sigma) was added and spun for 5 min at 13,000 rpm. The aqueous 
layer was transferred to a fresh microcentrifuge tube and an equal volume of chloroform-
isoamylic alcohol was added prior to spinning again at 13,000 rpm for 5 min. The aqueous 
layer was transferred to a fresh microcentrifuge tube and 0.7 x volume of absolute isopropanol 
was added and the DNA was precipitated at room temperature for 5 min with gentle agitation 
prior to spinning at 13,000 rpm for 10 min.  The supernatant was discarded, and the DNA 
washed twice with 70% cold-ethanol prior to spinning again at 13,000 rpm for 10 min. The 
supernatant was discarded, and the DNA was allowed to air dry overnight prior to adding 50 
µl of molecular grade water and kept at room temperature overnight allowing the DNA to 
dissolve. The sample was quantified (Thermo Scientific Nanodrop 2000 spectrophotometer) 
prior to storage at -20°C. 
4.2.3 Plasmid mini prep 
 
The QIAprep Spin Miniprep Kit (Qiagen) was used according to the manufacturer’s 
instructions. Therefore, an overnight culture was pelleted by centrifugation at 6800 x g for 3 
min at room temperature, re-suspended in 250 µl Buffer P1 and transferred to a micro 
centrifuge tube, then 250 µl of the lysis Buffer P2 was added and the tube inverted 4-6 times. 
After 5 min 350 µl of the neutralising Buffer N3 was added and the tube inverted again several 
times before spinning for 10 min at 13,000 rpm. Subsequently the supernatant was transferred 
into the provided spin column and centrifuged for 1 min at 13,000 rpm. The flow through was 
discarded and 750 µl of Buffer PE was added to the column which was then centrifuged again 
for 1 min at 13,000 rpm. The flow through was discarded and the column was spun again prior 
to eluting in 30 µl of warm water which was let to sit for 2 min. The sample was quantified 
(Thermo Scientific Nanodrop 2000 spectrophotometer) prior to storage at -20°C. 
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4.2.4 PCR and electrophoresis in agarose gel 
 
The polymerase chain reaction (PCR) amplification was performed on the Applied Biosystems 
2720 Thermal Cycler. The standard reactions for the GoTaq G2 Green master (Promega) 
contained 0.2 mM dATP, 0.2 mM dCTP, 0.2 mM dGTP, 0.2 mM, 1.5 mM MgCl2, 1.0 µM 
upstream and downstream primers, 1.25 U Taq DNA polymerase, <250 ng of DNA template 
and molecular grade water to make up to the required volume. The primers used for all the 
PCR reaction are listed in material and methods chapter. Negative controls without any 
template DNA were used in all reactions as well as appropriate positive controls. 
The thermo-cycling protocol consisted of an initial denaturation of 2 min at 94°C followed by 
25 cycles of denaturation of 30s at 94°C, annealing for 30s at a temperature calculated 
according to the primer melting temperatures and an extension time dependent upon the 
length of the template (1 min per Kb) prior to a final extension of 5 min at 72°C. 
To corroborate the correct band sizes the PCR products were visualised under UV light after 
running on a 0.8% agarose gel with 0.5X SYBR-safe DNA gel stain (Invitrogen) in 1X TAE 
buffer (Sigma) at 80V for 30-60 min. To size the products the 1 Kb ladder (Promega) was 
used. 
4.2.5 Sequencing analysis  
 
All the sequencing reactions were carried out using Sanger sequencing (Source Bioscience, 
Nottingham, UK). Samples were submitted by freepost in individual tubes. Plasmid DNA (5 µL 
per reaction) was sent at a concentration of 100 ng/µL, PCR products at 1 ng/µL and primers 
at 3.2 pmol/µL. The data was returned by Speed READ and the sequences analysed trough 
SnapGene software. The sequence analysis was carried out on the EMBL-EBI Clustal-Omega 
software to enable multiple sequence alignments. 
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4.2.6 M. smegmatis competent cells preparation 
 
In this study we followed the protocol suggested by Hatfull G.  et al., (Hatfull G., 2000). (Jr, 2000) 50 
mL of cells were grown with shaking at 200 rpm at 37°C to mid log phase 0.5-1 OD600 in 
LB/Tween 80 media, then incubated on ice for less than 2 hours prior to harvesting by 
centrifugation at 2,000 x g for 10 min at 4°C. The pellet was re-suspended in ice cold 10% 
glycerol and the wash cycle repeated twice, in half the starting volume, and re-suspended 
finally in 1-2 mL ice cold 10% glycerol. The cells were either used fresh or stored in 200 µl 
aliquots at -80°C. 
4.2.7 E. coli cells transformation 
 
Chemically competent E. coli DH5α cells (Invitrogen) were thawed on ice. 1-10 ng of DNA was 
added to 50 µl aliquots of cells and heat shocked at 42°C for 45 s. A positive control vector 
pmv306 kan   was used as a positive control to estimate the transformation efficiency of the cells 
and a cell only control was also used as a negative control. The tubes were placed on ice for 
2 min then 950 mL of pre-warmed Super Optimal broth with catabolite repression (S.O.C) 
media was added prior to recovery with shaking at 37°C for 1 hr. The cells were spun prior to 
plating on LB media containing the appropriate antibiotic for an overnight incubation. The 
following day, 10-20 colonies were transferred to new media with antibiotic and then screened 
by colony PCR or following an overnight sub-culture plasmid were obtained to further 
screening by restriction and sequencing. The PCR and sequencing primers used are listed in 
Table 2.2. 
 
4.2.8 M. smegmatis cells electroporation 
 
DNA between 0.5-5 µg was added to 200 µl electro-competent cells in a pre-chilled 0.2-cm 
electrode gap electroporation cuvette (VWR) and maintained on ice for 10 mins. The 
mycobacterial vector pmv306kan served as the positive control and for the negative control 
competent cells with molecular grade water was used. The cells were then exposed to a pulse 
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of 2.5 kV, 25 µF and 1000Ω in the Gene Pulser Xcell electroporator (Bio-Rad). The cuvettes 
were immediately placed back on ice again for 10 min. The cell suspension was then 
recovered into 5 mL of LB broth Tween 80 and incubated for at least 5 hours at 37°C. Cells 
were precipitated by centrifugation and plated on LB media with appropriate antibiotics for a 
48-72 h incubation prior to the colonies being screened.  
4.2.9 Transformant screening  
 
Following the transformation and overnight growth a few clones were selected for screening.  
Ten clones were selected from each of the constructs and were grown on antibiotic containing 
plates. The DNA was extracted by boiling a suspension of the clone (a loopful of colonies in 
100 µl of molecular grade water) for 10 min and centrifuged.  After, 5 µl of the supernatant 
were used as PCR template using the primers described in Table 2.2.  
4.2.10 Recombination Cloning –RC by Gateway 
 
The genes were cloned using the Gateway system (Invitrogen). Gateway cloning uses in vitro 
site-specific recombination to exchange DNA segments flanked by recombination sites 
between two parental molecules (Hartley J., 2000). Figure 4.1 indicates the schematic for 
gene cloning by Gateway used in our study. 
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Figure 4.1 Diagram of Gateway cloning used in this study 
leuD gene obtained from M. smegmatis is cloned into the entry vector pDO23A by in vitro recombination 
of the PCR product. Thereafter, the subclonings were carried out into the destination vector 
(pDE43_MCK).  Modified from tools.thermofisher.com 
 
4.2.10.1 Vector set  
 
To execute the cloning reaction, we firstly obtained the vector set which were kindly provided 
by Dirk Schnappinger D., Weill Medical College of Cornell University, US. These consist of 
donor, entry and destination vectors as specified below.  
pDO23A: donor clone, att sites attP2R and attP3, ampicillin and chloramphenicol resistance, 
origin of replication for E. coli, ccdB (encodes for the toxic protein CcdB). 
pDE43-MCK: destination vector containing att sites attR4 and attR3, origin of replication for 
E. coli, integration site chromosomally (in L5 site) and kanamycin resistance  
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pEN41A-T02: entry clone, att sites attL4 and attR1, ampicillin resistance, T02, empty plasmid.  
pEN12A-Puv15: entry clone, att sites attL1 and attL2, ampicillin resistance, promoter Puv15 
pEN12A-Ptb21: entry clone, att sites attL1 and attL2, ampicillin resistance, promoter Ptb21 
pGMCK-0X-Puv15-leuD: expression vector, contains origin of replication, integrates 
chromosomally (L5 site attP), kanamycin resistance, 0X=empty promoter Puv15 or Ptb21 
promoter and leuD 
4.2.10.2 Lb reaction  
 
As Figure 4.2 shows, firstly, an attB-flanked PCR product was created. It was designed with 
a primer set which allowed amplification the M. smegmatis leuD gene flanked by the attR2 
and attL3 sites. Primer sequences are shown in Table 2.2  
In order to gain lower mutation rates, we used a High-Fidelity Taq Polymerase (NEB). After 
amplification BP Recombination reaction was done using BP Clonase II (Invitrogen) and the 
donor vector pDO23A.Then, we mixed the PCR product attB-leuD (final amount ~15–150 ng) 
1–7 µl, pDO23A (150 ng/µl), 2 µl of BP Clonase II enzyme mix (Invitrogen) and TE buffer pH 
8.0 to 8 µl in a 1.5 mL tube and incubated at room temperature. After, 1 µl of the Proteinase 
K solution was added to each sample to terminate the reaction. Finally, 1 µl of the BP reaction 
was used to transform into 50 µl of competent E. coli DH5α cells as previously described. Cells 
were plated on LB plates containing 100 µg/mL amp. Clones were selected and transferred to 
a new LB plate with the appropriate antibiotic and confirmed by sequencing. 
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Figure 4.2 Schematic of BP reaction by Gateway cloning 
The triangles represent recombination sites.  Cloning attB-PCR products into Entry Vectors. Modified 
from Hartley J. et al., (Hartley J., 2000) 
 
4.2.10.3 LR reaction  
 
As Figure 4.3 displays, LR promotes in vitro recombination between attL- and attR flanked 
regions to generate attB containing expression clones. 
Each LR consisted of 4 components.  One destination vector, which provides the resistance 
cassette, the origin of replication for E. coli, and the integration site, pDE43-MCK and three 
entry clones, one was empty, pEN41A-T02, one contained a promoter to drive the leuD gene, 
pEN12A-Puv15 or Ptb21and one with the gene, pEN23A-leuD.  
To the LR reaction the fabricant recommendations were followed with some modifications. 
Briefly, 100 ng of the destination vector pDE43-MCK were mixed with 75 ng each of entry 
vectors, pEN12A-Puv15 (Ptb21), pEN41A-T02 and pEN23A-leuD, 2 µl of LR Clonase II 
enzyme mix (Invitrogen) and TE buffer pH 8.0 to 10 µl. The mix was incubated at 25°C for 16 
h. Then 1 µl of the Proteinase K solution was added to each sample to terminate the reaction. 
After, 4 µl of reaction were used to transform into 50 µl of competent E. coli DH5α cells or One 
Shot ccdB Survival™ Competent E. coli (Invitrogen). Cells were plated on LB plates containing 
50 µg/mL kan. Clones were selected and transferred to a new LB plate with the appropriate 
antibiotic. Finally, they were confirmed by sequencing. 
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Figure 4.3 Schematic of LR reaction by Gateway cloning  
The triangles represent recombination sites.  Subcloning of a gene from the Entry Vector into a 
Destination Vector.  Modified from Hartley J. et al., (Hartley J., 2000). 
 
4.2.11 Testing the clones functionality 
 
4.2.11.1 Minimal media preparation: Roisin’s media 
 
Roisin’s minimal medium was selected to test the leuD mutant strains. Firstly, the base 
element solutions were prepared, and glycerol was used as carbon source. Then, the pH was 
adjusted to 6.9 and final media filter purified. 
 
Chemical Amount / L 
 
KH2PO4 1.0 g 
Na2HPO4 2.5 g 
NH4Cl 5.9 g 
K2SO4 2.0 g 
Trace element Solution 1 mL 
1 M CaCl2 0.5 mL 
1 M MgCl2 0.5 mL 
Glycerol 5 mL 
Tween 80 2 mL 
Antifoam (fermenters) 0.5 mL 
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Trace element solution 
 
  
Chemical Amount / L 
  
ZnCl2 80 mg 
FeCl3-6H20 400 mg 
CuCl2-2H2O 20 mg 
MnCl2-4H2O 20 mg 
Na2B4O7-10H2O 20 mg 
(NH4)6Mo7O24-4H20 20 mg 
 
When solid media was required 1.2% agar (Sigma) was added and then autoclave sterilized. 
4.2.12 Measuring the leuD gene expression  
 
In order to measure leuD gene expression, our selected method was a quantitative real time 
PCR. It involved different steps, RNA extraction, amplification and quantification method. 
4.2.12.1 RNA extraction 
 
To extract RNA the kit FastRNA pro blue kit and FastPrep instrument (MP Biomedicals) were 
used. Briefly, 2 mL of an overnight culture was centrifuged 2,800 rpm for 15 min at 4°C. 
Pelleted cells were suspended in 1 mL of RNA pro solution. Then, the solution was transferred 
to a blue-cap tube containing the lysing matrix B provided in the kit. The tube was processed 
in the FastPrep instrument, removed and centrifuged at 12,000 g for 5 min at 4°C. Immediately 
after, the liquid was transferred to a new tube avoiding the debris pellet and lysing matrix, 
incubated at room temperature for 5 min and 300 µl of chloroform added. Tubes were 
centrifuged, and the upper phase transferred. RNA was precipitated with 500 µl of cold 
absolute ethanol and washed with cold 75% ethanol. The sample was quantified (Thermo 
Scientific Nanodrop 2000 spectrophotometer) prior to storage at -70°C 
4.2.12.2 Obtaining the cDNA  
 
For reverse transcription the Precision nanoScript TM 2 Reverse Transcription kit (Primer 
design) was used as indicated below. 
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Firstly, annealing step was done. Thus, in a thin walled 0.2 mL PCR tube RNA template (up 
to 2 µg), 1 µl random primer, and RNase/DNase free water up to final volume 5 μl were mixed 
and incubated at 65°C for 10 minutes. Immediately after, the tubes were cooled on ice.  
To extension step, 5 μl of 4X Buffer, 1.0 μl dNTP mix 10 mM, 3.0 μl RNase/DNase free water, 
1.0 μl nanoScript2 enzyme to a final volume 10 μl were mixed and added to the annealing 
tube. Tube was incubated at 42°C for 2 h, heat inactivated at 75°C for 10 min and stored at 
4°C until use. 
4.2.12.3 qPCR amplification  
 
The quantitative PCR was performed on the QuantStudio 7 Flex Real-Time PCR system 
(Applied Biosystems).  The reactions were done with QuantiTect SYBR green PCR kit 
(Qiagen) containing 10 μl master mix, 10 pmol upstream and downstream primers, 3 µl 
RNase/DNase free water and ≤ 1 μg cDNA up to final volume 20 µl. The primers used for all 
the PCR reaction are listed in material and methods chapter, Table 2.2.  Each sample was 
run in triplicate and appropriate negative and positive controls. 
4.3 Cloning design and data analysis  
 
Plasmid maps, in silico experiment design and cloning results were analysed by SnapGene 
software, version 4.1.1. 
qPCR results were analysed by QuantStudio 7 Flex Real-Time PCR software (Applied 
Biosystem) by relative quantification using the previously described method 2-ΔΔCT (Livak K. J., 
2001).(D., 2001).  
The housekeeping gene selection was done by validation of three genes dnaJ, gyrB and sygA 
genes.  Serial dilutions of cDNA were amplified by real-time PCR using gene-specific primers. 
Then, ΔCT was calculated in Excel (Office 15) using the 2-ΔΔ method (Livak K. J., 2001). (D., 2001).  
Briefly, ΔCT = CT leuD - CT housekeeping gene, i.e. dnaJ, gyrB and sygA was calculated for 
each cDNA dilution, and the data were analysed by regression linear.   
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After internal control was validated, the leuD expression was quantified by calculating pΔΔCT 
(ΔCT mutant strains – ΔCT wild type strain). 
Growth curve data were stored, processed and graphed with Excel (Office 15), and GraphPad 
Prism 7.0.3. 
 
4.4 Results 
 
4.4.1 Measuring the growth of M. smegmatis in batch cultures  
 
Our initial aim was to establish an experimental model to measure the persister cells in M. 
smegmatis cultured in batch. To do that we adopted the approach suggested by Keren. et al., 
(Keren I., 2011)  in which the level of M. tuberculosis persisters was tracked on batch cultures 
by removing a sample of the growing culture exposed to antibiotic along 7 incubation days. 
We firstly measured cell growth to clearly define the middle exponential growth phase from 
which cells would be harvested to be used for antibiotic killing experiments.  As Figure 4.4 
suggests, the lag, exponential and stationary growth phases for M. smegmatis mc2155 were 
observed along 50 h in LB media. After inoculation, the initial OD600 measurement at time zero 
was 0.05 which corresponded to 105 CFU/mL.  After this time, cell number gradually increased, 
therefore after 6 h cells got into exponential phase which prolonged up to 36 hours. We thereby 
concluded that early, middle and late exponential phases of M. smegmatis were characterized 
by OD600  measurements of 0.1, 0.5 and 1.8 respectively. In addition, after 50 h the number of 
cell levelled off suggesting stationary growth phase.  
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Figure 4.4 Growth curves for wild-type M. smegmatis mc2 155 
M. smegmatis wild type strain was cultured in LB media (Sigma) /0.5% Tween and glycerol. Culture 
samples were removed at regular times along 52 h for counting plate. Results are representative of 
three biological replicates with the bars showing standard errors Graph created with GraphPad 
 
4.4.2  Antibiotic killing curves 
 
As the next part in our model we aimed to measure killing in growing cultures of M. smegmatis 
using two different antibiotics: RIF and STM. The antibiotics were added to cultures at 0.5 OD 
and further samples removed for CFU counts.  
As Figures 4.5 and 4.6 show, time-killing experiments using RIF or STM revealed a typical 
biphasic pattern which has been related to bacterial persisters (Keren I., 2004b). In addition, 
the killing dynamic was similar for both antibiotics. Under rifampicin treatment the time killing 
assay revealed a reduction of almost four logs in the CFU over the first 24 h.  
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After that time, the killing effect was substantially slower with less than one log CFU for the 
next 24 h, representative of the persister subpopulation. Overall, as Figure 4.5 presents, the 
persister level of mycobacteria obtained with RIF was 1 in 1000 of our initial cell population. 
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Figure 4.5 RIF kill curve for M. smegmatis mc2 155 
An exponential culture of the wild type M. smegmatis mc2 155 was exposed to 60 µg/mL RIF. Bacterial 
counts along 48 h incubation were set up using Miles and Misra. Data is shown as mean ± SEM of 3 
independent experiments.   
 
On the other hand, the time killing curves using STM revealed a dramatic drop of 
approximately three logs of CFU during the first 6 h, after that the bacteria population was 
slightly reduced by a further one log at the end of 24 h. During the next 24 h there was a 
gradual killing by up to another two logs.  By extrapolating the slow kill phase back to the 
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origin, the fraction of mycobacteria persisters can be estimated to be around 1 in 10000 of the 
initial population, (Figure 4.6). 
Interestingly, the difference in the level of persisters obtained to each antibiotic suggested that 
these are different populations which may likely be affected by several factors during the killing 
experiment. In addition, these results reinforce the previous suggestion that mycobacterial 
persisters are drug-specific subpopulations (Singh R., 2010). 
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Figure 4.6 STM kill curve for M. smegmatis mc2 155 
The wild type M. smegmatis mc2 155 on exponential growth phase was exposed to 15 µg/mL STM. 
Bacterial counts along 54 h incubation were set up using Miles and Misra. Results are representative 
of three biological replicates with the bars showing standard errors.  
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In general, the time-killing experiments were limited to 48-50 h for both antibiotics RIF and 
STM because of the appearance of genetically resistant mutants and overgrowth of the 
population by mutants after this time. To test for mutants, our experimental strategy included 
removing 20 µl of the M. smegmatis cultures exposed to antibiotic at defined times and 
inoculating this onto media plates supplemented with either STM or RIF. The antibiotic killing 
curves enabled the detection of drug-resistant mutants as well as differentiation from the 
tolerant cell populations. 
Together these results suggest that behind a tolerant bacteria population is an 
underrepresented genetically resistant population which increases along antibiotic exposure 
to dominate the bacterial culture. Furthermore, Levin-Reisman I. et al., (Levin-Reisman I., 
2017) suggested that tolerance enables the establishment of a resistance mutation by 
lowering its probability of getting lost during the antibiotic treatment. 
So far, the results allowed us to establish an experimental model to measure the persister 
population using the wild-type M. smegmatis. Two stages were included in our approach, 
whereby the mycobacterial growth was characterised, and the middle exponential growth 
phase was defined as the appropriate time to proceed to the next step, in which antibiotic 
killing curves were done to identify the persister fractions. 
We attempted to replicate the established model in batch cultures to single cell experiments 
in the microfluidics device, however it was not possible to observe mycobacterial persisters 
by this experimental approach. Result that we mainly attribute to the fact that persisters 
represent a small fraction of the bacterial population, typically 10-6 to 10-4  (Keren I., 2004a). 
 
4.4.3 Measurement of the level of persisters in growth-controlled cells 
 
Having established the dynamics of the kill curves for wild-type M. smegmatis we next 
investigated growth-controlled strains of M. smegmatis. To do that, we used a system in which 
the native promoter of leuD was replaced by two different strength promoters, pUV15 (strong 
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promoter) and pTB21 (medium strength) using Gateway cloning (Invitrogen). These promoters 
were previously obtained and characterized by Ehrt S. et al. (Ehrt S., 2005), and kindly 
provided to this study. 
To create our new set of leuD-controlled M. smegmatis, via Gateway cloning, we firstly design 
a cloning strategy which is showed in Figure 4.1. The first stage of our cloning approach was 
to examine recombination sites, antibiotic resistant genes and orientation of the genes into 
our vector set by both restriction analysis and sequencing analysis using the primers described 
in Table 2.2.  
The restriction patterns observed on agarose gels were 100% in concordant to in-silico 
restriction analysis suggesting that all the vectors had the right sequence, (Figures 4.7 and 
4.8).  Similarly, sequencing results confirmed sequences and orientation of all the vectors. 
 
A.       B. 
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C.        D. 
 
 
 
E.  
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Figure 4.7 A-G  Restriction analysis in silico for Gateway cloning vectors 
Restriction enzymes were selected and used to digest vector maps in silico. A: Donor vector pDO23A 
with MluI and PvuI, B: destination vector pDE43-MCK with MluI and ApaI, C: entry vector pEN12A-
ptb21 with MluI and PvuI, D: entry vector: pEN12A-puv15 with MluI and PvuI, E: entry vector pEN41A 
with MluI and PvuI, F: agarose gel simulation for double digestion for each vector.  Created with 
SnapGene. 
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Figure 4.8 Restriction analysis on agarose gel for Gateway cloning vectors   
In the upper gel image, wells 1& 14: 1 KB ladder (Promega), well 2:vector pEN12A-ptb21 undigested, 
well 3:vector pEN12A-ptb21 digested with MluI,  well 4:vector pEN12A-ptb21 digested with PvuI, well 
5:vector pEN12A-ptb21 digested with both MluI and PvuI, well 6:vector pDO23A undigested, well 
7:vector pDO23A digested with MluI,  well 8:vector pDO23A digested with PvuI, well 9:vector pDO23A  
digested with both MluI and PvuI, well 10:vector pEN12A-puv15 undigested, well 11:vector pEN12A-
puv15 digested with MluI,  well 12:vector pEN12A-puv15 digested with PvuI, well 13:vector pEN12A-
puv15 digested with both MluI and PvuI.  In the lower gel image, wells 1 & 10: 1 KB ladder (Promega), 
well 2:vector pEN41A undigested, well 3:vector pEN41A digested with MluI,  well 4:vector pEN41A 
digested with PvuI, well 5:vector pEN41A digested with both MluI and PvuI, well 6:vector pDE43-MCK 
undigested, well 7:vector pDE43-MCK  digested with MluI,  well 8:vector pDE43-MCK digested with 
ApaI, well 9:vector pDE43-MCK  digested with both MluI and ApaI.  
1       2        3       4       5        6       7       8       9       10      11    12     13      14 
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To replace the leuD promoter using Gateway cloning, it was needed to construct expression 
systems via the multi-site system using recombination reactions.  As a first stage we 
constructed the entry plasmid (pEN23A-leuD) which contains the leuD gene flanked by the 
attR2 and attL3 sites, (Figure 4.9).  To do that we firstly created a PCR insert flanked by the 
sites attB2 and attB. Sequencing confirmation suggested that att sites attached correctly to 
leuD gene as well as that no mutations were caused during the amplification. 
Afterwards, we prepared a reaction with the obtained insert, the donor vector pDO23A which 
contained the att sites attP2 and attP3, and the BP Clonase.  Sequencing results confirmed 
us that the entry plasmid pEN23A-leuD was correctly obtained. 
As the final step of the cloning, we created the expression vector which contains the new 
promoter to drive the leuD gene expression (pGMCK-0X-Puv15-leuD and pGMCK-0X-Ptb21-
leuD). To obtain these, we made a multisite recombination using Gateway LR Clonase and 
mixing the vectors pEN23A-leuD, pDE43 - MCKa destination vector which provides the 
resistance cassette, the origin of replication for E. coli, and the integration site, and pEN12A-
Puv15 or pEN12A-Ptb21 which contains the promoter. 
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Figure 4.9 Construction of the entry vector pEN23A-leuD  
M. smegmatis leuD gene was amplified and recombination sites attB2 and attB3 attached to it. The 
product was cloned into pDO23A vector by Gateway BP clonase. As a result, we obtained the pEN23A-
leuD entry vector to be used in further cloning by Gateway. Cloning history created with SnapGene.  
 
As Figure 4.10 A-B indicates, the new expression vectors contained the new promoters puv15 
or ptb21 immediately followed by leuD gene to each. 
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Figure 4.10 A-B Sequencing analysis for the vectors pGMCK-0X-Puv15-leuD and pGMCK-
0X-Ptb21-leuD 
leuD in the image corresponds to the sequence for leuD gene of M. smegmatis sequence obtained from 
Genebank, Sequence for promoters Puv15 and Ptb21 kindly provided by Schnappinger D.  Alignment 
results suggested that leuD gene native promoter was successfully replaced. A. pGMCK-0X-Puv15-
leuD. Promoter sequence: blue color, leuD gene: orange color B. pGMCK-0X-Ptb21-leuD. Promoter 
sequence: green color, leuD gene: pink color.  Alignment analysis done with Clustal 0 (1.2.4).   
Ptb21 
leuD 
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So far, the results suggested that the cloning strategy used in our study allowed us to obtain 
a vector set in which leuD gene was under control of one of the variable strength promoters, 
pUV15 or pTB21. We next aimed to examine the functionality of the vectors in M. smegmatis. 
In order to do that, M. smegmatis mc2155 was transformed with the expression vectors and 
the functionality of the mutants was tested by measuring their competence to grow on Roisin’s 
minimal media plus kanamycin. Results obtained by colony PCR indicated that both promoters 
were correctly and uniquely inserted in wild-type M. smegmatis. In addition, the new strains 
were resistant to Kan. (Figures 4.11 A-B). 
 
A. 
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Figure 4.13 A-B Confirmation for M. smegmatis transformed with vectors pGMCK-0X-
Puv15-leuD and pGMCK-0X-Ptb21-leuD 
A. Antibiotic selection on minimal media. Nine colonies were picked after the transformation with each 
vector and cultured on Roisin’s minimal media plus Kan. As negative controls M. smegmatis mc2155 
and the auxotroph M. smegmatis ΔleuD were included. As a positive control we used M. smegmatis 
transformed with vector P.E. 1.1 (which confers kanamycin resistance). Plates on top correspond to 
transformation with pGMCK-0X-Ptb21-leuD. Plates on bottom correspond to transformation with 
pGMCK-0X-Puv15-leuD. Plate on middle right shows the negative controls. 
B. Colony PCR results. The nine colonies were tested for both molecular targets, promoter Ptb21 and 
Pvu15. Expected size to Puv15 307bp and to Ptb21 126bp. Each colony amplified only for the expected 
promoter. Then two colonies were selected and retested by PCR for both promoters. Lane 1: 1 KB 
ladder (Promega), lane 2: negative control for Ptb21 master mix, lane 3: positive control for promoter 
Ptb21, lane 4: colony 1 for Ptb21, lane 5:colony 2 for Ptb21, lane 6: colony 1 for Puv15, lane 7: colony 
2 for Puv15, lane 8: 1 KB ladder (Promega), lane 9: negative control for Puv15 master mix, lane 10: 
positive control for promoter Puv15, lane 11: colony 1 for Puv15, lane 12:colony 2 for Puv15, lane 13: 
colony 1 for Ptb21, lane 14: colony 2 for Ptb21 
 
250bp 
 1    2      3      4       5       6       7       8      9    10    11     12    13   14 
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4.3.4 Measuring the leuD gene expression in the new strains 
 
Having obtained two new strains which have the leuD under the control of each pUV15 or 
pTB21, we thought to examine the level of expression of leuD gene in each case. To do that 
we executed a qPCR and relative quantification to measure the change of the target relative 
to some reference group such as untreated control or a sample at zero-time in a time-course 
study.  
To validate the internal control gene for each experiment we followed a method previously 
reported in which the template is diluted and amplified, then variations on threshold cycle (CT) 
are measured (Livak K.J., 2001). (D., 2001). 
Our study evaluated three genes dnaJ, gyrB and sygA to be used as a housekeeping for 
measuring the expression level of leuD gene.  Results indicated similar performance on the 
amplification by real time PCR to all the tested genes. Positive amplification was obtained after 
18 cycles using the 1:10 cDNA dilution which corresponded to around 0.1 µg/mL, to the next 
cDNA dilution 1:100a CT consistent on 22 was observed, and so on up to the last dilution 
which was 1: 100000 to which the CT was 34. Furthermore, standard curves were carried out 
to all the designed primers, and results indicated high efficiencies with proportional dose-
response as supported by the curve slopes around -3 to -3.8.  Since 3.3 (-1/log (2)) means 
that for each cycle the DNA quantity is perfectly doubled, (Figure 4.12 A-B). 
In addition, examination of primer specificity by melting curve analysis revealed, a unique 
amplification peak to both, leuD and dnaJ genes. Therefore, dnaJ was selected as internal 
control gene for further quantification of leuD gene, (Figure 4.12 C). 
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Figure 4.12 A-C Validation of qPCR primers to the internal control gene dnaJ and leuD 
A. Amplification plot of a real time PCR in which the dnaJ gene was validated to be used as a 
housekeeping gene to further qPCR. Red corresponds to 100 cDNA (~100 ng/mL), yellow corresponds 
to 10-1 cDNA dilution, light green corresponds to 10-2 cDNA dilution, dark green corresponds to 10-3 
cDNA dilution and blue corresponds to 10-4 cDNA dilution. Primers used to this experiment are 
described on chapter 2, Table 2.2. The graph is a representation of one of the experiments.  Three 
replicates were done per sample. 
B. Standard curve to test the efficiency of the dnaJ primers. A lineal regression was used to 
compare cDNA (µg/mL) input with CT values.  Slope of -3.8 suggested a 95% efficiency of the tested 
primers. In addition, the correlation coefficient was calculated, R2 0.99. 
C.  Melting curve plot. The observation of only one peak indicated that dnaJ primers allowed a 
specific amplification by qPCR. In X axis meting temperature and Y axis fluorescence variation in the 
reaction 
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Once the housekeeping gene was defined and primers evaluated, we aimed to measure the 
leuD gene expression on wild-type M. smegmatis mc2155, the leuD-controlled M. smegmatis: 
pGMCK-0X-Puv15-leuD, M. smegmatis: pGMCK-0X-Ptb21-leuD and the leuD auxotroph M. 
smegmatis.  To do that, we first amplified both targets leuD and dnaJ, then we calculated the 
leuD fold change compared to dnaJ. Results presented in Figure 4.13 indicate that the 
wildtype strain in which the leuD gene was under the control of its native promoter had the 
lowest gene expression, whereas the mutant strain in which the leuD gene was under the 
control of pUV15 promoter had the highest expression level for the gene, followed by the 
mutant strain with the medium strength promoter pTB21. As expected, there was not gene 
expression for the M. smegmatis mc2155 leuD auxotroph. 
 
 
Figure 4.13 Calculating the fold change of leuD gene relative to the internal control gene 
dnaJ 
A bar graph indicating the fold change to leuD gene was calculated to wild type (M. smegmatis mc2155) 
and M. smegmatis mutant strains (M. smegmatis: pGMCK-0X-Puv15-leuD, M. smegmatis: 
pGMCK-0X-Ptb21-leuD and the leuD auxotroph M. smegmatis); using the formula 2^- ΔΔCT as 
described on the method section of this chapter.  
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Together these results demonstrated the utility of real-time PCR for measuring the gene 
expression using the intercalant agent SYBR green. Moreover, we validated dnaJ as an 
efficient internal control gene to be used on quantification assays by quantitative PCR. The 
analysis of our qPCR data was notably facilitated by the 2-ΔΔ method which allowed to quantify 
the fold change of the leuD gene relative to the internal control, dnaJ. Significantly, the 
obtained results supported the difference on leuD gene expression among M. smegmatis wild 
type and the leuD promoter replaced strains, and confirmed the success of the cloning 
approach by Gateway. 
Up to this point we obtained and validate a new set of M. smegmatis strains which have 
controlled and differential level of leuD expression. We next addressed our initial hypothesis 
that strains with different levels of gene expression, would grow at different growth rates by 
establishing the growth curve to each new strain in a minimal media.  Surprisingly, as Figure 
4.14 indicates there were no observable differences in the growth rate  between the promoter-
replaced strains and the wild type with native promoter.  
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Figure 4.14 Growth curves to wild type M.smegmatis mc2 155 and mutant strains with leuD 
replaced-promoter  
Growth rate for M.smegmatis wild type, M. smegmatis: pGMCK-0X-Puv15-leuD, M. 
smegmatis:pGMCK-0X-Ptb21-leuD  and M. smegmatis ΔleuD was analyzed by growth curves on 
Roisin’s media/0.5% Tween and glycerol using the OD600 measurement. p=0.9 
 
Even though the promoters pUV15 and pTB21 have been widely used to investigate the 
function of different mycobacterial genes by altering  their expression (Rego E.H., 2017, Li 
JM., 2008). The experimental approach used in this study in which the promoter of an essential 
growth gene such as leuD gene was replaced was not enough to produce a notable change 
in the growth rate for M. smegmatis. Therefore, it could be hypothesized that the essential 
gene selected, leuD had a low effect on growth rate as it has been previously suggested by 
Goh S. et al. (Goh S., 2009),  after examining the growth stringency requirement for E. 
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coli genes.  Interestingly their findings revealed that essential genes affect unequally the 
bacteria growth rate by measuring the mRNA of four essential genes in conjunction with 
growth rate, thus genes have a degree of essentiality, or stringency (Goh S., 2009). 
 
4.4 Conclusions 
 
a) We established a laboratory model using rifampicin and streptomycin that allowed us 
to select and quantify drug-tolerant M. smegmatis persisters in batch cultures. This system 
could be extended to microfluidic and improve the understanding of drug tolerant/ persisters 
at single cell level.  
b) Despite many experimental attempts, it was not possible to observe M. smegmatis 
drug-tolerant/persisters at single cell level due to the low fraction of this subpopulation.  
c)  We successfully replaced the promoter of an essential gene to growth, leuD using a 
high-throughput cloning system Gateway. However, the selected promoters pUV15 and 
pTB21 did not allow to observe differences in M. smegmatis growth rate.  
d) Promoters used in this study are likely to be as strong as the wild-type promoter of 
leuD hence the expression of this gene did not affect the growth rate.  
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5. Results chapter: Identifying genes 
affecting the level of M. tuberculosis 
persisters 
 
 
5.1 Introduction and aims 
 
An effective strategy used by bacteria to survive in a hostile environment is to produce 
specialized survivor cells or persisters.  These are a small sub-population of cells that 
becomes highly tolerant to killing by antibiotics (Keren I., 2011). Persisters are thought to be 
responsible for the fact that TB treatment requires at least six months of a multidrug regimen 
in order to sterilize the small subpopulation of drug-tolerant or persistent M. tuberculosis bacilli 
(Islam M. S., 2012) 
Even though persisters were discovered many years ago (Hobby G., 1942) and they have an 
important role in a clinical setting, there is little knowledge about persistence mechanisms and 
to the formation of persisters, in part  because of the paucity of tools to isolate and characterise 
them.  
Fortunately, molecular tools and single cell technologies have improved our understanding of 
bacterial persisters and has led to the identification of genes and pathways that modify the 
frequency of persisters in the population, for instance, toxin-Antitoxin (TA) systems. Deletion 
studies provided strong evidence that multiple TA loci encoding mRNases contribute 
cumulatively to the formation of persisters in E. coli  (Maisonneuve E., 2011).  TA’s are small 
genetic modules typically composed of a protein toxin and a more labile antagonistic antitoxin. 
Under adverse circumstances, the antitoxin is rapidly degraded and the free active toxin 
targets an essential cellular processes leading to growth inhibition which is often reversible 
when new antitoxins are available (Sala A., 2014b).  
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TA loci have also been identified in M. tuberculosis and each toxin may have a separate, 
defined subset of the transcriptome with which it interacts (Singh R., 2010). Investigators have 
also examined the transcriptome signature of M. tuberculosis persisters generated by treating 
an exponentially growing population with D-cycloserine. The surviving cells, enriched for 
persisters, were examined using hybridization to an Affymetrix array. Results revealed 10 TA 
modules in the set of upregulated genes which are likely involved in persister formation and 
maintenance. It was also found that genes involved in growth and energy metabolism were 
extremely downregulated (Keren I., 2011).  Despite the importance of the phenomenon of 
persisters, little is known about their mechanism of formation in M. tuberculosis.  Singh et al. 
(Singh R., 2010),  determined that M. tuberculosis persisters to one drug are not cross-tolerant 
to other drugs by exposing early-log-phase cultures of M. tuberculosis to INH, RIF and 
pyrazinamide (PZA) alone or combined at concentrations 10-fold higher than their MICs. 
Results indicated that combination of all three drugs resulted in a severe reduction in the 
survival of M. tuberculosis compared to that found with any single drug treatment. Whereas, 
PZA killed less than 90% of the cells, RIF-mediated killing continued through day 7, with a 
final population representing 0.0016% of the input bacilli surviving.  INH-mediated killing was 
achieved at day 4, after INH-resistant mutants began to emerge, and population increased 
more than 10-fold by day 7. Combined use of the drug showed that PZA did not reduce M. 
tuberculosis survival when used in concert with INH, while the combination of PZA and RIF 
did reduce survival compared to that found with RIF alone, and combination of INH and RIF 
reduced M. tuberculosis survival compared to the maximal killing seen with either INH or RIF 
alone.  
Overall, the mechanisms involved in mycobacterial persisters formation is likely to be 
dependent of the antibiotic, but it remains uncertain.  Result presented in this chapter allowed 
the identification of several interesting groups of genes that appear to be involved in 
persistence but very different patterns for genes associated with persistence to RIF and STM, 
(Appendix 1). 
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Gene identification has been greatly facilitated in bacteria using transposon mutagenesis and 
sequencing (Tn-seq) of genes/regions of bacterial chromosomes that appear to be essential 
under different selective conditions. It is a robust and sensitive method in which a saturated 
transposon insertion library is assembled and subjected to selective pressure. After library 
selection, changes in frequency of each insertion mutant in the library may be determined by 
sequencing (Tn-seq) of the flanking regions. These changes are used to calculate each 
mutant’s fitness under the selective condition. Genes that affect that fitness under the test 
condition may then be identified by comparison of the input vs output pool of mutants (Chao 
M. C., 2016, De Jesus M. A., 2017b). 
Statistical analysis of Tn-seq data is critical to identify essential genes and gene interactions, 
and software tools that automate the analysis have facilitated the analysis of Himar1 Tn-Seq 
datasets.  TRANSIT software applies several in-built analysis methods to identify essential 
(and conditionally essential) regions, as well calculating statistical significance (De Jesus M. 
A., 2015).  For essentiality analysis, TRANSIT provides two alternative methods: a Bayesian 
method and a Hidden Markov Model (HMM), and for comparative analysis the software utilizes 
a permutation test that compares the difference of the Tn-insertion counts in a genomic region 
between two different conditions to determine if there is a statistically significant difference (De 
Jesus M. A., 2015). 
Resampling is a comparative test offered by TRANSIT which sums the read counts at all the 
TA sites and all replicates in each condition.  Following this, the difference between the sums 
of read-counts at each condition is calculated and the significance of this difference is 
evaluated by comparing to a resampling distribution generated from randomly reshuffling the 
observed counts at TA sites in the region among all the datasets. This creates a distribution 
of read count differences that might be observed by chance, assuming a null hypothesis that 
the two conditions are not in fact different. A p-value is then calculated from the proportion of 
reshuffled samples with the extreme differences that were observed in the real experimental 
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data (permutation test) and this is adjusted by the Benjamini-Hochberg method (De Jesus M. 
A., 2015). In this study, genes were examined using TRANSIT- resampling method.  
The aim of this study was to use Tn-seq to identify genes that modify the frequency of 
persisters in M. tuberculosis populations. We therefore screened a Himar1 transposon library 
in M. tuberculosis H37Rv to identify mutations that affected tolerance to rifampicin and 
streptomycin independently. Sequencing results were processed in TRANSIT software, and 
reliability of the statistic approaches provided in the software to our dataset was then 
examined. The work results could provide new insights into the mechanisms and pathways 
that M. tuberculosis persisters use to face antibiotic stress; and thereby lead to novel 
approaches to control of tuberculosis. 
 
5.2 Materials and methods   
 
 
5.2.1 Strains, media culture and laboratory conditions 
 
All procedures were done in the Containment CL3 Laboratory Suite, Faculty of Health and 
Medical Sciences, Department of Microbial and Cellular Sciences, University of Surrey. 
In this study, we used the reference strain M. tuberculosis H37RV as well as a Tn- library in 
M. tuberculosis H37Rv using the Mariner Himar1 mini-transposon which was kindly prepared 
and provided by Willians K., TB group, University of Surrey. 
Strains were inoculated on liquid media Middlebrook 7H9/Glycerol/0.05% Tween and 
incubated at 37°C with 200 rpm up to 4 weeks. Further, we used Middlebrook 7H11/Glycerol 
for culture on plates and these were incubated at 37°C for up to 4 weeks. 
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5.2.2 Measuring persistence in M. tuberculosis  
 
For time-killing experiments we followed the previously reported method (Keren I., 2011), with 
adjustments, which are mentioned in brief below. We inoculated a culture of M. tuberculosis 
H37Rv from a plate into 10 mL of Middlebrook 7H9 /Glycerol/0.05% Tween and incubated as 
above. Once cells reached exponential phase (0.6-0.8 O.D600) the antibiotic was added. 
Different rifampicin or streptomycin concentrations were tested, thus to rifampicin 3, 5 and 10 
times the MIC as described in second chapter. Therefore, to RIF (0.09 µg/mL, 0.15 µg/mL and 
0.3 µg/mL, respectively) and to STM 3, 5 and 10 times the MIC (1.5 µg/mL, 2.5 µg/mL and 5 
µg/mL, respectively).  At time 0 (before antibiotic addition) and after 2, 7 and 14 days, 100 µl 
was aseptically removed and diluted in 900 µl PBS. Serial 1:10 dilutions were made and plated 
on Middlebrook 7H11/Glycerol/OADC, incubated at 37°C and colonies counted after 
approximately 4 weeks incubation.  Dilutions which gave between 20-200 colonies were 
selected to count (Miles A.A., 1938).  At least 3 biological and 3 technical replicates were done 
for each experiment.  
5.2.3 Selecting a mariner transposon library in M. tuberculosis H37Rv by RIF 
or STM exposure 
 
A Himar1 transposon library on M. tuberculosis H37Rv with an estimated size of 5x10-5 
mutants was previously created by Williams K., TB group, University of Surrey. For our 
experiments, a vial stored at -70°C was kindly provided. Firstly, cells were thawed and 
aseptically inoculated in 10ml of Middlebrook 7H9 /Glycerol/0.05% Tween/25 µg/mL Kan. The 
culture was grown at 37°C, under agitation at 200 rpm overnight. Following this, 1.5 mL 
aliquots were prepared on 30% glycerol and stored at -70 °C until use.  
To evaluate viability and growing time, one vial was randomly selected and inoculated in 100 
mL of Middlebrook 7H9 /Glycerol/0.05% Tween.  After 6 days the culture was tested by OD600 
measurement. 
The method followed for H37Rv tn-library selection following exposure to RIF or STM is 
illustrated on Figure 5.1. 
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Figure 5.1. Schematic representation of M. tuberculosis H37Rv tn-library selection after 
exposure to RIF or STM 
The mariner Tn-library in M. tuberculosis H37Rv was grown to exponential phase, then 5X the MIC of 
RIF or 10X the MIC of STM was independently added, and samples removed at 0, 2, 7 and 14 days to 
determine the CFU. The input was represented by the population of mutants before drug treatment and 
the output was obtained after 14 days of drug treatment. The experiment was done in triplicate for each 
antibiotic. 
 
5.2.3.1 Obtaining the input sample for Tn-seq analysis   
 
One of the stored vials of the Tn-library in M. tuberculosis H37RV was thawed and inoculated 
into broth, 100 mL of 7H9/glycerol/OADC/Tween. The culture was incubated at 37°C with 
agitation at 200 rpm until it reached exponential phase (OD600 0.7). Then, 10 mL were 
removed, and 10 petri plates (100 x 15 mm, Fisher) with 7H11/glycerol/OADC/Tween 80 were 
inoculated with 1 mL each. The plates were incubated at 37°C for 15 days. Afterwards, the 
cells were aseptically scraped, resuspended in 10 mL of 30% glycerol and stored at -70°C 
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until DNA was extraction. Three replicates were done for each cell culture and labelled as A, 
B and C. 
5.2.3.2  Obtaining the output sample for Tn-seq analysis 
 
Once 10 ml were removed from the 100 ml exponential culture of mariner Tn-library in M. 
tuberculosis H37RV, the remaining volume was aseptically split, and 40 ml was transferred to 
two new 250 ml bottles. One of the mycobacterial cultures was then exposed to RIF (0.15 
µg/ml) and the other one to STM (5 µg/mL). To measure the CFU, samples were removed at 
0, 2, 7 and 15 days of treatment with antibiotic. Following this, the total volume was transferred 
to a conical tube and centrifuged at 4000 rpm for 10 min. The supernatant was discarded, and 
the pellet suspended in 3 mL of 7H9/glycerol/OADC. One ml was then spread to on three petri 
plates (100 x 15 mm, Fisher) containing 7H11/glycerol/OADC/Tween 80. The plates were then 
incubated at 37°C for 15 days. Cells were then scraped and suspended in 10 mL of 30% 
glycerol in a conical tube and stored at -70°C until DNA extraction. The same process was 
carried out for each antibiotic with three biological replicates. 
 
5.2.4 DNA extraction from input and output samples 
 
From each stored input and output tube, 5 ml was transferred to a new sterile tube for genomic 
DNA extraction.  We used the approved protocol from our CL3 Laboratory Suite (Faculty of 
Health and Medical Sciences, Department of Microbial and Cellular Sciences, University of 
Surrey). Briefly, the cells from the liquid culture were harvested by centrifugation at 4000 rpm 
at room temperature, the supernatant was then discarded, and the pellet was resuspended in 
TE, pH 8.0. (Sigma). Following this, an equal volume of methanol: chloroform (Sigma) (2:1) 
was added and the solution rocked by hand for 5 min. The suspension was then centrifuged 
at 4000 rpm for 10 min at room temperature and the aqueous and organic phases carefully 
removed from the solid bacterial mass, into another 50 mL conical tube, leaving the sloppy 
pellet in the original falcon tube. The solid bacterial mass was then allowed to dry by leaving 
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the tube open in the hood for approx. 2-3 h and 5 ml TE buffer, pH 9.0 was then added to the 
pellet. Lysozyme (Sigma) to a final concentration of 100 μg/mL and 0.1 volume of 10% SDS 
and 100 μg/mL of proteinase K (Sigma) were added and the solution then incubated at 50 ºC 
for 3 at least h. The viscous solution was transferred into a clean tube containing an equal 
volume of phenol: chloroform (Sigma): isoamyl alcohol (Sigma) and mixed by hand for some 
min. Following this, the tubes were removed to a CL2 laboratory, and rocked for 15 min at 
room temperature. The aqueous phase was removed to a new tube, extracted once again with 
an equal volume of chloroform and centrifuged again.  The aqueous phase was then 
transferred to a new tube, and the DNA precipitated with 1/10th volume of 3 M sodium acetate 
(Sigma) and one volume of isopropanol. (Sigma). Recovered DNA was washed twice with 
70% ethanol and dissolved in molecular grade water at RT. DNA quality and quantity was 
measured on 0.8% agarose, and by Nanodrop (Thermo Scientific). 
5.2.5 Processing DNA for next generation sequencing 
 
Several steps were required to prepare the DNA to further analysis by next generation 
sequencing (Illumina). 
5.2.5.1 Shearing the DNA 
 
Approximately 5 μg of the DNA was suspended in 130 µl of molecular grade water. The 
suspension was transferred to a cuvette (Covaris) and DNA sheared using a Covaris Sono 7 
machine with settings of Incident Power - 105, Duty Factor – 5% for 200 cycles/burst for 80 
sec. Resultant DNA fragments were quantified and checked on agarose to determine if 
shearing had occurred. 
5.2.5.2 Blunt ending and 3’ A tailing DNA 
 
To blunt end the DNA fragments we used the NEBNext End Repair Module (New England 
BioLabs) by following the manufacturer’s recommendations. Briefly, 1-5 µg of DNA was mixed 
with 10 µl NEBNext End Repair buffer (10x), 5 μl NEBNext End Repair Enzyme mix and water 
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to a total volume of 100 µl.  Following this, the mix was incubated at 20°C for 30 min. The 
product was then cleaned up with a QiaQuick PCR cleanup kit (Qiagen) and resuspended in 
50 μl water. 
To add a 3’ A to the blunt-ended DNA, the NEBNext dA-Tailing Module (New England 
BioLabs) was used following the manufacturer’s instructions.  The 48 µl of recovered DNA 
was then mixed with 5 µl NEBNext dA-Tailing reaction buffer (10x), 3 μl Klenow fragments (3’-
5’ exo) and molecular grade water to 50 μl. The mix was then incubated at 37 °C for 30 min 
then cleaned with a QiaQuick PCR cleanup kit and eluted into 50 μl water. 
5.2.5.3 Adapters, preparation and ligation 
 
Two adapters (Adap) were linked to the DNA samples.   They combined to form the linker with 
a 3’ ‘T’ overhang.  
Adap1 
caagcAGAAGACGGCATACGAGATNNNNNNNNGTGACTGGAGTTCAGACGTGTGCTCT
TCCgatct 
Adap2 
 gatcgGAAgagca- PHO 
The bold text for adapter 1 corresponds to the 5’ Illumina binding region, the NNNNNNN index 
allows removal of PCR amplification artefacts, therefore products with an identical position 
and index to an already identified product are discarded, and finally in red/bold the Illumina 
read sequence. Lower case indicates the phosphorothioates (PTO) bonds to prevent any 
endonuclease degradation. For adapter 2, PHO is 3’ phosphate to prevent extension of the 
adapter by polymerases 
To prepare the adapters, we mixed equal volumes of 100 μM stocks of each adapter together 
in 2 mM MgCl2 (to 50 μM) and heated at 95 °C for 5 min, then allowed to cool slowly to room 
temperature.  We then ligated the adapters by adding 4μl of the 50 μM adapter mix to 250 ng 
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A-tailed DNA (100-200 molar excess) using T4 ligase (Promega) with incubation for 2 h at 
room temperature. The resultant product was cleaned up with the QiaQuick PCR cleanup kit 
(Qiagen) with 4 PE washes, and the final product was eluted into 50 μl molecular grade water. 
 
5.2.5.4 Determination of the adjacent loci to the transposon insert site using PCR 
amplification 
 
5.2.5.4.1 Primers  
 
To amplify the adjacent loci to the Mariner transposon.  The primers MarA to MarJ were used, 
each primer corresponded to a unique sample. i.e., sample number 1 was amplified with 
primer MarA, sample 2 with primer MarB and so on. In addition, to MarJ, we designed a tag 
as previously suggested by Kozarewa I. et al., (Kozarewa I.,2011). (DJ., 2011)As internal control, the 
primer IS6 was added to each PCR mix, IS6 is homologous with the 5’ Illumina binding region 
of the final product. The primers sequences are showed on (Table 5.1).  
 
Primer Sequence 
MarA AATGATACGGCGACCACCGAGATCTACACTGTTCCGAACACTCTTTCCCT
ACACGACGCTCTTCCGATCTCGGGGACTTATCAGCCAACC 
MarB AATGATACGGCGACCACCGAGATCTACACTTCCGGAGACACTCTTTCCC
TACACGACGCTCTTCCGATCTTCGGGGACTTATCAGCCAACC 
MarC AATGATACGGCGACCACCGAGATCTACACGCCGATGTACACTCTTTCCC
TACACGACGCTCTTCCGATCTGATACGGGGACTTATCAGCCAACC 
MarD AATGATACGGCGACCACCGAGATCTACACCATGATCGACACTCTTTCCC
TACACGACGCTCTTCCGATCTTATCTACGGGGACTTATCAGCCAACC 
MarE AATGATACGGCGACCACCGAGATCTACACCGCGCGGTACACTCTTTCCC
TACACGACGCTCTTCCGATCTCGGGGACTTATCAGCCAACC 
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MarF AATGATACGGCGACCACCGAGATCTACACACACGATCACACTCTTTCCC
TACACGACGCTCTTCCGATCTTCGGGGACTTATCAGCCAACC 
MarG AATGATACGGCGACCACCGAGATCTACACAAGTAGAGACACTCTTTCCC
TACACGACGCTCTTCCGATCTGATACGGGGACTTATCAGCCAACC 
MarH AATGATACGGCGACCACCGAGATCTACACGAGATCTTACACTCTTTCCCT
ACACGACGCTCTTCCGATCTTATCTACGGGGACTTATCAGCCAACC 
MarJ 
 
 
 
AATGATACGGCGACCACCGAGATCTACACAGATCGCAACACTCTTTCCC
TACACGACGCTCTTCCGATCTTATCTACGGGGACTTATCAGCCAACC 
IS6      CAAGCAGAAGACGGCATACGA 
 
Table 5. 1 Primers for Tn-seq analysis  
Primers Mar A – Mar J contain the Illumina binding region, an index to identify the sample, the Illumina 
read sequence, a spacer to allow the sequencer to keep track of sequencing spots and the transposon 
specific sequence 
 
5.2.5.4.2 PCR amplification 
 
A real time PCR optimisation was carried out to determine the correct cycle number in which 
we observed an amplification without over-saturation. We used a 10 μl PCR with 5 μl Phusion 
High Fidelity PCR master mix with GC buffer (New England BioLabs), 0.5 μl EvaGreen (×20), 
2 pmol/μl each primer, MarA & IS6 primer, and 1 μl of the DNA.  The thermocycling conditions 
were, initial denaturation at 98°C for 30 secs, followed by 45 cycles of 98°C for 10 secs, 58°C 
for 10 secs and then 72°C for 30 sec. In addition, the PCR   product was checked on an 
agarose gel where it should appear as a smear of <1 kb.  
Once the number of cycles was optimized, we carried out the preparative PCRs. Briefly, 4 
PCR mixes were prepared for each sample with 50 μl volume each.  
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Reagent     1 X 
Phusion PCR mix  25 μl 
MarA primer (2 pmol)* 10 μl 
IS6 primer mix  (2 pmol) 10 μl 
Template                5 μl 
Final volume   50 μl 
* Same mix was prepared for the total of Mar primers 
The PCR was carried out using the optimised number cycles. As controls we also included a 
mix with only IS6 primer and template in which, and one with IS6/MarA primers and no DNA, 
in which no amplification signal was expected. 
 
To remove PCR artefacts such as primer dimers and get the appropriate fragment sizes, we 
ran the PCR products on a 1% agarose gel and cut-out the resulting fragments of between 
~400 - 600 bp. We then cleaned-up with the QiaQuick Gel extraction kit (Qiagen), with 6 PE 
washes. The final product was eluted into 50 μl molecular grade water after a 2 min incubation 
at RT. 
 
5.2.5.4.3 Determining fragment size distribution and quantification of PCR 
products 
 
In order to determine the fragment size distribution as well as sample quality, the PCR 
products were assessed on the BioAnalyser (Agilent 2100) using a DNA chip (Agilent).  In 
addition, the samples were quantified using the peak height.  
5.2.6. Next generation sequencing 
 
Quantified samples were pooled at 100 mM each into a total volume of 48 µl. The samples 
were then dry ice packaged and sent to GENEWIZ company for Illumina sequencing, with 
instructions for a double read of at least 100 bp, and double indexing.  
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5.2.7. Processing sequencing results 
 
Sequencing results were returned as fastq files and firstly processed by Dr Huihai Wu as 
described below  
5.2.7.1 Bioinformatics analysis 
 
Briefly, the pipeline for bioinformatics included: 
1. fastqFilter.py :  filter input read sequences where end nucleotides with a bad fastq score '#' 
were chopped, and disposed of if the number of '#' > 50.  
2. transposonFilter.py : filter out those non-transposon reads, using the simple rule that a read 
will be kept if there is a 'TGTTA' at the beginning of read.  
3.  fasta file 'tsp_filter_AAA033' were aligned on the M. tuberculosis H37Rv  genome (NC- 
018143) using Bowtie2 for alignment.  
4. countTnPCRdedup.py : get Tn counts by removing PCR duplicates. This script was able to 
count read number from alignment same file on TA positions after filtering out PCR duplicates 
and those with mapping quality <=30.  
5. Gene essentiality analysis using the TRANSIT resampling method: relative essentiality was 
analysed between 2 conditions using the TRANSIT tool.   
5.2.7.2  Persister gene selection 
 
Different methods were examined to select the most valid gene selection method to identify 
M. tuberculosis persisters  
A. Gumbel method:  
This method carries out a gene-by-gene analysis of the insertions at TA sites with each gene 
and makes a call based on the longest consecutive sequence of TA sites without insertion in 
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the genes, and calculates the probability of this using a Bayesian model (De Jesus M. A., 
2013). Using this approach essential and non-essential gene were discriminated. 
B.  Hidden Markov Model (HMM) 
This method can be used to determine the essentiality of the entire genome. It can identify 
regions that have unusually high or unusually low read counts. For this analysis we excluded 
the recently reported site less permissible for insertion, (GC)GNTANC(GC) (De Jesus M. A., 
2017a). Each gene is assigned to an essentiality class belonging to the most frequent state 
found within its boundaries, i.e. essential, growth defect, non-essential and growth-advantage.  
C.   TRANSIT - Resampling 
TRANSIT is a software tool to analyse Himar1 Tn-seq datasets, this method allowed us to 
examine the genes based on the fold change (log2-fold change between two conditions (after 
selection over before selection). A negative value indicates under represented genes and 
positive values over represented genes.  In addition, a p- value calculated by the permutation 
test allowed selection of the statistically significant genes. 
We established as the cut-off point to rifampicin selection a fold change ≥ 1.8 to over 
represented genes and ≤ 2.0 to underrepresented genes. To streptomycin selected genes the 
values were ≥ 2.0 and ≤ 2.0 respectively. 
As a validation criterion for all the examined methods, candidate genes were individually 
analysed by insertion location and number of insertions.  
5.2.8 Testing individual mutants from output 
 
To obtain individual mutants, the output sample of each antibiotic was diluted 1:10 and plated 
on 7H11/glycerol/OADC/tween.  After growth, ten single colonies were selected from each 
biological replicate and their MIC was measured as described in chapter 2.  Colonies that 
showed no change in the susceptibility to the drug compared with the wild type M. tuberculosis 
119 
 
 
H37Rv were considered drug-tolerant cells, therefore they were re-tested by time- killing to 
confirm their phenotype and Sanger sequencing to determine the disrupted gene 
5.2.8.1 Time-Kill experiments of individual mutants 
 
A frozen vial stored at -70°C with the single mutant preserved in 30% glycerol was thawed, 
inoculated on 10 mL of 7H9/Glycerol/OADC/Tween and incubated under agitation (200 rpm) 
at 37°C. Once the culture reached exponential growth (OD600 0.7-0.8) the antibiotic was added 
at the same concentration as previously used for selection and CFU measured at 0, 7 and 14 
days.  
5.2.8.2 Sanger sequencing 
 
To determine the mutant insertion site, two rounds of PCR amplification were carried out using 
the primers designed by Smith A. from TB group, University of Surrey and described on 
Chapter 2, Table 2.2. 
5.2.8.2.1 DNA extraction from individual mutants 
 
Under CL3 conditions, a large swab from each cultured mutant was suspended in 400 µl TE 
buffer pH 8.0 (Sigma) and boiled for 10 min to kill the mycobacterial cells.  Following this, in 
the CL2 facility the DNA extraction was carried out by following the method described by 
Soolingen D. et al. (Soolingen D., 1991). 
Briefly, we added 1 mg/ml of Lysozyme (Sigma) and incubated for 1 h at 37°C. Following this, 
10% SDS and Proteinase K (Sigma) were added and incubated for 10 min at 65°C. An 80 µl 
volume of N-cetyl-N,N,N-trimethyl ammonium bromide (CTAB) was added and incubated for 
10 min at 65°C. After centrifugation, cholorofom-isoamylic alcohol was added and the mixture 
was vortexed. The DNA was then precipitated with 0.6 volume of isopropanol, and twice 
washed with 70% ethanol.  Finally, the DNA was dissolved in 20 µl molecular grade water. 
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5.2.8.2.2 PCR amplification and sequencing of Mariner adjacent genomic region 
 
Briefly, in the initial PCR one of the primers aligns to the transposon while the second one 
randomly binds to genomic DNA until it binds the bit adjacent to transposon. We then carried 
out a second amplification which is more specific and uses the sequence introduced in the 
first amplification to amplify both transposon as adjacent genomic region. 
After each PCR round the product was evaluated on 1% agarose. Further, after the second 
PCR, the product was cleaned up with the QiaQuick PCR cleanup kit (Qiagen), quantified 
and sent for sequencing by the Sanger method with the primer described in Table 2.2 
Sequencing results were analysed against all genomes by Basic Local Alignment Search 
Tool (BLAST), NCBI. 
5.2.8 Data management and statistical analysis  
 
Sequencing data were stored on Excel (Office 15), and selected gene lists from each method 
were compared by Venn diagrams. Selected genes were reviewed on the website TubercuList 
(version 2.6), Global Health Institute at the Ecole Polytechnique Fédérale de Lausanne, and 
in collaboration with the Swiss Institute of Bioinformatics (https://mycobrowser.epfl.ch/).   
Time-killing results were analysed and graphed on Excel (Office 15).  
 
5.3 Results 
 
Unlike previous chapters, the results and discussion of this chapter are illustrated separately 
as it involves a large amount of data as shown. As already described, our basic approach was 
to expose the M. tuberculosis transposon library to a concentration of antibiotic that would kill 
non-persisters and leave a population enriched for persisters. We would then determine the 
mutant population in the input and output libraries to identify genes that modify persister 
frequency. 
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5.3.1 Determining the optimal antibiotic concentration for persister selection 
 
To determine the optimal antibiotic concentration for the experiment we firstly measured the 
MIC of M. tuberculosis H37Rv for both rifampicin and streptomycin.  We next selected 3X, 5X 
and 10X the MIC of each antibiotic for determination of antibiotic kill curves. As it can be 
observed on Figure 5.2, the antibiotic kill curves using the selected concentrations showed 
the characteristic biphasic pattern of persisters in which the first phase is represented by the 
bulk of the population which is killed exponentially whereas the persister sub-population is 
represented by the slower killing second phase (Keren I., 2004a).  Quantification of persister 
fractions after RIF treatment indicated a persister frequency between 10-4 to 10-5, and for STM, 
the persister frequency was about 10-5 using 10X the MIC (5 µg/ml). For both antibiotics, the 
kill curves were characterized by a substantial reduction of almost three logs in the CFU over 
the first 5 days for both antibiotics, followed by a diminishing killing rate for the next 3 days 
that plateaued by day 15. 
Interestingly, the RIF concentrations of 3, 5 and 10 times the MIC did not show significant 
differences in the number of persisters.  Likewise, Keren I. et al.  (Keren I., 2011), also showed 
killing experiments for an exponentially growing population of M. tuberculosis using rifampicin 
which did not show differences in the persisters numbers when 3, 5 or 10 times the MIC was 
used.  Together, these results could suggest that RIF concentrations in the range of 3-10 times 
MIC independently allow us to obtain equal number of mycobacterial persisters under our 
experimental conditions. We, therefore selected 5 times the RIF MIC for later experiments of 
selection. 
On the other hand, treatment with STM indicated that drug concentration significantly affected 
the surviving persister frequency (p>0.5). As can be observed on Figure 5.2 B, 3 times the 
MIC achieved one and a half log reduction in the exponential killing phase whilst 10 times the 
MIC reduced the population by approximately 3 logs. For further studies, we therefore, decided 
to use 10 times the MIC of STM to our mutant library selection. 
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A. 
 
B.  
 
Figure 5.2 A-B. Antibiotic kill curve for M. tuberculosis H37Rv 
An exponential culture was treated with 3, 5 and 10 times the MIC. A: RIF (MIC=0.03 µg/ml); B: STM 
(MIC= 0.5 µg/ml), p>0.5. The survivors are shown over time in log CFU/ml. Results are representative 
of three biological replicates with the bars showing standard errors. 
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Overall, the kill curves analysis indicated that between 7 and 14 days of antibiotic treatment 
the mycobacteria population was dominated by drug-tolerant persisters with the expected 
plateau in CFU number. Moreover, the antibiotic used affected the levels of mycobacterial 
persisters.  
 
5.3.2 Selection of the M. tuberculosis H37Rv mariner transposon library 
 
Since the frequency of persisters in the population was between 10-4 – 10-5, the ideal selection 
criterion would aim for a similar frequency of survivors. However, with 10-4 – 10-5 of cells 
surviving antibiotic exposure, the surviving population is unlikely to be representative of the 
transposon library unless an infeasibly large input library population was used. We therefore 
opted for a survival frequency of 10-3 to ensure adequate representation of the input library, in 
the selection output.  As shown on Figure 5.3, the killing pattern was quite similar for each 
antibiotic. Firstly, treatment with RIF substantially reduced the cell number by nearly 3 logs 
during the first 7 days, after that CFU number remained relatively constant until day 14.  Killing 
by STM caused a dramatic drop of about 2 and a half logs during the first 2 days followed by 
a slight decrease in the CFU number until the end of the exposure.  
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Figure 5.3.  Antibiotic kill curve for mariner transposon library in M. tuberculosis H37Rv. An 
exponential culture of the transposon library was exposed to 0.15 µg/ml of RIF or 5 µg/ml of STM. The 
survivors are shown over time in log CFU/ml. Results are representative of three biological replicates 
with the bars showing standard errors. 
 
Resistant mutant are naturally present in the mycobacteria population at low frequencies of  
3.8 X 10-6 and  3.1 x 10-8 mutants  for STM and  RIF respectively (Hugo D., 1970).  (D., 1970).  
To ensure that we did not get mutant take-over in the population, we measured the frequency 
of resistant mutants throughout the experiments, by plating cultures onto media with and 
without antibiotic, which allowed us to quantify and differentiate between phenotypically 
tolerant persisters and genetically resistant mutants [6]. Results suggested that prior to 
antibiotic exposure, the CFU counts of resistant mutants for RIF and STM were 8x10-5 and 
1x10-4 CFU/ml respectively. As expected this number gradually increased throughout the 
experiment, thus after 14 days they were estimated as 81x102 CFU/ml for RIF and 32x103 
CFU/ml for STM. Finally, the resistant mutants were compared with total survivors (e.g., 
persisters plus genetically resistant mutants) at the end of each drug treatment, and resistant 
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mutants represented ~ 16% (RIF) and 25% (STM) of the population. Overall, our results 
demonstrate that, although mutants were present in the antibiotic survivor population, they 
remained at a relatively low level and the population was dominated by persisters.     
  
Our library size was estimated to include 5x105 mutants so our inoculum to the experiments 
was 40 times the size of the library. Antibiotic selection reduced the mutant population by 
1000- fold; however, with that still allowed us to recover about 104 cells in the putative persister 
population, which should provide a statistically valid sample of the mycobacterial genome of 
about 4,000 genes. Together, these results demonstrated that our selection condition was 
appropriate for the purposes of the experiment.  
 
5.3.3 DNA processing and quality examination to further sequencing by next 
generation sequencing 
 
After subjecting the library to antibiotic selection for 14 days for each single antibiotic, the cells 
were recovered, and DNA was extracted. As can be observed on Figure 5.4, the DNA showed 
the expected smear pattern of genomic DNA suggesting a successful extraction. Additionally, 
the quantification by Nanodrop suggested that the amount of nucleic acid was between 2- 4 
µg/µl.  We can therefore conclude that our DNA samples had the required quality and quantity. 
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Figure 5.4.  Gel electrophoresis of DNA obtained from both input and output  
DNA quality was measured by electrophoresis on an agarose gel at 0.8%.  Lane 1: 1 Kb ladder 
(Promega), Lane 2- 10: samples in the following order, input A, input B, input C, output RIF A output 
RIF B, output RIF C, output STM A, output STM B and output STM C.  INPUT: Himar1 transposon 
library colonies immediately before antibiotic treatment. OUTPUT: Himar1 transposon library selected 
with RIF or STM treatment  
 
To amplify the extracted DNA, it must be prior sheared to size <1 Kb.  To do that we 
fragmented the DNA by a mechanical process based on ultrasonic acoustic energy in an 
isothermal environment.   As Figure 5.5 indicates, DNA shearing allowed us to obtain 
fragments with lengths under 1 Kb. 
 
 
 
 
1   2    3     4     5    6     7     8    9    10 
   1.000bp 
   3.000bp 
10.000bp 
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Figure 5.5 Gel electrophoresis of the sheared DNA samples  
5 µg of extracted DNA were sheared, and size of fragments evaluated on agarose gel.    Well 1: 1 Kb 
ladder (Promega), wells 2- 10: samples in the follow order, input A, input B, input C, output RIF A output 
RIF B, output RIF C, output STM A, output STM B and output STM C.  INPUT: Himar1 transposon 
library colonies immediately before antibiotic treatment. OUTPUT: Himar1 transposon library selected 
with RIF or STM treatment  
 
The sheared DNA was repaired and modified by A-tailing. After, two adapters were ligated 
onto the repaired DNA, and the transposon junction site PCR amplified using the primers 
(MarA, MarB, MarC, MarD, MarE, MarF, MarG, MarH, and MarJ).  In order to optimize the 
PCR, we firstly determined the exponential phase of the PCR amplification curve and selected 
the low cycle number to avoid bias by nonspecific bands, accumulation of products and 
depletion of reaction components.  As it can be observed on Figure 5.6, the lower number of 
cycles that allowed us to replicate our target DNA unbiased was 24. 
 1       2      3      4         5         6     7      8        9    10 
1.000 bp 
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Figure 5.6 Optimization of the PCR for the transposon-adjacent loci  
A representative graph of a real time PCR in which 5 µl of each sample was used to amplify the 
transposon junction site in the interrupted gene with primer Mar H. Based on results, after 24 
amplification cycles an unbiased replication of target DNA was observed (indicated by dotted line and 
number on the graph).  Same analysis was carried out on the rest of samples with the Mar primers A, 
B, C, D, E, F, G and J with similar results. 
 
After amplification, we investigated the distribution of fragments in our samples using the 
Agilent Bioanalyzer which uses a micro-capillary based electrophoretic cell.  Results allowed 
us to confirm the fragment size distribution of between around 400-600 bp using the peak 
height, (Figure 5.7). Also, quantification of purified samples demonstrated that the yield was 
between 2 µg/µl – 20 µg/µl.   
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Figure 5.7  Determination of fragment size distribution of the PCR products   
The purified products were investigated on BioAnalyser using a DNA100 chip, and the expected 
fragment size distribution was seen, a “bump” at ~400 bp to ~600 bp. The concentration of the DNA 
was estimated by calculating the area under the curve at the x-axis. At either end of the x-axis are DNA 
markers which enable the determination of fragment size. In x-axis DNA size in bp, and y-axis fluoresce 
intensity FU. 
 
Therefore, the laboratory multi-step approach executed in this study allowed us to obtain and 
prepare the DNA.  All our samples exhibited good quality, quantity, and were within the 
expected range size 400-600 bp which allowed us to move on to further sequencing analysis  
 
5.3.4 Sequencing results of our transposon library samples revealed 
suggested a good saturation level in both input and output samples  
 
Once sequencing results were obtained, the mutant richness was validated by mapping our 
sequences to a reference genome, M. tuberculosis H37Rv (access, NC_018143). This 
genome has 4,411,709bp with 4,286 genes from which 4,143 are coding, 51 RNAs, 92 
pseudogenes and 74,602 TA insertion sites (De Jesus M. A., 2017a). All our samples shared 
> 90% similarity to the reference genome which eliminated the possibility of contamination. 
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We also assessed the level of saturation in both input and output samples by determining the 
cumulative density of insertions. As shown on Figure 5.8, in our input sample we obtained 
reads in 47, 504 sites (63.68%) from a total of 74,602 TA sites. On the other hand, our output 
samples showed variable results according to the antibiotic. After RIF selection we counted 
mutants in 44,235 sites (58%), and after STM mutants were counted at 30,655 sites (41%).  
To interpret our results, we examined previous studies which indicate that good saturation 
levels ranked between 50% -60% (Griffin J. E., 2011, Zhang Y. J., 2012). We therefore 
concluded that RIF selection maintained the complexity of the Tn-library after selection; 
whereas a reduced mutant representation was observed in our output library after STM 
treatment. 
 
Figure 5.8  A representative plot that shows the number of sequences (reads starting with 
TA and following transposon) against the number of TA-mutants in an output library. 
The blue curve is based on the original sampled data and the red curve is an extrapolated curve fitted 
by the Michaelis-Menten function which allow to predict the number of mutants when sampling number 
goes to infinite, number indicated by the dashed green line. This graph is representative of one output 
data set obtained after RIF treatment. TA-mutant (when a unique TA site inserted by a transposon is 
located within a gene). 
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After we examined the enrichment of our output libraries and confirmed the sequence identity, 
we removed TA sites matching with the non-permissive (NP) sequence (GC)GNTANC(GC).  
The NP pattern was recently identified as a restrictive site for Himar1 insertion, and previous 
studies which included this site misclassified genes as being over-represented amongst 
essential genes (De Jesus M. A., 2017a).   In this study, 5986 (8%) of the total TA sites 
corresponded to NP site which we then filtered out from all sequencing data. 
Overall, mapping our input and output libraries to a reference genome allowed us to confirm 
that all sequenced genes corresponded to M. tuberculosis. In addition, measurement of 
enrichment level in the output sample after RIF treatment indicated that the identified genes 
affecting persister levels were truly caused by the antibiotic selection not mutant under-
representation.  However, the low mutant representation observed into output sample after 
STM treatment indicated that random loss of mutants may affect the resulting library 
composition.  
 
5.3.5 Analysis of the transposon library after selection using computational 
methods  
 
Once the sequencing data were validated; consistent to M. tuberculosis genome, and the 
enrichment level was measured in both input and output libraries, we aimed to identify genes 
affecting the persister frequency to RIF or STM independently. To do that we examined the 
sequencing results of our ouput libraries by statistical analysis assisted by the computational 
method TRANSIT resampling.  Considering that bacterial persisters have been described as 
cells able to survive drug treatments as a consequence of a reversible phenotypic tolerance 
rather than stable genetic mutations (Yuichi Wakamoto and Fr ançois  Signorino-Gelo, 2013) ,(Wakamoto Y., 2013)  our gene identification was 
mainly focused on comparing genes which were not absolutely essential, but instead have 
variable read counts after antibiotic treatment and whose disruption leads to a reduction or 
advantage in the ability of mycobacterial cell to deal with the antibiotic stress.    
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Our approach included calculating the read counts at all the TA sites and to all our 
experimental replicates in each condition. Following this, the difference between the sums of 
read-counts at each condition was calculated and the significance of this difference was 
evaluated by comparing it to a resampling distribution generated from randomly reshuffling 
the observed counts at TA sites in the region among all the datasets. A p-value was then 
calculated from the proportion of reshuffled samples with extreme differences that were 
observed in the real experimental data and it was adjusted by the Benjamini-Hochberg method 
(q-value) (De Jesus M. A., 2015). 
Once the data were processed by TRANSIT-resampling, genes were inspected by two criteria: 
the frequency of transposon insertions after antibiotic treatment and before antibiotic treatment  
(log2-fold change of output over input), with statistical significance estimated by q-value > 
0.05. To the former, we defined two categories, over-represented genes which had > 1, 6-fold 
and > 2-fold over-representation after exposure to RIF or STM respectively, and under-
represented genes which had > 2-fold under-representation. Once the conditions to analyse 
the dataset were defined, we ranked the genes from highest to lowest values according to the 
statistical significance. 
Using this approach, 16 and 96 genes respectively were identified as under-represented after 
RIF or STM treatment, suggesting that functions of those genes are required to survive 
antibiotic treatment, (Appendix 1).  In contrast, only 1 and 7 genes were identified as being 
over-represented in the libraries after STM or RIF selection respectively, suggesting that 
inactivation of these genes confers an advantage to survive the antibiotic exposure, (Figure 
5.9). To validate the accuracy of TRANSIT resampling method to identify genes affecting the 
level of persisters, we followed described procedures which examined the number and 
location of transposon insertions in each identified gene. Obtained results were  compared 
among the three experimental replicates in order to stablish the reproducibility of the results 
(De Jesus M. A., 2017b).  We expected a notable difference in the number of TA insertions 
between input and output libraries, and TA insertions at different locations along the gene. 
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Also, similar results among replicates confirm the reproducibility in our experiment.  Results 
showed a systematic variable count among individual TA sites across the genes with 
transposon insertions at different TA sites in each identified gene and a reduced number of 
insertions to the 5’ or 3’ ends. In addition, the over and under-represented genes were 
consistently identified among our three experimental replicates after selection with each 
antibiotic which demonstrated the reproducibility of our analysis.  
 
Figure 5.9 Genes identified using TRANSIT- resampling method were classified as 
being over-represented in the output libraries.  
The diagram shows the number of genes related to mycobacterial persisters identified by the TRANSIT-
resampling method.  The frequency between the number of insertions that were significantly different 
after antibiotic treatment was calculated as log2-fold change and used to classify the genes. In the top, 
over-represented genes which had > 1.6 or 2-fold change after RIF and STM treatment, respectively. 
In the bottom, under-represented genes which had < - 2-fold for both drugs. Genes obtained after RIF 
selection (purple colour), and genes obtained after STM treatment (green colour). 
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Once, TRANSIT resampling method was validated to accuracy and reproducibility, we went 
through the identified genes to identify common and individual characteristics as well as their 
relationship to genes previously associated with mycobacterial persisters.  Firstly, our study 
revealed that genes identified after RIF treatment were completely different to those identified 
after STM exposure, (Figure 5.10). This is consistent with previous results indicating that 
mechanisms involved in persistence are antibiotic-specific (Singh R., 2010).  
 
Figure 5.10 Relationship between genes identified after RIF and STM selection  
Venn diagram comparing the identified genes after treatment with RIF or STM. Genes are labelled as 
under and over-represented.   Results revealed no common genes across groups. Created on Venny 
2.1. 
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Because identified genes were antibiotic-specific, we wondered if there was a functional link 
between them. In order to test this we examined the identified genes by product, biological 
function and functional group using the information provided in the web site, TubercuList  (Lew 
JM., 2011).  As is showed on Appendix 1 and Figure 5.11, the results allowed us to categorize 
the identified genes by biological function. Most of the genes under and over- represented in 
the output libraries after each antibiotic treatment belonged to the functional group cell wall 
and cell processes. In addition, over-represented genes after RIF selection, and under-
represented genes after STM treatment participate in metabolism and respiration processes. 
This finding is in line with earlier studies of  the M. tuberculosis persisters in which the  
transcription profile revealed that pathways involved in energy and metabolism are important 
to survive under the presence of antibiotic (Keren I., 2011).   
Genes whose function is lipid metabolism were only identified in the under-represented gene 
group after both RIF and STM exposure.  However, the frequency observed was different to 
each antibiotic, while lipid metabolism genes represented 19% of under-represented genes 
after RIF treatment, a lower frequency consistent in 5% was identified after STM. Based on 
this result we concluded that lipids play a significant role in the ability of M. tuberculosis to 
bear stress caused by antibiotic treatment, and they are critical to survive under RIF presence, 
(Figure 5.11).  
Although genes involved in virulence, detoxification and adaptation were also identified as 
under-represented after treatment with both RIF and STM, they were more abundant after 
STM selection (9%). Interestingly 90% of genes belonging to this functional group identified 
after STM corresponded to toxin genes which confirmed TA modules as a formation 
mechanism of mycobacteria persisters (Keren I., 2011).  In addition, the fact that we only 
identified toxin genes after STM not RIF selection indicated that TA mechanism was specific 
to survive to this antibiotic.  
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Figure 5.11 Functionality analysis for identified genes in the library after antibiotic selection 
A pie chart showing the biological function for identified under-represented genes (A) and over-
represented (B) genes after RIF selection, 16 and 7 genes were included, respectively.  Biological 
function for under-represented genes after STM selection (C), a total of 96 genes were categorised.  
Values indicates the number of identified genes. Only one gene gid which encodes the glucose-inhibited 
division protein B Gid was identified as over-represented after STM treatment. Information obtained 
from TubercuList  (Lew JM., 2011).  Charts created on Excel, Office 2015  
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Due to the central role of the mycobacterial cell wall to survive the antibiotic treatment with 
39% and 23% of the identified genes after RIF and STM treatment, respectively. We 
scrutinised some of the genes belonging to this functional group.    
In this study ponA2 which encodes a class A penicillin-binding protein (PBP) responsible 
for glycan chain assembly and peptide cross-linking of bacterial peptidoglycan rodA  which 
encodes  a probable cell division protein RodA that plays a role in the stabilization of the FTSZ 
ring during cell division, and rpfE which encodes a probable  resuscitation promoting factor 
E (Rpf) involved implicated in resuscitation of M. tuberculosis from dormancy via a 
mechanism involving hydrolysis of the peptidoglycan were identified as under-represented 
after RIF and STM selection, respectively, (Appendix 1).   Previous investigations about these 
genes demonstrated their essential role to peptidoglycan remodelling required to both 
elongation and septation (Hett E. C., 2010).  We therefore postulated that if M. tuberculosis 
persisters in our study were less tolerant to insertions in ponA2, rodA and rpfE genes, the 
surviving mechanism implies fine modifications at cell wall level which adjust the bacterial 
division and cause a reduction in the growth rate. Future examination of this hypothesis is 
required to establish a possible relationship between ponA2, rodA and rpfE genes as well to 
clarify how modifications of a highly conserved process such as cell division take place without 
affecting the cell viability.  
 
On the other hand, since TA genes have been widely identified to be involved in bacterial 
persistence (Keren I., 2004b, Helaine S., 2014), we were particularly interested into examine 
TA modules in our identified genes. As Appendix 1 shows, many toxin genes were 
significantly under-represented after STM treatment, and they belonged mainly to VapBC 
(Virulence associated protein) family, and one to MazEF family. Interestingly, when we 
reviewed previous studies, we found that toxin families identified in our study inhibit the 
mechanism of translation which is also the action mode of STM (Ahidjo BA., 2011, Ramage 
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HR., 2009).  Because we found that insertions in these genes decrease the ability of the 
bacteria to survive the STM treatment, we concluded that activation of these toxin genes is a 
mechanism for generating mycobacterial persisters to STM. 
Previous studies demonstrated that persisters in vitro and in vivo have reduced metabolic 
activity, consistent with our observation that metabolic genes were over-represented in the 
RIF output pool  (Baek S., 2011).  For that reason, we reviewed the individual role of the 
identified genes belonging to metabolism functional category in order to elucidate their 
relationship to mycobacterial persisters.  
Genes corresponding to the operon Rv1129-1130-1131 were all over-represented in the 
output library after RIF, but not STM treatment, meaning that insertions in these genes 
increased the ability to survive under the presence of this antibiotic. Rv1129 is responsible for 
regulation of the transcription of the genes, prpC (Rv1131) and prpD (Rv1130) which encode 
the methylcitrate synthase (MCS) and 2-methyl-isocitrate lyase (MCL), respectively. These 
enzymes are in charge of the first two steps in the methylcitrate cycle which is required to 
metabolize the propionyl-CoA into pyruvate generated by β-oxidation of odd-chain fatty acids 
(Munoz-Elias E., 2006, Schnappinger D., 2003).  Our results indicate that inactivation of 
propionyl-CoA metabolism via the methylcitrate cycle increases M. tuberculosis persisters 
selected by RIF treatment, suggesting that accumulation of propionate (in the absence of a 
functional methyl citrate cycle), which is toxic to the cell may be a mechanism for forming 
persisters. Nevertheless, further studies are necessary to support this relationship as well to 
clarify how the persister cells face the higher concentration of a toxic metabolite such as 
propionate.   
Interestingly, after RIF selection we found that disruption of the Rv3420 (rimI) gene increased 
the ability of M. tuberculosis to survive to this antibiotic. This gene encodes RimI which is a 
protein/peptide Nα-acetyltransferase responsible of a post-translational modification 
consistent in N-terminal acetylation (Nα-acetylation) of proteins including the chaperones 
GroES and GroEL1 (Pathak D., 2016).  In eukaryotes acetylation has been linked to regulating 
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protein stability, degradation and protein-protein interactions, however the functional 
consequence of this modification in bacteria is unclear. Results obtained in this study revealed 
a possible persister formation mechanism in which M. tuberculosis down-regulates the protein 
acetylation to endure the RIF stress. 
Selection with RIF allowed us to identify ceoB gene as over-represented. Earlier investigation 
showed that K+ is essential requirement for bacterial metabolism and growth, and the two K+-
uptake systems, Trk and Kdp have been identified in M. tuberculosis. The Trk system 
comprises two TrkA proteins, CeoB and CeoC, which are encoded by the ceoB and ceoC, 
respectively  (Cholo M.C., 2008).   Recent studies demonstrated that disruption of trkA 
enhances rifampicin resistance in M. smegmatis (Castaneda-Garcıa A., 2011), however the 
situation around M. tuberculosis is unknown. We therefore conclude that disruption of ceoB 
gene in M. tuberculosis allowed to survive RIF exposure, and further investigation is required 
to stablish the mechanism behind. 
 
Selection with STM allowed us to identify gid (Rv3919) as the only over-represented gene. 
This gene encodes a conserved 7-methylguanosine (m7G) methyltransferase specific for the 
16S rRNA, and mutations within the gene confer low-level streptomycin resistance by the loss 
of a conserved m7G modification in 16S rRNA (Okamoto S., 2007).  The identification of gidB 
indicated that our selection with STM was limited because the surviving mechanism was 
resistance instead of persistence. 
 
Overall, identified genes in our output library indicate that M. tuberculosis persisters operate 
via independent parallel mechanisms, and how each one is activated depends of the antibiotic. 
Furthermore, persister phenotype appears to be controlled by a network of genes with a 
diversity of functions and future investigation may likely require combining several approaches  
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5.3.6 Examination of single- colony mutants obtained after antibiotic selection 
  
After screening our transposon library we aimed to confirm persister phenotype in the survivor 
fractions after treatment to each antibiotic (the survivor fraction is expected to be enriched for 
genes whose inactivation increases the frequency of persisters). We picked single colonies 
from the survivor pool to further test by killing curves and Sanger sequencing.  We sampled 
the output sample of each RIF or STM selection. A total of 30 colonies were isolated and 
resistance examined by measuring minimal inhibitory concentration (MIC). Results showed no 
changes in the MIC in 16 of the 30 colonies after RIF selection as well in 1 of the selected 
colonies after STM treatment, suggesting their possible persister phenotype. To the other 
colonies, 14 and 29 after RIF and STM treatment, respectively, the MIC was increased 
suggesting resistance was genetic rather than phenotypic. These were discarded to further 
sequencing.  
For the possible persister-associated transposon mutants, we next investigated the adjacent 
loci to the transposon to identify the mutated gene using Sanger sequencing. In order to do 
that we grew the colonies, extracted the DNA and PCR amplified with specific primers to the 
transposon Himar1. The amplified product was purified and sequenced by Sanger method.   
Results of the examination of sequences using Basic Local Alignment Search Tool (BLAST), 
NCBI are presented in Table 5.2, and allowed us to identify genes coding for cell entry proteins 
McE1A in our surviving colonies after RIF treatment. Previous findings suggested that 
inactivation of any of the genes in the mce1 operon confers a competitive growth advantage 
during the switch to from fast to slow growth rate (Beste D., 2009).  Our results indicate that 
this may also confer an increased tolerance to antibiotics. 
Finally, we attempted to compare identified genes by the individual colony examination and 
Tn-seq approach. Single mutants sequencing indicated that inactivation of genes involved in 
cell wall and cell processes, Rv2301, Rv2597 and RV3454 contributed to survive under the 
presence of RIF and reinforced our Tn-seq findings that pointed out that genes ponA2, rodA 
and rpfE whose participates in cell wall processes are important to survive the antibiotic 
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treatment. We also found that different genes were identified by each method, and only one 
genes in the over-represented category was detected in the single colony investigation, prpC, 
(Table 5.2). Despite the poor concordance between both results our comparison was useful 
to confirm the importance of the inactivation propionyl-CoA metabolism via the methylcitrate 
cycle a mechanism for forming persisters as prpC was identified by both methods. 
In addition, identification of riml after RIF selection in the over-represented category, and 
groeL1 after STM selection by the individual colony testing indicated that important 
modifications at post-translational level can contribute to M. tuberculosis persisters formation, 
and this mechanism might be shared by tolerance to RIF and STM. 
 
 
Table 5.2   Genes identified as being associated with persistence by sequencing the transposon 
adjacent loci of individual colony mutants obtained from survivor fractions in each antibiotic  
Information to each adjacent locus identified by Sanger sequencing.   Gene information obtained from 
TubercuList, https://mycobrowser.epfl.ch/. Mutant ID A4 to C10 were obtained from survivor fractions 
after RIF treatment, and STM_9 from survivor fraction after STM selection. Antibiotic indicates the 
mutant selection with RIF (R) or STM (S).  Letters represent the replicate where they came from A to C 
(three experimental replicates), numbers were randomly assigned to each colony at the moment of 
isolation.   
 
 
Mutant ID antibiotic Locus Gene Function Product Functional category
A4 R Rv1131 prpC citrate synthase Involved in methyl citrate cycle intermediary metabolism and respiration
A2 R Rv0814 sseC2 thought to be involved in sulphur metabolism conserved protein sseC2 intermediary metabolism and respiration
C6 R Rv0169 mce1A Mce - family protein Mce1A
unknown, but thought to be involved in host cell 
invasion (entry and survival inside macrophage) virulence,detoxification, adaptation
B8 R Rv2809 Rv2809 unknown Hypothetical protein Conseved hypotheticals
C2 R Rv0177 Rv01787 unknown probable conserved Mce asociated protein virulence,detoxification, adaptation
B9 R Rv2301 cut2 hydrolysis of cutin probable cutinase Cut2 cell wall and cell proccesses
A6 R Rv2082 Rv2082 unknown hypothetical protein Conseved hypotheticals
A7 R Rv2597 Rv2697 unknown probable membrane protein cell wall and cell proccesses
C3 R Rv0121 Rv0121 unknown conserved protein Conseved hypotheticals
C5 R Rv3454 Rv3454 unknown probable conserved integral membrane protein cell wall and cell proccesses
STM _9 S Rv3417 groEL1
prevents missfolding and promote the refolding and 
proper assembly of unfolded polypeptides 
generated 
under stress conditions 60 Kda chaperonin 1 GroEL1 virulence,detoxification, adaptation
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5.4 Discussion  
 
The power of any transposon-insertion sequencing (TIS) study is critically influenced by the 
complexity of the initial library generated and the maintenance of this complexity during 
selection. A library with a high degree of complexity contains multiple unique insertions in 
every locus, which together serve as independent indicators of a locus’ fitness and enables 
greater genomic precision in mapping the boundaries of regions of interest (Chao M. C., 2016). 
Therefore, one of the most challenging facets of our experimental design was to select the 
rare persister subpopulation, which is a small fraction of ~ 0.001-0.0001%, and simultaneously 
retain the representation of our mutant library. The library used in this study included 5x105 
mutants and our inoculum to the experiments was 40 times this number before selection. 
Antibiotic selection reduced the mutant population by 1000-fold; however, that still allowed us 
to recover about 104 cells in the putative persister population, which should provide a 
statistically valid sample of the mycobacterial genome of about 4,000 genes.  Despite our 
experimental procedures initially suggested an optimal complexity in our output library, the 
sequencing results indicated only good saturation level after RIF selection. In contrast 
sequencing result indicated a poor mutant enrichment after STM selection. This result can be 
supported by other studies which have also examined tn-libraries to identify genes required in 
specific conditions. For instance, Sassetti C. et al. (Sassetti et al., 2001), carried out a study 
to identify genes required for M. tuberculosis optimal growth using transposon site 
hybridization (TraSH). Results indicated that this method did not allow differentiation between  
non-viable and under-represented mutants, suggesting that the number of genes identified as 
essential could be underestimated (Sassetti C., 2003).  In contrast, Griffin J. et al. (Griffin J. 
E., 2011), used highly parallel Illumina sequencing to identify under-represented mutants by 
lower number of sequence reads, and reclassified genes previously predicted as essential as 
viable mutants with a fitness defect (Griffin J. E., 2011) . 
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Genes affecting STM persistence 
Results showed that VapBC3, VapBC31, and VapBC49 genes were among the under-
represented genes after STM treatment.  As described in the Introduction, several toxin-
antitoxin systems have been associated with persistence in bacteria, including M. 
tuberculosis.  Our output library after STM selection revealed that vapC3 is important to 
survive the antibiotic treatment as it was significantly under-represented after STM selection.  
We also  identified in the sequencing data from the output library after STM treatment that the 
genes vapC19, vapC7, vapC30 and vapC17 were under-represented which reinforce the 
previous suggestion that TA systems are regulated independently and multiple VapC could 
act as regulators of translation in response to an environmental stress (Ramage HR., 2009) 
(Sala A., 2014a).   
Our results could support a link between slow growth and persistence based on studies which 
demonstrated that VapBC provides the cell with an elegant mechanism to regulate sugar 
metabolism by targeting specific genes involved in carbon source utilization in response to the 
anabolic demands of the cell (e.g., fast or slow growth), thus acting as a link between energy-
producing and energy-consuming reactions in the cell  (McKenzie J., 2012). 
We also identified the mazF6 gene as under-represented after STM selection. This was 
consistent with previous observations that indicated that several mazF genes of the M. 
tuberculosis mazF6, mazF5 and mazF1 led to a state of reversible bacteriostasis which may 
be a strategy to survive antibiotic exposure (Singh R., 2010). Furthermore, interesting findings 
revealed that the MazF6 toxin is induced by the septum inhibiting protein SojMtb which 
coordinates a regulatory mechanism involving cell cycle control at the point of septum 
formation. The endoribonuclease activity of this toxin contributes to produce transcripts 
needed for successful entry into non-replicating persistence (Ramirez M., 2013). Further 
investigation of these genes could contribute to establishing a link between mycobacterial non-
replicating persistence, and drug- tolerant persisters. 
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Another set of genes intimately involved in growth regulation are the Rpf (Resuscitation-
promoting factors) identified by Downing K. et al. (Downing K. J., 2004) who suggested that 
are likely peptidoglycan hydrolases involved in cell wall modification.  Mutants of each of the 
five rpf-like genes of M. tuberculosis H37Rv did show growth defects and/or changes in 
colonial morphology when plated on solid media, but an increased tendency to clump in liquid 
culture was also found for the rpfA mutant. Interestingly, regulatory interdependence between 
the rpf-like genes was found, which may permit compensation for loss of gene function to 
occur. Furthermore, deletion of rpfA and -B resulted in altered cell wall structure. Also, 
intracellular growth defect was observed for rpf mutant strains of M. tuberculosis in 
macrophages with greater amounts of both TNF- α and IL-6 than those infected with wild type 
strain. Together these results suggest that Rpfs may play a role in host immune evasion, 
possibly through their activities on the mycobacterial cell wall and consequent ability to survive 
the presence of antibiotic  (Russell-Goldman E., 2008).  
Overall, the principle characteristic of genes that modify the frequency of persisters to STM in 
M. tuberculosis is their involved in cell growth control. 
Genes affecting persistence to RIF 
Slow growth is another mechanism responsible of bacterial persistence (Balaban N. Q., 2004), 
and the fact that we identified genes encoding to proteins required to growth and division was 
very exciting because they could support a link between  mycobacterial persisters and 
changes in growth. Previously, Hett E. et al. (Hett E. C., 2010),  identified the bifunctional 
peptidoglycan-synthesizing enzyme, penicillin binding protein 1 (PBP1). Depletion of the 
ponA1 gene, which encodes PBP1 in M. smegmatis, caused a severe growth defect and 
abnormally shaped cells indicating that PBP1 is essential for viability and cell wall stability. In 
addition, the complex between PBP1 with RipA (an endopeptidase that interacts with the lytic 
transglycosylase, RpfB, at the septum of dividing cells) inhibits peptidoglycan (PG) hydrolysis 
sufficiently to allow septal PG synthesis. Overall, coordination between PG synthases and 
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hydrolases (autolysins) is critical for growth and division, as well as maintenance of cellular 
shape. In this study ponA1 gene was identified as under-represented after RIF treatment.   
Another gene that was identified as under-represented after RIF treatment was rodA (ftsW) 
which works together with ftsZ which is recruited to the septum, and subsequently other 
interactions with other cell division proteins take place in a spatially and temporally controlled 
manner. In addition, it has been suggested that the observed FtsZ and FtsW interactions are 
biologically relevant because the FtsZ mutant protein that is shown to be defective for 
interactions with FtsW in vitro, is not proficient for cell division and viability. Thus, it is likely 
that the function of mycobacterial FtsW is pleiotropic in that it could promote the targeting of 
FtsZ protein to the pre-divisional site and subsequently be involved in the stabilization of FtsZ 
rings and or for other aspects of cytokinesis following the assembly of Z-rings  (Datta P., 2002)  
(Rajagopalan M., 2005).  Once again, the identification of these genes as affecting persistence 
indicate the intimate role that cell growth control plays in mycobacterial persistence. 
Many of the gene affecting persistence to RIF were associated with central metabolism and 
energy metabolism. These included several genes involved in propionate metabolism that 
were over-represented in the output library indicating that their inactivation increased the 
frequency of persisters.  Propionyl-CoA is a central metabolite required to produce the methyl-
branched lipids of the cell wall but elevated concentrations of this are toxic to cells and lead to 
slow growth (Aguilar-Ayala DA., 2017).  In addition, it has been found that genes required for 
propionate metabolism prpD and prpC are upregulated after internalization by resting and IFN-
γ-activated murine macrophages which indicated that methylcitrate cycle is required for M. 
tuberculosis metabolism during intracellular growth because it uses fatty acids as a carbon 
source during in vivo growth (Schnappinger D., 2003).  Our data suggests that, in wild-type 
cells, propionyl-CoA metabolism via methylcitrate cycle is used to remove toxic propionate 
that would slow growth. However, inactivation of these genes by transposon insertion leads to 
persistence since toxic propionyl-CoA then accumulates leading to slow growth, which is 
associated with persistence.  Our initial assumption was that persisters optimize their energy 
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consumption by switching off the methylcitrate cycle and keeping active the metabolic pathway 
to propionyl-CoA via isocitrate lyases (ICL1 and ICL2)  (Munoz-Elias E., 2006). However, a 
very recent study of genome-wide association of M. tuberculosis isolates from China found 
mutations in the gene encoding the transcription factor prpR enriched in drug-resistant strains 
(Hicks N., 2018). In the study, prpR mutations were found to confer conditional drug tolerance 
to INH, ofloxacin (OFLX) and RIF in clinical strains by altering propionyl-CoA metabolism, and 
prpR-mediated drug tolerance took place only in the presence of propionate as a carbon 
source. Importantly, the cited study validated our finding of the involvement of propionyl-CoA 
metabolism in M. tuberculosis persistence, but in a clinical setting. However, many questions 
remain to be answered, for instance. For example, why is propionyl-CoA metabolism involved 
in the persister mechanism when our media did not include propionate or any substrate like to 
generate propionate, such as odd-chained fatty acids ?   
Because propionyl-CoA results from degradation of odd-chain fatty acids, branched-chain 
amino acids, or the side chain of cholesterol (Chopra T., 2013), it is possible that propionyl 
CoA in our experiment resulted from degradation of branched-chain amino acids. Overall 
future investigation can contribute to establish how propionate was generated and to answer 
other important questions, what is the mechanism used by persisters to survive under the 
propionate toxicity?  Do persisters require the methyl-branched lipids?  If so how do cells 
synthetize them?  
In this study, transposon insertions in the riml gene were found over-represented after RIF 
treatment.  This gene encodes Riml which is possibly responsible of N-terminal acetylation 
(Nα-acetylation) of ribosomal proteins and chaperone proteins GroES and GroEL1 (Pathak 
D., 2016). While chaperons are important to survival during various stress conditions, Nα-
acetylation of proteins appears essential in all three domains of life, for instance, in eukaryotes 
Nα-acetylation is related to protein degradation signal, protein translocation to ER and protein-
protein interactions (Stkarheim K., 2012). Despite that little is known about Nα-acetylation in 
bacteria, reports of acetylated protein in mycobacteria revealed that acetylation of EsxA 
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(ESAT-6, for early secreted antigenic target, 6 kDa) is inversely associated to virulence 
probably he N-terminal charge reduction that results from N-α-terminal acetylation could 
affect protein interaction as well as the levels of EsxA export to the cell surface (Medie F., 
2014). Results presented in this study indicated that important changes at post-transcriptional 
and protein-protein interaction can be executed as a formation mechanism to M. tuberculosis 
persisters. Firstly, Tn-seq allowed to identify riml as over-represented gene after RIF treatment 
indicating that a mechanism used by M. tuberculosis persisters to this antibiotic involved 
alteration in the acetylation process.  Next, single colony testing from cultures exposed to STM 
showed that gene groEL1 indicating that M. tuberculosis persisters inhibits the chaperone 
GroEL1 to survive STM. Due to the described relationship between the genes riml (encodes 
Riml) and groEL1 (encodes GroEL1) in which Riml is possibly responsible of the N-terminal 
acetylation of GroEL1 (Pathak D., 2016), future studies are essential to understand functional 
consequences of alteration in the acetylation of GroEL1.  
K+ is essential requirement for bacterial metabolism and growth, and M. tuberculosis has two 
K+ uptake systems, TrkA and Kdp. While the former system has a major role in osmotic stress 
tolerance, internal pH maintenance, regulation of protein activity and the control of bacterial 
virulence, the Kdp system is expressed when the Trk system is inactivated and its activation 
follows a response to several stimuli including ionic and non-ionic solutes, pH, growth 
temperature and low concentrations of K+ (Cholo M.C., 2008).  Here we found that disruption 
of ceoB gene which is a component of Trk system increased the ability of M. tuberculosis to 
survive to RIF. Several options could arise; mycobacterial persisters K+ uptake using Kdp 
system or lower levels of K+ are required by a persister cell growing a slow rate.  We cannot 
exclude that ceoB disruption increase the ability to survive to RIF because resistance rather 
than persistence since investigators demonstrated that mutations in ceoB enhanced the 
resistance to RIF in M. smegmatis by cell permeability alterations  (Castaneda-Garcıa A., 
2011). 
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Other identified gene in this study as related to persisters  to RIF was mce which was also 
found in a previous screening of a transposon mutant library in Mycobacterium bovis (BCG by 
Transposon site hybridization (TraSH) (Beste D., 2009). In the mentioned study, investigators 
aimed to define genes required for slow and fast growth and for the requirements of switching 
growth rate.  Results showed that inactivation of any of the genes in the mce1 operon and 
their associated genes confers a competitive growth advantage during the switch to from fast 
to slow growth rate. Importantly, the identification of mce in our output library can help to 
establish if mycobacterial persisters switch to slow growth to survive under the antibiotic 
presence.  
Our attempt to identify genes affecting persister frequency by two methods, tn-seq and 
examination of single colonies showed concordance in one gene, prpC. This result pointed 
out the important role of inhibition of propionate metabolism via methyl citrate cycle as a 
mechanism for mycobacteria persister formation in response to RIF. 
 
5.5 Conclusions 
 
▪ The Tn-seq method was a valuable tool that allowed us to identify genes affecting the 
frequency of persisters after RIF or STM treatment, independently.    
▪ TRANSIT resampling was a reliable method to analyse our dataset which allowed us 
to identify gene inactivations that increase or decrease the ability of  M. tuberculosis to 
survive under the presence of antibiotic. 
▪ The majority of genes related to persister phenotype were different for each antibiotic, 
suggesting that persister phenotype operates independent parallel mechanisms 
dependent on the antibiotic used. 
▪ Identified genes after RIF selection were mainly associated with cell wall and cell 
processes and metabolism and respiration functions, which may both be part of a 
highly synergistic and coordinated persister formation and survival mechanism. 
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▪ This study confirmed the important role of TA modules to mycobacterial persisters as 
several toxin genes were identified after STM treatment. 
▪ There was a marked redundant functionality within the identified genes, therefore 
examining whole pathways or making multiple knock-out might be a rational approach 
to investigate the mechanism behind persister phenotype. 
▪ The results obtained in this study have opened a new insight into mycobacterial 
persisters, and further investigation of these identified genes could contribute to 
advancement in the development of therapies to control this mycobacterial sub-
population and reduce treatment length. 
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6. General discussion and future work 
 
Tuberculosis continues to present serious problems to public health, and one of the main 
obstacles to control this infectious disease has been the length of the treatment which is 
needed to sterilize a small fraction of cells widely known as persisters  (Islam M. S., 2012).  
This cell subpopulation is able to survive in the presence of the antibiotic, but the factor or 
mechanims related are still unclear.  Slow growth is clearly a factor so improving the 
understanding of the population heterogeneity of cell size and growth is considered to be a 
key to future advances in understanding how to eradicate persiters faster.   The majority of 
studies of persistence  have used E. coli in which cells divides symetrically (Taheri-Araghi S., 
2015).  In contrast, mycobacteria has a polar asymetrical growth, thus the daughter that 
inherited the older pole is larger and and elongates faster while the sister inheriting the new 
pole, is born smaller and elongates more slowly (Aldridge B., 2012). Importantly, this growth 
mechanism has diferential effects to antibiotic treatment.  In adittion, whereas some studies 
suggested that mycobacteria regulate their size by timer model (Aldridge B., 2012), a recent 
investigation found that mycobacteria cells follow the adder model (Priestman M., 2017).  
There is therefore controversy around how mycobacteria maintain their size homeostasis. The 
findings presented in this work supported the previous findings to some extent, thus we 
confirmed that M. smegmatis growth is extensively variable in the general population. 
However, our single cell studies indicated that while smaller cells follow a timer model, the 
longer cells are more compatible with an adder model. These variability in growth creates a 
heterogeneous population that underlies mycobacterial persisters.  Furthermore, our 
inheritance studies suggested that birth and division length are inherited from mother to 
daughters while elongation length and time are fixed each cell generation.  Therefore, while 
bacterial growth has been considered as a highly conserved process it could be hypothesized 
as a dynamic process in which the cell division is controlled by both deterministic and 
stochastic mechanisms. Future work could include performing similar studies on a large cell 
sample to improve the statistical robustness.  Most importantly, further studies could examine 
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how the different subpopulations originated by the variable growth respond to antibiotic 
treatment. In this study, we stablished an experimental model to measure the persister cells 
in M. smegmatis cultured in batch. Our method allowed to obtain reproducible results using 
different antibiotics, and mycobacteria strains. We also attempted to assess the relationship 
between growth rate and mycobacterial persistence. We designed experiments to control 
growth rate through the expression of an essential gene such as leuD, however this strategy 
did not work so we were unable to test out hypothesis that changes in the growth underlie 
mycobacterial persistence.  Future work could include a weaker promoter to obtain a notable 
difference in the growth rate. Another attractive alternative could be exploring regulated 
expression systems to control gene expression. 
This study is a first insight to identify genes that contribute, either negatively or positively, to 
the emergence of RIF and STM persisters in M. tuberculosis using Tn-seq.  Our analysis 
revealed that genes involved in drug-tolerance for both antibiotics participate on different cell 
processes, cell wall assembly, lipid metabolism, adaptation and respiration functions, 
suggesting that a highly coordinated mechanism among several cell processes is involved in 
persistence suggesting that future studies could require combining several complementary 
approaches. Future work includes evaluating defined mutants to confirm persisters 
phenotype, as well as complementation studies. Obtained results could contribute to 
advances in the development of therapies to control this mycobacterial sub-population. 
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8. Appendix 
 
 
Identified genes by in output libraries after A) RIF or B) STM treatments 
Information to each locus is presented as well as log2 fold- change (FC) values. Negative sign 
on the log2FC indicates genes that were under-represented (disruption on these genes 
decreases the ability to survive under antibiotic presence), no sign on the log2FC are genes 
which were over represented (insertion in these genes confers advantage to survive the 
antibiotic treatment). Gene specific Data obtained from TubercuList web site. 
 
 
A.  
 
 
Gene 
 
log 2-fold 
change 
 
Function 
 
Product 
 
Functional 
category 
 
Rv3267 
 
-4.29 
 
unknown 
Conserved protein (CPSA-
related protein) 
 
conserved 
hypothetical 
 
Rv0007 
 
-4.23 
 
Unknown 
 
Possible conserved 
membrane protein 
 
cell wall and cell 
processes 
 
 
 
mmAa4 
 
 
 
-3.77 
 
Involved in mycolic acids 
modification.  
Catalyzes unusual S-
adenosyl-methionine-
dependent 
transformation  
of a cis-olefin mycolic 
acid into a secondary 
alcohol 
 
 
Methoxy mycolic acid 
synthase 4 MmaA4  
 
 
 
lipid metabolism 
 
Rv1085 
 
-3.56 
 
Unknown, but supposedly 
involved in virulence 
 
Possible hemolysin-like 
protein 
virulence, 
detoxification, 
adaptation 
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Rv2700 
 
-3.14 
 
unknown 
Possible conserved 
secreted alanine rich 
protein 
cell wall and cell 
processes 
 
Rv1096 
 
-2.71 
 
Probably involved in 
carbohydrate 
degradation 
 
Possible glycosyl hydrolase 
intermediary 
metabolism and 
respiration 
 
sirA 
 
-2.6 
 
Catalyzes the reduction of 
sulfite to sulphide 
 
 
Ferredoxin-dependent 
sulfite reductase SirA 
 
intermediary 
metabolism and 
respiration 
 
 
glnQ 
 
 
-2.56 
Thought to be involved in 
active transport of 
glutamine across the 
membrane (import).  
Responsible for the 
translocation of the 
substrate across the 
membrane 
 
Probable glutamine-
transport ATP-binding 
protein ABC transporter 
GlnQ 
 
 
cell wall and cell 
processes 
 
fadE5 
 
 
-2.55 
 
Function unknown, but 
involved in lipid 
degradation 
 
Probable acyl-CoA 
dehydrogenase FadE5 
 
lipid metabolism 
 
ponA2 
 
-2.54 
 
Involved in peptidoglycan 
synthesis (at the final 
stages), cell wall 
formation.  
 
Probable bifunctional 
membrane-associated 
penicillin-binding protein 
1A/1B PonA2  
 
cell wall and cell 
processes 
 
cpsA 
 
-2.53 
 
unknown 
 
Possible conserved protein 
CpsA 
 
conserved 
hypothetical 
 
Rv3220 
 
-2.52 
 
Sensor part of a two 
component regulatory 
system 
 
Probable two component 
sensor kinase 
 
regulatoty proteins 
 
TB8.4 
 
-2.27 
 
Unknown function 
(secreted protein) 
 
Low molecular weight T-
cell antigen TB8.4 
 
cell wall and cell 
processes 
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mpa -2.26 Involved in proteasomal 
protein degradation 
Mycobacterial proteasome 
ATPase Mpa 
cell wall and cell 
processes 
 
 
rodA 
 
 
-2.23 
This is a septum-
peptidoglycan 
biosynthetic protein, 
involved in cell wall 
formation.  
Plays a role in the 
stabilization of the FTSZ 
ring during cell division. 
 
 
Probable cell division 
protein RodA 
 
cell wall and cell 
processes 
 
Rv0129c 
 
-2.12 
Proteins of the antigen 85 
complex are responsible 
for  high affinity of 
mycobacteria to 
fibronectin.  
Secreted antigen 85-C FbpC 
(85C) (antigen 85 complex 
C) (AG58C)  
lipid metabolism 
 
Rv1129c 
 
2.76 
 
transcriptional regulator 
 
Involved in transcriptional 
mechanism 
 
regulatory proteins 
 
Rv2690c 
 
2.54 
 
hypothetical protein 
 
Unknown 
cell wall and cell 
processes 
 
prpC 
 
2.24 
 
citrate synthase 
 
Involved in methyl citrate 
cycle  
intermediary 
metabolism and 
respiration 
 
rimI 
 
2.14 
 
ribosomal-protein-
alanine acetyltransferase 
 
Acetylates the N-terminal 
alanine of ribosomal 
protein S18  
 
information 
pathways 
 
prpD 
 
2 
 
2-methylcitrate 
dehydratase 
 
Involved in methyl citrate 
cycle 
intermediary 
metabolism and 
respiration 
ceoB 1.61 trk system potassium 
uptake protein TrkA 
TRK system potassium 
uptake protein CeoB 
cell wall and cell 
processes 
Rv1957 1.56 hypothetical protein Hypothetical protein conserved 
hypothetical 
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B. 
 
 
Gene 
 
Product 
log 2-fold 
change 
 
Function 
 
Functional group 
Rv0201c hypothetical protein -4.09 unknown conserved 
hypotheticals 
Rv0108c hypothetical protein -3.65 unknown conserved 
hypotheticals 
 
mbtG 
 
L-lysine 6-
monooxygenase mbtG 
 
-3.53 
Involved in the biogenesis 
of the 
hydroxyphenyloxazoline-
containing siderophore 
mycobactins. 
 
lipid metabolism 
 
vapC19 
Possible toxin VapC19  
-3.28 
unknown virulence, 
detoxification, 
adaptation 
 
Rv0207c 
 
hypothetical protein 
 
-3.19 
 
unknown 
conserved 
hypotheticals 
 
Rv3677 
 
possible hydrolase 
 
-3.18 
Function unknown; 
probably involved in 
cellular metabolism 
intermediary 
metabolism and 
respiration 
Rv0612 hypothetical protein -3.14 unknown conserved 
hypotheticals 
PE_PGRS10 PE-PGRS family protein -3.13 unknown lipid metabolism 
PPE23 PPE family protein PPE23 -3.01 unknown cell wall and cell 
proccesses 
rsfA Anti-anti-sigma factor 
RsfA 
-2.99 Regulates negatively 
Rv3287c|RSBW|USFX 
Information pathways 
 
Rv1352 
 
hypothetical protein 
 
-2.98 
 
unknown 
conserved 
hypotheticals 
 
Rv1707 
 
Probable conserved 
transmembrane protein 
 
-2.97 
Unknown; possibly 
involved in transport of 
sulfate across the 
membrane 
 
cell wall and cell 
proccesses 
Rv1580 phiRv1 phage protein -2.91 unknown insertion seqs and 
phages 
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Rv2857 
Probable short-chain type 
dehydrogenase/reductase 
 
-2.82 
Function unknown; 
possibly involved in 
cellular metabolism 
intermediary 
metabolism and 
respiration 
  
rpfE 
 
Probable resuscitation-
promoting factor RpfE 
 
-2.82 
Thought to promote the 
resuscitation and growth 
of dormant, nongrowing 
cells. 
 
cell wall and cell 
proccesses 
 
mazF6 
  
Toxin MazF6 
 
-2.81 
Sequence-specific mRNA 
cleavage 
virulence, 
detoxification, 
adaptation 
 PPE51 PPE family protein PPE51 -2.8 unknown cell wall and cell 
proccesses 
 
folP2 
 
dihydropteroate synthase 
2 folP2 
 
-2.78 
 
Involved in dihydrofolate 
biosynthesis 
intermediary 
metabolism and 
respiration 
 
vapC7 
  
Possible toxin VapC7 
 
-2.77 
 
unknown 
virulence, 
detoxification, 
adaptation 
 
PE_PGRS20 
PE-PGRS family protein 
PE_PGRS20 
 
-2.69 
 
unknown 
 
PE/PPE 
  
Rv3493c 
Conserved hypothetical 
Mce associated alanine 
and valine rich protein 
 
-2.66 
 
unknown 
 
cell wall and cell 
proccesses 
 
Rv2078 
Conserved hypothetical 
Mce associated alanine 
and valine rich protein 
 
-2.63 
 
unknown 
 
cell wall and cell 
proccesses 
Rv0163  Conserved protein -2.62 unknown conserved 
hypotheticals 
 
ahpD 
alkyl hydroperoxide 
reductase AhpD 
 
-2.59 
 
Involved in oxidative stress 
response 
 
virulence, 
detoxification, 
adaptation 
Rv2309c  Possible integrase -2.58 Use for sequence 
integration 
insertion seqs and 
phages 
 
Rv2792c 
 
possible resolvase 
 
-2.56 
Prevents the cointegration 
of foreign DNA before 
integration into the 
chromosome 
 
insertion seqs and 
phages 
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Rv2700 
Possible conserved 
secreted alanine rich 
protein 
 
-2.55 
 
unknown 
 
cell wall and cell 
proccesses 
 
ugpB 
Probable Sn-glycerol-3-
phosphate-binding 
lipoprotein UgpB 
 
-2.51 
Involved in active 
transport of Sn-glycerol-3-
phosphate and 
glycerophosphoryl 
diesters across the 
membrane 
 
cell wall and cell 
proccesses 
Rv0272c unknown protein -2.5 unknown conserved 
hypotheticals 
Rv1546 conserved protein -2.5 unknown conserved 
hypotheticals 
 
Rv1115 
  
Possible exported protein 
 
-2.48 
 
unknown 
intermediary 
metabolism and 
respiration 
Rv0762c Conserved hypothetical 
protein 
-2.48 unknown conserved 
hypotheticals 
 
PE_PGRS36 
PE-PGRS family protein 
PE_PGRS36 
 
-2.47 
 
unknown 
 
PE/PPE 
Rv1598c conserved protein -2.47 unknown conserved 
hypotheticals 
 
mtn 
 
MTA/SAH nucleosidase 
 
-2.47 
 
Probable bifunctional 
MTA/SAH nucleosidase  
intermediary 
metabolism and 
respiration 
 
fabG3 
Possible 20-beta-
hydroxysteroid 
dehydrogenase FabG3 
-2.45 Not really known; thought 
to be involved in lipid 
biosynthesis 
 
lipid metabolism 
Rv0405c beta lactamase like 
protein 
-2.43 unknown conserved 
hypotheticals 
Rv0911 conserved protein -2.43 conserved proteins conserved 
hypotheticals 
Rv1597 hypothetical protein -2.41 unknown cell wall and cell 
proccesses 
 
Rv1524 
 
Probable 
glycosyltransferase 
 
-2.4 
 
unknown 
 
intermediary 
metabolism and 
respiration 
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cyp123 
probable cytochrome 
P450 123 cyp123 
 
-2.4 
Cytochromes P450 are a 
group of heme-thiolate 
monooxygenases 
intermediary 
metabolism and 
respiration 
 
Rv0881 
Possible rRNA 
methyltransferase 
 
-2.4 
  
Causes methylation 
cell wall and cell 
proccesses 
  
vapC30 
 
Possible toxin VapC30 
 
-2.39 
 
unknown 
virulence, 
detoxification, 
adaptation 
 
mycP1 
Membrane-anchored 
mycosin MycP1 
 
-2.39 
 
Has proteolytic activity. 
intermediary 
metabolism and 
respiration 
 
dnaQ 
 
Probable DNA 
polymerase III (epsilon 
subunit) DnaQ 
 
-2.39 
DNA polymerase III is a 
complex, multichain 
enzyme responsible for 
most of the replicative 
synthesis in bacteria 
 
information pathways 
  
echA6 
 
Possible enoyl-CoA 
hydratase EchA6 
 
-2.38 
Could possibly oxidize 
fatty acids using specific 
components 
 
lipid metabolism 
  
dacB2 
 
Probable penicillin-
binding protein DacB2 
 
-2.37 
 
Involved in peptidoglycan 
synthesis 
 
cell wall and cell 
proccesses 
 PE12  PE family protein PE12 -2.37 unknown PE/PPE 
 
Rv2144 
Probable transmembrane 
protein 
-2.36 unknown cell wall and cell 
proccesses 
 
Rv3542 
 Conserved hypothetical 
protein 
-2.36 unknown conserved 
hypotheticals 
  
vapC17 
Possible toxin VapC17 -2.35  Unknown virulence, 
detoxification, 
adaptation 
 
Rv3690 
 
Probable conserved 
membrane protein 
 
-2.34 
  
Unknown 
 
cell wall and cell 
proccesses 
Rv3363  Conserved hypothetical 
protein 
-2.34  Unknown conserved 
hypotheticals 
 
mce3D 
  
Mce-family protein 
Mce3D 
 
-2.32 
Unknown, but thought to 
be involved in host cell 
invasion 
virulence, 
detoxification, 
adaptation 
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Rv2326c 
Possible transmembrane 
ATP-binding protein ABC 
transporter 
 
-2.31 
Probably involved in active 
transport accross the 
membrane 
 
cell wall and cell 
proccesses 
 
 
mbtN 
 
Acyl-CoA dehydrogenase 
MbtN 
 
 
-2.28 
Thought to be involved in 
the biogenesis of the 
hydroxyphenyloxazoline-
containing siderophore 
mycobactins 
 
 
lipid metabolism 
 
Rv0397a 
 Conserved 13E12 repeat 
family protein 
 
-2.27 
 
Unknown 
 
insertion seqs and 
phages 
 
Rv1138c 
  
Possible oxidoreductase 
 
-2.27 
 Function unknown; 
probably involved in 
cellular metabolism. 
intermediary 
metabolism and 
respiration 
 
pepC 
 
Probable aminopeptidase 
PepC 
 
-2.26 
Function unknown; 
possibly hydrolyzes 
peptides and/or proteins. 
intermediary 
metabolism and 
respiration 
Rv2308 hypothetical protein -2.24 unknown conserved 
hypotheticals 
 Rv2315c  Conserved protein -2.24 unknown conserved 
hypotheticals 
 
Rv3632 
  
Possible conserved 
membrane protein 
 
-2.22 
 
unknown 
 
cell wall and cell 
proccesses 
Rv2035 hypothetical protein -2.22 unknown conserved 
hypotheticals 
  
galE2 
Possible UDP-glucose 4-
epimerase GalE2 
 
-2.21 
 
Involved in galactose 
metabolism 
intermediary 
metabolism and 
respiration 
  
sugB 
Probable sugar-transport 
integral membrane 
protein ABC transporter 
SugB 
 
-2.2 
 
Involved in active 
transport of sugar across 
the membrane 
 
cell wall and cell 
proccesses 
 
nth 
 
Probable endonuclease III 
Nth 
 
-2.17 
Has both an apurinic 
and/or apyrimidinic 
endonuclease activity and 
a DNA N-glycosylase 
activity 
 
information pathways 
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Rv1322  Conserved hypothetical 
protein 
-2.16 Unknown conserved 
hypotheticals 
 
Rv2850 
 
Possible magnesium 
chelatase 
 
-2.16 
Function unknown; 
possibly introduces a 
magnesium ion into 
specific 
substrate/compound. 
 
intermediary 
metabolism and 
respiration 
 
Rv0063 
 
Possible oxidoreductase 
 
-2.16 
Function unknown; 
probably involved in 
cellular metabolism. 
intermediary 
metabolism and 
respiration 
 
Rv3054 
Conserved hypothetical 
protein 
 
-2.15 
unknown  
conserved 
hypotheticals 
 
Rv0839 
Conserved hypothetical 
protein 
 
-2.15 
unknown  
conserved 
hypotheticals 
 
Rv3191c 
  
Probable transposase 
 
-2.15 
Involved in the 
transposition of an 
insertion sequence. 
 
insertion seqs and 
phages 
 
sugA 
Probable sugar-transport 
integral membrane 
protein ABC transporter 
SugA 
 
-2.14 
 
Involved in active 
transport of sugar across 
the membrane (import) 
 
cell wall and cell 
proccesses 
 
iniB 
 Isoniazid inductible gene 
protein IniB 
 
-2.14 
 
unknown 
 
cell wall and cell 
proccesses 
  
aldA 
Probable aldehyde 
dehydrogenase NAD 
dependent AldA  
 
-2.13 
 
Oxidizes a variety of 
aldehydes 
intermediary 
metabolism and 
respiration 
 
 ureD 
Probable urease 
accessory protein UreD 
 
-2.12 
  
Probably facilitates nickel 
incorporation 
intermediary 
metabolism and 
respiration 
Rv1132 Conserved membrane 
protein 
-2.09 unknown cell wall and cell 
proccesses 
 
Rv2136c 
 
Possible conserved 
transmembrane protein 
 
-2.09 
 
unknown 
 
cell wall and cell 
proccesses 
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Rv2663 hypothetical protein -2.09 unknown conserved 
hypotheticals 
 
Rv0265c 
 
iron complex transporter 
substrate-binding 
 
-2.08 
Thought to be involved in 
iron transport across the 
membrane (import) 
 
cell wall and cell 
proccesses 
Rv1507A hypothetical protein -2.07 unknown Unknown 
Rv1673c hypothetical protein -2.07 unknown conserved 
hypotheticals 
 
lipV 
 
possible lipase lipV 
 
-2.07 
Function unknown; 
presumed lipolytic enzyme 
involved in cellular 
metabolism 
intermediary 
metabolism and 
respiration 
 
vapC3 
 
Possible toxin VapC3 
 
-2.06 
 
unknown 
virulence, 
detoxification, 
adaptation 
  
hisC2 
Probable histidinol-
phosphate 
aminotransferase HisC2 
 
-2.06 
 
Involved in histidine 
biosynthetic pathway 
intermediary 
metabolism and 
respiration 
Rv0061 hypothetical protein -2.05 unknown conserved 
hypotheticals 
 
Rv3446c 
hypothetical alanine and 
valine rich protein 
 
-2.05 
 
unknown 
 
conserved 
hypotheticals 
 
Rv2943 
Probable transposase for 
insertion sequence 
element IS1533 
 
-2.05 
Required for the 
transposition of the 
insertion element IS1533 
 
insertion seqs and 
phages 
Rv2517 hypothetical protein -2.04 unknown conserved 
hypotheticals 
PPE12 PPE family protein -2.04 unknown PE/PPE 
 
Rv1520 
 
probable sugar 
transferase 
 
-2.03 
unknown; probable 
involved on cellular 
metabolism 
intermediary 
metabolism and 
respiration 
 
Rv 0669 
 
possible hydrolase 
 
-2.03 
unknown; probable 
involved on cellular 
metabolism 
intermediary 
metabolism and 
respiration 
 
Rv1855c 
 
possible oxidoreductase 
 
-2.02 
unknown; probable 
involved on cellular 
metabolism 
intermediary 
metabolism and 
respiration 
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Rv3705A 
 
conserved hypothetical 
proline rich protein 
 
-2.01 
 
Unknown 
 
conserved 
hypotheticals 
 
Rv1723 
 
probable hydrolase 
-2.01 unknown; probable 
involved on cellular 
metabolism 
intermediary 
metabolism and 
respiration 
 
vapC27 
 
probable toxin vapC27 
 
-2 
 
Unknown 
virulence, 
detoxification, 
adaptation 
 
gid 
Probable glucose-
inhibited division protein 
B Gid 
 
5.1 
 
unknown 
 
cell wall and cell 
proccesses 
 
 
 
 
 
 
 
 
